<!DOCTYPE html>
<html lang="en" class="grade-c">
<head>
    <title>Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator | Scientific Reports</title>
    
        
<link rel="alternate" type="application/rss+xml" href="https://www.nature.com/srep.rss"/>


    

<link rel="preconnect" href="https://cmp.nature.com" crossorigin>

<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="applicable-device" content="pc,mobile">
<meta name="viewport" content="width=device-width,initial-scale=1.0,maximum-scale=5,user-scalable=yes">
<meta name="360-site-verification" content="5a2dc4ab3fcb9b0393241ffbbb490480" />

<script data-test="dataLayer">
    window.dataLayer = [{"content":{"category":{"contentType":"article","legacy":{"webtrendsPrimaryArticleType":"research","webtrendsSubjectTerms":"biochemistry;chemical-biology;chemistry;drug-discovery","webtrendsContentCategory":null,"webtrendsContentCollection":null,"webtrendsContentGroup":"Scientific Reports","webtrendsContentGroupType":null,"webtrendsContentSubGroup":"Article","status":null}},"article":{"doi":"10.1038/s41598-025-03387-9"},"attributes":{"cms":null,"deliveryPlatform":"oscar","copyright":{"open":true,"legacy":{"webtrendsLicenceType":"http://creativecommons.org/licenses/by/4.0/"}}},"contentInfo":{"authors":["Ayman M. Ibrahim","Mai E. Shoman","Radwa Taher Mohie el-dien","Entesar Ali Saber","Mahmoud Abdelnaser","Sherif A. Maher","Alaa M. Hayallah","Mahmoud Abdul-Aziz El-Rehany","Gamal El-Din A. Abuo-Rahma"],"publishedAt":1748736000,"publishedAtString":"2025-06-01","title":"Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator","legacy":null,"publishedAtTime":null,"documentType":"aplusplus","subjects":"Biochemistry,Chemical biology,Chemistry,Drug discovery"},"journal":{"pcode":"srep","title":"scientific reports","volume":"15","issue":"1","id":41598,"publishingModel":"Open Access"},"authorization":{"status":true},"features":[{"name":"furtherReadingSection","present":true}],"collection":null},"page":{"category":{"pageType":"article"},"attributes":{"template":"mosaic","featureFlags":[{"name":"nature-onwards-journey","active":false}],"testGroup":null},"search":null},"privacy":{},"version":"1.0.0","product":null,"session":null,"user":null,"backHalfContent":true,"country":"IN","hasBody":true,"uneditedManuscript":false,"twitterId":["o3xnx","o43y9","o3ef7"],"baiduId":"d38bce82bcb44717ccc29a90c4b781ea","japan":false}];
    window.dataLayer.push({
        ga4MeasurementId: 'G-ERRNTNZ807',
        ga360TrackingId: 'UA-71668177-1',
        twitterId: ['3xnx', 'o43y9', 'o3ef7'],
        baiduId: 'd38bce82bcb44717ccc29a90c4b781ea',
        ga4ServerUrl: 'https://collect.nature.com',
        imprint: 'nature'
    });
</script>

<script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
            d.classList.remove('no-js');
        }
    })(window, document.documentElement);
</script>
 



     
    
    
        
    
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  .c-card--major .c-card__title,.u-h1,.u-h2,h1,h2{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h3,h4,h5,h6{letter-spacing:-.0117156rem}html{line-height:1.15;text-size-adjust:100%;box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}body{background:#eee;color:#222;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.125rem;line-height:1.76;margin:0;min-height:100%}details,main{display:block}h1{font-size:2em;margin:.67em 0}a,sup{vertical-align:baseline}a{background-color:transparent;color:#069;overflow-wrap:break-word;text-decoration:underline;text-decoration-skip-ink:auto;word-break:break-word}b{font-weight:bolder}sup{font-size:75%;line-height:0;position:relative;top:-.5em}img{border:0;height:auto;max-width:100%;vertical-align:middle}button,input,select{font-family:inherit;font-size:100%;line-height:1.15;margin:0}button,input{overflow:visible}button,select{text-transform:none}[type=submit],button{-webkit-appearance:button}[type=checkbox]{box-sizing:border-box;padding:0}summary{display:list-item}[hidden]{display:none}.c-card--major .c-card__title,.u-h1,.u-h2,button,h1,h2{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}button{border-radius:0;cursor:pointer}.c-card--major .c-card__title,.u-h1,.u-h2,h1,h2{font-weight:700}h1{font-size:2rem;letter-spacing:-.0390625rem;line-height:2.25rem}.c-card--major .c-card__title,.u-h2,h2{font-size:1.5rem;letter-spacing:-.0117156rem;line-height:1.6rem}.u-h3{letter-spacing:-.0117156rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-card__title,.c-reading-companion__figure-title,.u-h3,.u-h4,h3,h4,h5,h6{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:700;line-height:1.4rem}.c-article-editorial-summary__container .c-article-editorial-summary__article-title,.c-reading-companion__figure-title,.u-h4,h3,h4,h5,h6{letter-spacing:-.0117156rem}.c-reading-companion__figure-title,.u-h4,h4{font-size:1.125rem}input+label{padding-left:.5em}nav ol,nav ul{list-style:none none}p:empty{display:none}.sans-serif{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.article-page{background:#fff}.c-article-header{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-bottom:40px}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;margin:0 0 8px;padding:0}.c-article-identifiers__item{border-right:1px solid #6f6f6f;list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{border-right:0;margin-right:0;padding-right:0}.c-article-title{font-size:1.5rem;line-height:1.25;margin:0 0 16px}@media only screen and (min-width:768px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list svg{margin-left:4px}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:539px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#069;border-color:transparent;color:#fff}.c-article-info-details{font-size:1rem;margin-bottom:8px;margin-top:16px}.c-article-info-details__cite-as{border-left:1px solid #6f6f6f;margin-left:8px;padding-left:8px}.c-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3}.c-article-metrics-bar__wrapper{margin:16px 0}.c-article-metrics-bar__item{align-items:baseline;border-right:1px solid #6f6f6f;margin-right:8px}.c-article-metrics-bar__item:last-child{border-right:0}.c-article-metrics-bar__count{font-weight:700;margin:0}.c-article-metrics-bar__label{color:#626262;font-style:normal;font-weight:400;margin:0 10px 0 5px}.c-article-metrics-bar__details{margin:0}.c-article-main-column{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;margin-right:8.6%;width:60.2%}@media only screen and (max-width:1023px){.c-article-main-column{margin-right:0;width:100%}}.c-article-extras{float:left;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;width:31.2%}@media only screen and (max-width:1023px){.c-article-extras{display:none}}.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{border-bottom:2px solid #d5d5d5;font-size:1.25rem;margin:0;padding-bottom:8px}@media only screen and (min-width:768px){.c-article-associated-content__container .c-article-associated-content__title,.c-article-section__title{font-size:1.5rem;line-height:1.24}}.c-article-associated-content__container .c-article-associated-content__title{margin-bottom:8px}.c-article-body p{margin-bottom:24px;margin-top:0}.c-article-section{clear:both}.c-article-section__content{margin-bottom:40px;padding-top:8px}@media only screen and (max-width:1023px){.c-article-section__content{padding-left:0}}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-code-block{border:1px solid #eee;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#069;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-editorial-summary__container{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem}.c-article-editorial-summary__container .c-article-editorial-summary__content p:last-child{margin-bottom:0}.c-article-editorial-summary__container .c-article-editorial-summary__content--less{max-height:9.5rem;overflow:hidden}.c-article-editorial-summary__container .c-article-editorial-summary__button{background-color:#fff;border:0;color:#069;font-size:.875rem;margin-bottom:16px}.c-article-editorial-summary__container .c-article-editorial-summary__button.active,.c-article-editorial-summary__container .c-article-editorial-summary__button.hover,.c-article-editorial-summary__container .c-article-editorial-summary__button:active,.c-article-editorial-summary__container .c-article-editorial-summary__button:hover{text-decoration:underline;text-decoration-skip-ink:auto}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-context-bar{box-shadow:0 0 10px 0 rgba(51,51,51,.2);position:relative;width:100%}.c-context-bar__title{display:none}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__sticky{max-width:389px}.c-reading-companion__scroll-pane{margin:0;min-height:200px;overflow:hidden auto}.c-reading-companion__tabs{display:flex;flex-flow:row nowrap;font-size:1rem;list-style:none;margin:0 0 8px;padding:0}.c-reading-companion__tabs>li{flex-grow:1}.c-reading-companion__tab{background-color:#eee;border:1px solid #d5d5d5;border-image:initial;border-left-width:0;color:#069;font-size:1rem;padding:8px 8px 8px 15px;text-align:left;width:100%}.c-reading-companion__tabs li:first-child .c-reading-companion__tab{border-left-width:1px}.c-reading-companion__tab--active{background-color:#fff;border-bottom:1px solid #fff;color:#222;font-weight:700}.c-reading-companion__sections-list{list-style:none;padding:0}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__sections-list{margin:0 0 8px;min-height:50px}.c-reading-companion__section-item{font-size:1rem;padding:0}.c-reading-companion__section-item a{display:block;line-height:1.5;overflow:hidden;padding:8px 0 8px 16px;text-overflow:ellipsis;white-space:nowrap}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:8px 8px 8px 16px}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-reading-companion__figure-full-link svg{height:.8em;margin-left:2px}.c-reading-companion__panel{border-top:none;display:none;margin-top:0;padding-top:0}.c-cod,.c-reading-companion__panel--active{display:block}.c-cod{font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-basis:75%;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#069;border:1px solid #069;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#069}.c-pdf-download__link .u-icon{padding-top:2px}.c-pdf-download{display:flex;margin-bottom:16px;max-height:48px}@media only screen and (min-width:540px){.c-pdf-download{max-height:none}}@media only screen and (min-width:1024px){.c-pdf-download{max-height:48px}}.c-pdf-download__link{display:flex;flex:1 1 0%}.c-pdf-download__link:hover{text-decoration:none}.c-pdf-download__text{padding-right:4px}@media only screen and (max-width:539px){.c-pdf-download__text{text-transform:capitalize}}@media only screen and (min-width:540px){.c-pdf-download__text{padding-right:8px}}.c-context-bar--sticky .c-pdf-download{display:block;margin-bottom:0;white-space:nowrap}@media only screen and (max-width:539px){.c-pdf-download .u-sticky-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}}.c-pdf-container{display:flex;justify-content:flex-end}@media only screen and (max-width:539px){.c-pdf-container .c-pdf-download{display:flex;flex-basis:100%}}.c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:16px}.c-article-extras .c-pdf-container .c-pdf-download{width:100%}.c-article-extras .c-pdf-container .c-pdf-download+.c-pdf-download{margin-left:0}@media only screen and (min-width:540px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:none}@media only screen and (max-width:1023px){.article-page--commercial .c-article-main-column .c-pdf-button__container .c-pdf-download{display:block}}.c-recommendations-column-switch .c-meta{margin-top:auto}.c-article-recommendations-card__meta-type,.c-meta .c-meta__item:first-child{font-weight:700}.c-article-metrics__heading a,.c-article-metrics__posts .c-card__title a{color:inherit}.c-article-metrics__posts .c-card__title{font-size:1.05rem}.c-article-metrics__posts .c-card__title+span{color:#6f6f6f;font-size:1rem}p{overflow-wrap:break-word;word-break:break-word}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad__label{color:#333;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.app-author-list{color:#6f6f6f;font-family:inherit;font-size:1rem;line-height:inherit;list-style:none;margin:0;padding:0}.app-author-list>li,.c-breadcrumbs>li,.c-footer__links>li,.js .app-author-list,.u-list-comma-separated>li,.u-list-inline>li{display:inline}.app-author-list>li:not(:first-child):not(:last-child):before{content:", "}.app-author-list>li:not(:only-child):last-child:before{content:" & "}.app-author-list--compact{font-size:.875rem;line-height:1.4}.app-author-list--truncated>li:not(:only-child):last-child:before{content:" ... "}.js .app-author-list__hide{display:none;visibility:hidden}.js .app-author-list__hide:first-child+*{margin-block-start:0}.c-meta{color:inherit;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;list-style:none;margin:0;padding:0}.c-meta--large{font-size:1rem}.c-meta--large .c-meta__item{margin-bottom:8px}.c-meta__item{display:inline-block;margin-bottom:4px}.c-meta__item:not(:last-child){border-right:1px solid #d5d5d5;margin-right:4px;padding-right:4px}@media only screen and (max-width:539px){.c-meta__item--block-sm-max{display:block}.c-meta__item--block-sm-max:not(:last-child){border-right:none;margin-right:0;padding-right:0}}@media only screen and (min-width:1024px){.c-meta__item--block-at-lg{display:block}.c-meta__item--block-at-lg:not(:last-child){border-right:none;margin-right:0;padding-right:0}}.c-meta__type{font-weight:700;text-transform:none}.c-skip-link{background:#069;bottom:auto;color:#fff;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#fff}.c-status-message{align-items:center;box-sizing:border-box;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;position:relative;width:100%}.c-card__summary>p:last-child,.c-status-message :last-child{margin-bottom:0}.c-status-message--boxed{background-color:#fff;border:1px solid #eee;border-radius:2px;line-height:1.4;padding:16px}.c-status-message__heading{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-breadcrumbs{color:#000;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs__link{color:#666}svg.c-breadcrumbs__chevron{margin:4px 4px 0;fill:#888;height:10px;width:10px}@media only screen and (max-width:539px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-card{background-color:transparent;border:0;box-shadow:none;display:flex;flex-direction:column;font-size:14px;min-width:0;overflow:hidden;padding:0;position:relative}.c-card--no-shape{background:0 0;border:0;box-shadow:none}.c-card__image{display:flex;justify-content:center;overflow:hidden;padding-bottom:56.25%;position:relative}@supports (aspect-ratio:1/1){.c-card__image{padding-bottom:0}}.c-card__image img{left:0;min-height:100%;min-width:100%;position:absolute}@supports ((-o-object-fit:cover) or (object-fit:cover)){.c-card__image img{height:100%;object-fit:cover;width:100%}}.c-card__body{flex:1 1 auto;padding:16px}.c-card--no-shape .c-card__body{padding:0}.c-card--no-shape .c-card__body:not(:first-child){padding-top:16px}.c-card__title{letter-spacing:-.01875rem;margin-bottom:8px;margin-top:0}[lang=de] .c-card__title{hyphens:auto}.c-card__summary{line-height:1.4}.c-card__summary>p{margin-bottom:5px}.c-card__summary a{text-decoration:underline}.c-card__link:not(.c-card__link--no-block-link):before{bottom:0;content:"";left:0;position:absolute;right:0;top:0}.c-card--flush .c-card__body{padding:0}.c-card--major{font-size:1rem}.c-card--dark{background-color:#29303c;border-width:0;color:#e3e4e5}.c-card--dark .c-card__title{color:#fff}.c-card--dark .c-card__link,.c-card--dark .c-card__summary a{color:inherit}.c-header{background-color:#fff;border-bottom:5px solid #000;font-size:1rem;line-height:1.4;margin-bottom:16px}.c-header__row{padding:0;position:relative}.c-header__row:not(:last-child){border-bottom:1px solid #eee}.c-header__split{align-items:center;display:flex;justify-content:space-between}.c-header__logo-container{flex:1 1 0px;line-height:0;margin:8px 24px 8px 0}.c-header__logo{transform:translateZ(0)}.c-header__logo img{max-height:32px}.c-header__container{margin:0 auto;max-width:1280px}.c-header__menu{align-items:center;display:flex;flex:0 1 auto;flex-wrap:wrap;font-weight:700;gap:8px 8px;line-height:1.4;list-style:none;margin:0 -8px;padding:0}@media print{.c-header__menu{display:none}}@media only screen and (max-width:1023px){.c-header__menu--hide-lg-max{display:none;visibility:hidden}}.c-header__menu--global{font-weight:400;justify-content:flex-end}.c-header__menu--global svg{display:none;visibility:hidden}.c-header__menu--global svg:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__menu--global svg{display:block;visibility:visible}}.c-header__menu--journal{font-size:.875rem;margin:8px 0 8px -8px}@media only screen and (min-width:540px){.c-header__menu--journal{flex-wrap:nowrap;font-size:1rem}}.c-header__item{padding-bottom:0;padding-top:0;position:static}.c-header__item--pipe{border-left:2px solid #eee;padding-left:8px}.c-header__item--padding{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-header__item--dropdown-menu{position:relative}}@media only screen and (min-width:1024px){.c-header__item--hide-lg{display:none;visibility:hidden}}@media only screen and (max-width:767px){.c-header__item--hide-md-max{display:none;visibility:hidden}.c-header__item--hide-md-max:first-child+*{margin-block-start:0}}.c-header__link{align-items:center;color:inherit;display:inline-flex;gap:4px 4px;padding:8px;white-space:nowrap}.c-header__link svg{transition-duration:.2s}.c-header__show-text{display:none;visibility:hidden}.has-tethered .c-header__heading--js-hide:first-child+*{margin-block-start:0}@media only screen and (min-width:540px){.c-header__show-text{display:inline;visibility:visible}}.c-header__dropdown{background-color:#000;border-bottom:1px solid #2f2f2f;color:#eee;font-size:.875rem;line-height:1.2;padding:16px 0}@media print{.c-header__dropdown{display:none}}.c-header__heading{display:inline-block;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1.25rem;font-weight:400;line-height:1.4;margin-bottom:8px}.c-header__heading--keyline{border-top:1px solid;border-color:#2f2f2f;margin-top:16px;padding-top:16px;width:100%}.c-header__list{display:flex;flex-wrap:wrap;gap:0 16px;list-style:none;margin:0 -8px}.c-header__flush{margin:0 -8px}.c-header__visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}.c-header__search-form{margin-bottom:8px}.c-header__search-layout{display:flex;flex-wrap:wrap;gap:16px 16px}.c-header__search-layout>:first-child{flex:999 1 auto}.c-header__search-layout>*{flex:1 1 auto}.c-header__search-layout--max-width{max-width:720px}.c-header__search-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #fff;border-radius:2px;color:#fff;cursor:pointer;display:flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.15;margin:0;padding:8px 16px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:100%}.u-button svg,.u-button--primary svg{fill:currentcolor}.c-header__input,.c-header__select{border:1px solid;border-radius:3px;box-sizing:border-box;font-size:1rem;padding:8px 16px;width:100%}.c-header__select{-webkit-appearance:none;background-image:url("data:image/svg+xml,%3Csvg height='16' viewBox='0 0 16 16' width='16' xmlns='http://www.w3.org/2000/svg'%3E%3Cpath d='m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z' fill='%23333' fill-rule='evenodd' transform='matrix(0 1 -1 0 11 3)'/%3E%3C/svg%3E");background-position:right .7em top 50%;background-repeat:no-repeat;background-size:1em;box-shadow:0 1px 0 1px rgba(0,0,0,.04);display:block;margin:0;max-width:100%;min-width:150px}@media only screen and (min-width:540px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:auto;right:0}}@media only screen and (min-width:768px){.c-header__menu--journal .c-header__item--dropdown-menu:last-child .c-header__dropdown.has-tethered{left:0;right:auto}}.c-header__dropdown.has-tethered{border-bottom:0;border-radius:0 0 2px 2px;left:0;position:absolute;top:100%;transform:translateY(5px);width:100%;z-index:1}@media only screen and (min-width:540px){.c-header__dropdown.has-tethered{transform:translateY(8px);width:auto}}@media only screen and (min-width:768px){.c-header__dropdown.has-tethered{min-width:225px}}.c-header__dropdown--full-width.has-tethered{padding:32px 0 24px;transform:none;width:100%}.has-tethered .c-header__heading--js-hide{display:none;visibility:hidden}.has-tethered .c-header__list--js-stack{flex-direction:column}.has-tethered .c-header__item--keyline,.has-tethered .c-header__list~.c-header__list .c-header__item:first-child{border-top:1px solid #d5d5d5;margin-top:8px;padding-top:8px}.c-header__item--snid-account-widget{display:flex}.c-header__container{padding:0 4px}.c-header__list{padding:0 12px}.c-header__menu .c-header__link{font-size:14px}.c-header__item--snid-account-widget .c-header__link{padding:8px}.c-header__menu--journal{margin-left:0}@media only screen and (min-width:540px){.c-header__container{padding:0 16px}.c-header__menu--journal{margin-left:-8px}.c-header__menu .c-header__link{font-size:16px}.c-header__link--search{gap:13px 13px}}.u-button{align-items:center;background-color:transparent;background-image:none;border:1px solid #069;border-radius:2px;color:#069;cursor:pointer;display:inline-flex;font-family:sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button--primary{background-color:#069;background-image:none;border:1px solid #069;color:#fff}.u-button--full-width{display:flex;width:100%}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-hide:first-child+*{margin-block-start:0}.u-visually-hidden{border:0;clip:rect(0,0,0,0);height:1px;margin:-100%;overflow:hidden;padding:0;position:absolute!important;width:1px}@media print{.u-hide-print{display:none}}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}.u-hide-at-lg:first-child+*{margin-block-start:0}}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-color-open-access{color:#b74616}.u-float-left{float:left}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-full-height{height:100%}.u-link-inherit{color:inherit}.u-list-reset{list-style:none;margin:0;padding:0}.u-text-bold{font-weight:700}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-16{margin-bottom:16px}.u-mb-24{margin-bottom:24px}.u-mb-32{margin-bottom:32px}.c-nature-box svg+.c-article__button-text,.u-ml-8{margin-left:8px}.u-pa-16{padding:16px}html *,html :after,html :before{box-sizing:inherit}.c-article-section__title,.c-article-title{font-weight:700}.c-card__title{line-height:1.4em}.c-article__button{background-color:#069;border:1px solid #069;border-radius:2px;color:#fff;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem;line-height:1.4;margin-bottom:16px;padding:13px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-article__button,.c-article__button:hover{text-decoration:none}.c-article__button--inverted,.c-article__button:hover{background-color:#fff;color:#069}.c-article__button--inverted:hover{background-color:#069;color:#fff}.c-header__link{text-decoration:inherit}.grade-c-hide{display:block}.c-nature-box{background-color:#fff;border:1px solid #d5d5d5;border-radius:2px;box-shadow:0 0 5px 0 rgba(51,51,51,.1);line-height:1.3;margin-bottom:24px;padding:16px 16px 3px}.c-nature-box__text{font-size:1rem;margin-bottom:16px}.c-nature-box--access-to-pdf{display:none}@media only screen and (min-width:1024px){.c-nature-box--mobile{display:none}}.c-nature-box .c-pdf-download{margin-bottom:16px!important}.c-nature-box--version{background-color:#eee}.c-nature-box__wrapper{transform:translateZ(0)}.c-nature-box__wrapper--placeholder{min-height:165px}.c-pdf-download__link{padding:13px 24px} } </style>




    
        <link data-test="critical-css-handler" data-inline-css-source="critical-css" rel="stylesheet" href="/static/css/enhanced-article-5f1e651687.css" media="print" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null">
    
    <noscript>
        <link rel="stylesheet" type="text/css" href="/static/css/enhanced-article-5f1e651687.css" media="only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)">
    </noscript>

<link rel="stylesheet" type="text/css" href="/static/css/article-print-c9121fecab.css" media="print">
    



<link rel="apple-touch-icon" sizes="180x180" href=/static/images/favicons/nature/apple-touch-icon-f39cb19454.png>
<link rel="icon" type="image/png" sizes="48x48" href=/static/images/favicons/nature/favicon-48x48-b52890008c.png>
<link rel="icon" type="image/png" sizes="32x32" href=/static/images/favicons/nature/favicon-32x32-3fe59ece92.png>
<link rel="icon" type="image/png" sizes="16x16" href=/static/images/favicons/nature/favicon-16x16-951651ab72.png>
<link rel="manifest" href=/static/manifest.json crossorigin="use-credentials">
<link rel="mask-icon" href=/static/images/favicons/nature/safari-pinned-tab-69bff48fe6.svg color="#000000">
<link rel="shortcut icon" href=/static/images/favicons/nature/favicon.ico>
<meta name="msapplication-TileColor" content="#000000">
<meta name="msapplication-config" content=/static/browserconfig.xml>
<meta name="theme-color" content="#000000">
<meta name="application-name" content="Nature">


<script>
    (function () {
        if ( typeof window.CustomEvent === "function" ) return false;
        function CustomEvent ( event, params ) {
            params = params || { bubbles: false, cancelable: false, detail: null };
            var evt = document.createEvent( 'CustomEvent' );
            evt.initCustomEvent( event, params.bubbles, params.cancelable, params.detail );
            return evt;
        }

        CustomEvent.prototype = window.Event.prototype;

        window.CustomEvent = CustomEvent;
    })();
</script>



<!-- Google Tag Manager -->
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                        j = d.createElement(s),
                        dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>
<!-- End Google Tag Manager -->

    <script>
    (function(w,d,t) {
        function cc() {
            var h = w.location.hostname;
            if (h.indexOf('preview-www.nature.com') > -1) return;

            var e = d.createElement(t),
                    s = d.getElementsByTagName(t)[0];

            if (h.indexOf('nature.com') > -1) {
                if (h.indexOf('test-www.nature.com') > -1) {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                } else {
                    e.src = 'https://cmp.nature.com/production_live/en/consent-bundle-8-85.js';
                    e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
                }
            } else {
                e.src = '/static/js/cookie-consent-es5-bundle-cb57c2c98a.js';
                e.setAttribute('data-consent', h);
            }
            s.insertAdjacentElement('afterend', e);
        }

        cc();
    })(window,document,'script');
</script>


<script id="js-position0">
    (function(w, d) {
        w.idpVerifyPrefix = 'https://verify.nature.com';
        w.ra21Host = 'https://wayf.springernature.com';
        var moduleSupport = (function() {
            return 'noModule' in d.createElement('script');
        })();

        if (w.config.mustardcut === true) {
            w.loader = {
                index: 0,
                registered: [],
                scripts: [
                    
                        {src: '/static/js/global-article-es6-bundle-c8a573ca90.js', test: 'global-article-js', module: true},
                        {src: '/static/js/global-article-es5-bundle-d17603b9e9.js', test: 'global-article-js', nomodule: true},
                        {src: '/static/js/shared-es6-bundle-d2e878d982.js', test: 'shared-js', module: true},
                        {src: '/static/js/shared-es5-bundle-9638c44580.js', test: 'shared-js', nomodule: true},
                        {src: '/static/js/header-150-es6-bundle-5bb959eaa1.js', test: 'header-150-js', module: true},
                        {src: '/static/js/header-150-es5-bundle-994fde5b1d.js', test: 'header-150-js', nomodule: true}
                    
                ].filter(function (s) {
                    if (s.src === null) return false;
                    if (moduleSupport && s.nomodule) return false;
                    return !(!moduleSupport && s.module);
                }),

                register: function (value) {
                    this.registered.push(value);
                },

                ready: function () {
                    if (this.registered.length === this.scripts.length) {
                        this.registered.forEach(function (fn) {
                            if (typeof fn === 'function') {
                                setTimeout(fn, 0); 
                            }
                        });
                        this.ready = function () {};
                    }
                },

                insert: function (s) {
                    var t = d.getElementById('js-position' + this.index);
                    if (t && t.insertAdjacentElement) {
                        t.insertAdjacentElement('afterend', s);
                    } else {
                        d.head.appendChild(s);
                    }
                    ++this.index;
                },

                createScript: function (script, beforeLoad) {
                    var s = d.createElement('script');
                    s.id = 'js-position' + (this.index + 1);
                    s.setAttribute('data-test', script.test);
                    if (beforeLoad) {
                        s.defer = 'defer';
                        s.onload = function () {
                            if (script.noinit) {
                                loader.register(true);
                            }
                            if (d.readyState === 'interactive' || d.readyState === 'complete') {
                                loader.ready();
                            }
                        };
                    } else {
                        s.async = 'async';
                    }
                    s.src = script.src;
                    return s;
                },

                init: function () {
                    this.scripts.forEach(function (s) {
                        loader.insert(loader.createScript(s, true));
                    });

                    d.addEventListener('DOMContentLoaded', function () {
                        loader.ready();
                        var conditionalScripts;
                        
                            conditionalScripts = [
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es6-bundle-464a2af269.js', test: 'pan-zoom-js',  module: true },
                                {match: 'div[data-pan-container]', src: '/static/js/pan-zoom-es5-bundle-98fb9b653b.js', test: 'pan-zoom-js',  nomodule: true },
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es6-bundle-23597ae350.js', test: 'math-js', module: true},
                                {match: 'math,span.mathjax-tex', src: '/static/js/math-es5-bundle-6532c6f78b.js', test: 'math-js', nomodule: true}
                            ];
                        

                        if (conditionalScripts) {
                            conditionalScripts.filter(function (script) {
                                return !!document.querySelector(script.match) && !((moduleSupport && script.nomodule) || (!moduleSupport && script.module));
                            }).forEach(function (script) {
                                loader.insert(loader.createScript(script));
                            });
                        }
                    }, false);
                }
            };
            loader.init();
        }
    })(window, document);
</script>










<meta name="robots" content="noarchive">
<meta name="access" content="Yes">


<link rel="search" href="https://www.nature.com/search">
<link rel="search" href="https://www.nature.com/opensearch/opensearch.xml" type="application/opensearchdescription+xml" title="nature.com">
<link rel="search" href="https://www.nature.com/opensearch/request" type="application/sru+xml" title="nature.com">





    
    <script type="application/ld+json">{"mainEntity":{"headline":"Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator","description":"Peroxisome proliferator-activated receptor γ (PPARγ) remains a critical target for antidiabetic drug development due to its role in glucose and lipid metabolism. However, the adverse effects associated with full agonists of the thiazolidinedione (TZD) class, such as weight gain and hepatotoxicity, limit their clinical utility. Herein, we report the design and synthesis of (Z)-5-benzylidene-3-((2-chloroquinolin-3-yl)methyl)thiazolidine-2,4-dione (compound 7), a novel TZD derivative that functions as a potential PPARγ modulator. Compound 7 reduced blood glucose level (BGL) by 22.33% after 15 days of treatment with a daily single oral dose, demonstrating an antidiabetic effect comparable to TZDs. Additionally, it elevated PPARγ expression to 75% of the activation level induced by Pioglitazone (PIO). Further characterization of its safety profile reveals that compound 7 is safer on the liver compared to PIO, as alanine transaminase (ALT) and aspartate transaminase (AST) levels remained significantly lower (147.4 ± 4.2 IU/L and 229.9 ± 2.7 IU/L, respectively). Moreover, compound 7 exerts a protective effect on hepatic and pancreatic tissues. Computational metabolic studies predict that compound 7 does not produce toxic metabolites or undergo hydrolysis of the TZD ring, contributing to its improved safety. The docking of Compound 7 into the PPARγ ligand-binding domain (LBD) demonstrates a unique binding mode, positioning it centrally within the LBD and interacting with key amino acids critical for selective modulation. These findings emphasize the potential of compound 7 as a selective PPARγ modulator to dissociate insulin-sensitizing effects from adverse side effects, offering a safer alternative to current TZD-based therapies.","datePublished":"2025-06-01T00:00:00Z","dateModified":"2025-06-01T00:00:00Z","pageStart":"1","pageEnd":"19","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1038/s41598-025-03387-9","keywords":["Biochemistry","Chemical biology","Chemistry","Drug discovery","Quinoline","Thiazolidinedione","PPARγ","Antidiabetic","SPPARMs","Science","Humanities and Social Sciences","multidisciplinary"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig1_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig2_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig3_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig4_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig5_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig6_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig7_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig8_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig9_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig10_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig11_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig12_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig13_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig14_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig15_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig16_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig17_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig18_HTML.png"],"isPartOf":{"name":"Scientific Reports","issn":["2045-2322"],"volumeNumber":"15","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Nature Publishing Group UK","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Ayman M. Ibrahim","affiliation":[{"name":"Deraya University","address":{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Mai E. Shoman","affiliation":[{"name":"Minia University","address":{"name":"Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Radwa Taher Mohie el-dien","affiliation":[{"name":"New Valley University","address":{"name":"Department of Pharmacognosy, Faculty of Pharmacy, New Valley University, El-kharga City, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Entesar Ali Saber","affiliation":[{"name":"Deraya University","address":{"name":"Department of Medical science, Histology and Cell Biology, Faculty of Pharmacy, Deraya University, New Minia, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Mahmoud Abdelnaser","affiliation":[{"name":"Deraya University","address":{"name":"Department of Biochemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Sherif A. Maher","affiliation":[{"name":"New Valley University","address":{"name":"Department of Biochemistry, Faculty of pharmacy, New Valley University, El-kharga City, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Alaa M. Hayallah","affiliation":[{"name":"Assiut University","address":{"name":"Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt","@type":"PostalAddress"},"@type":"Organization"},{"name":"Sphinx University","address":{"name":"Pharmaceutical Chemistry Department, Faculty of Pharmacy, Sphinx University, New Assiut, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"email":"alaa_hayalah@yahoo.com","@type":"Person"},{"name":"Mahmoud Abdul-Aziz El-Rehany","affiliation":[{"name":"Deraya University","address":{"name":"Department of Biochemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Gamal El-Din A. Abuo-Rahma","affiliation":[{"name":"Deraya University","address":{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt","@type":"PostalAddress"},"@type":"Organization"},{"name":"Minia University","address":{"name":"Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, Egypt","@type":"PostalAddress"},"@type":"Organization"}],"email":"gamal.aborahma@mu.edu.eg","@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>




    
    
    


    
    <link rel="canonical" href="https://www.nature.com/articles/s41598-025-03387-9">
    
    
    <meta name="journal_id" content="41598"/>
    <meta name="dc.title" content="Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator"/>
    <meta name="dc.source" content="Scientific Reports 2025 15:1"/>
    <meta name="dc.format" content="text/html"/>
    <meta name="dc.publisher" content="Nature Publishing Group"/>
    <meta name="dc.date" content="2025-06-01"/>
    <meta name="dc.type" content="OriginalPaper"/>
    <meta name="dc.language" content="En"/>
    <meta name="dc.copyright" content="2025 The Author(s)"/>
    <meta name="dc.rights" content="2025 The Author(s)"/>
    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com"/>
    <meta name="dc.description" content="Peroxisome proliferator-activated receptor &#947; (PPAR&#947;) remains a critical target for antidiabetic drug development due to its role in glucose and lipid metabolism. However, the adverse effects associated with full agonists of the thiazolidinedione (TZD) class, such as weight gain and hepatotoxicity, limit their clinical utility. Herein, we report the design and synthesis of (Z)-5-benzylidene-3-((2-chloroquinolin-3-yl)methyl)thiazolidine-2,4-dione (compound 7), a novel TZD derivative that functions as a potential PPAR&#947; modulator. Compound 7 reduced blood glucose level (BGL) by 22.33% after 15 days of treatment with a daily single oral dose, demonstrating an antidiabetic effect comparable to TZDs. Additionally, it elevated PPAR&#947; expression to 75% of the activation level induced by Pioglitazone (PIO). Further characterization of its safety profile reveals that compound 7 is safer on the liver compared to PIO, as alanine transaminase (ALT) and aspartate transaminase (AST) levels remained significantly lower (147.4&#8201;&#177;&#8201;4.2 IU/L and 229.9&#8201;&#177;&#8201;2.7 IU/L, respectively). Moreover, compound 7 exerts a protective effect on hepatic and pancreatic tissues. Computational metabolic studies predict that compound 7 does not produce toxic metabolites or undergo hydrolysis of the TZD ring, contributing to its improved safety. The docking of Compound 7 into the PPAR&#947; ligand-binding domain (LBD) demonstrates a unique binding mode, positioning it centrally within the LBD and interacting with key amino acids critical for selective modulation. These findings emphasize the potential of compound 7 as a selective PPAR&#947; modulator to dissociate insulin-sensitizing effects from adverse side effects, offering a safer alternative to current TZD-based therapies."/>
    <meta name="prism.issn" content="2045-2322"/>
    <meta name="prism.publicationName" content="Scientific Reports"/>
    <meta name="prism.publicationDate" content="2025-06-01"/>
    <meta name="prism.volume" content="15"/>
    <meta name="prism.number" content="1"/>
    <meta name="prism.section" content="OriginalPaper"/>
    <meta name="prism.startingPage" content="1"/>
    <meta name="prism.endingPage" content="19"/>
    <meta name="prism.copyright" content="2025 The Author(s)"/>
    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com"/>
    <meta name="prism.url" content="https://www.nature.com/articles/s41598-025-03387-9"/>
    <meta name="prism.doi" content="doi:10.1038/s41598-025-03387-9"/>
    <meta name="citation_pdf_url" content="https://www.nature.com/articles/s41598-025-03387-9.pdf"/>
    <meta name="citation_fulltext_html_url" content="https://www.nature.com/articles/s41598-025-03387-9"/>
    <meta name="citation_journal_title" content="Scientific Reports"/>
    <meta name="citation_journal_abbrev" content="Sci Rep"/>
    <meta name="citation_publisher" content="Nature Publishing Group"/>
    <meta name="citation_issn" content="2045-2322"/>
    <meta name="citation_title" content="Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator"/>
    <meta name="citation_volume" content="15"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_online_date" content="2025/06/01"/>
    <meta name="citation_firstpage" content="1"/>
    <meta name="citation_lastpage" content="19"/>
    <meta name="citation_article_type" content="Article"/>
    <meta name="citation_fulltext_world_readable" content=""/>
    <meta name="citation_language" content="en"/>
    <meta name="dc.identifier" content="doi:10.1038/s41598-025-03387-9"/>
    <meta name="DOI" content="10.1038/s41598-025-03387-9"/>
    <meta name="size" content="182571"/>
    <meta name="citation_doi" content="10.1038/s41598-025-03387-9"/>
    <meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1038/s41598-025-03387-9&amp;api_key="/>
    <meta name="description" content="Peroxisome proliferator-activated receptor &#947; (PPAR&#947;) remains a critical target for antidiabetic drug development due to its role in glucose and lipid metabolism. However, the adverse effects associated with full agonists of the thiazolidinedione (TZD) class, such as weight gain and hepatotoxicity, limit their clinical utility. Herein, we report the design and synthesis of (Z)-5-benzylidene-3-((2-chloroquinolin-3-yl)methyl)thiazolidine-2,4-dione (compound 7), a novel TZD derivative that functions as a potential PPAR&#947; modulator. Compound 7 reduced blood glucose level (BGL) by 22.33% after 15 days of treatment with a daily single oral dose, demonstrating an antidiabetic effect comparable to TZDs. Additionally, it elevated PPAR&#947; expression to 75% of the activation level induced by Pioglitazone (PIO). Further characterization of its safety profile reveals that compound 7 is safer on the liver compared to PIO, as alanine transaminase (ALT) and aspartate transaminase (AST) levels remained significantly lower (147.4&#8201;&#177;&#8201;4.2 IU/L and 229.9&#8201;&#177;&#8201;2.7 IU/L, respectively). Moreover, compound 7 exerts a protective effect on hepatic and pancreatic tissues. Computational metabolic studies predict that compound 7 does not produce toxic metabolites or undergo hydrolysis of the TZD ring, contributing to its improved safety. The docking of Compound 7 into the PPAR&#947; ligand-binding domain (LBD) demonstrates a unique binding mode, positioning it centrally within the LBD and interacting with key amino acids critical for selective modulation. These findings emphasize the potential of compound 7 as a selective PPAR&#947; modulator to dissociate insulin-sensitizing effects from adverse side effects, offering a safer alternative to current TZD-based therapies."/>
    <meta name="dc.creator" content="Ibrahim, Ayman M."/>
    <meta name="dc.creator" content="Shoman, Mai E."/>
    <meta name="dc.creator" content="el-dien, Radwa Taher Mohie"/>
    <meta name="dc.creator" content="Saber, Entesar Ali"/>
    <meta name="dc.creator" content="Abdelnaser, Mahmoud"/>
    <meta name="dc.creator" content="Maher, Sherif A."/>
    <meta name="dc.creator" content="Hayallah, Alaa M."/>
    <meta name="dc.creator" content="El-Rehany, Mahmoud Abdul-Aziz"/>
    <meta name="dc.creator" content="Abuo-Rahma, Gamal El-Din A."/>
    <meta name="dc.subject" content="Biochemistry"/>
    <meta name="dc.subject" content="Chemical biology"/>
    <meta name="dc.subject" content="Chemistry"/>
    <meta name="dc.subject" content="Drug discovery"/>
    <meta name="citation_reference" content="citation_journal_title=Nat. Rev. Dis. Primers; citation_title=Type 2 diabetes mellitus; citation_author=RA DeFronzo; citation_volume=1; citation_publication_date=2015; citation_pages=15019; citation_doi=10.1038/nrdp.2015.19; citation_id=CR1"/>
    <meta name="citation_reference" content="citation_journal_title=N. Engl. J. Med.; citation_title=Thiazolidinediones; citation_author=H Yki-J&#228;rvinen; citation_volume=351; citation_publication_date=2004; citation_pages=1106-1118; citation_doi=10.1056/NEJMra041001; citation_id=CR2"/>
    <meta name="citation_reference" content="citation_journal_title=Curr. Diab Rep.; citation_title=The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus; citation_author=H Yau, K Rivera, R Lomonaco, K Cusi; citation_volume=13; citation_publication_date=2013; citation_pages=329-341; citation_doi=10.1007/s11892-013-0378-8; citation_id=CR3"/>
    <meta name="citation_reference" content="citation_journal_title=N Engl. J. Med.; citation_title=Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy; citation_author=SE Kahn; citation_volume=355; citation_publication_date=2006; citation_pages=2427-2443; citation_doi=10.1056/NEJMoa066224; citation_id=CR4"/>
    <meta name="citation_reference" content="citation_journal_title=Cell. Metab.; citation_title=Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes; citation_author=RE Soccio, ER Chen, MA Lazar; citation_volume=20; citation_publication_date=2014; citation_pages=573-591; citation_doi=10.1016/j.cmet.2014.08.005; citation_id=CR5"/>
    <meta name="citation_reference" content="citation_journal_title=J. Adv. Res.; citation_title=An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes; citation_author=G Bansal, PV Thanikachalam, RK Maurya, P Chawla, S Ramamurthy; citation_volume=23; citation_publication_date=2020; citation_pages=163-205; citation_doi=10.1016/j.jare.2020.01.008; citation_id=CR6"/>
    <meta name="citation_reference" content="citation_journal_title=Nat. Med.; citation_title=PPAR&#947; signaling and metabolism: the good, the bad and the future; citation_author=M Ahmadian; citation_volume=19; citation_publication_date=2013; citation_pages=557-566; citation_doi=10.1038/nm.3159; citation_id=CR7"/>
    <meta name="citation_reference" content="citation_journal_title=J. Biol. Chem.; citation_title=PPAR&#947;: A nuclear regulator of metabolism, differentiation, and cell growth; citation_author=ED Rosen, BM Spiegelman; citation_volume=276; citation_publication_date=2001; citation_pages=37731-37734; citation_doi=10.1074/jbc.R100034200; citation_id=CR8"/>
    <meta name="citation_reference" content="citation_journal_title=Cell; citation_title=The RXR heterodimers and orphan receptors; citation_author=DJ Mangelsdorf, RM Evans; citation_volume=83; citation_publication_date=1995; citation_pages=841-850; citation_doi=10.1016/0092-8674(95)90200-7; citation_id=CR9"/>
    <meta name="citation_reference" content="citation_journal_title=Biochim. Biophys. Acta; citation_title=The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation; citation_author=K Schoonjans, B Staels, J Auwerx; citation_volume=1302; citation_publication_date=1996; citation_pages=93-109; citation_doi=10.1016/0005-2760(96)00066-5; citation_id=CR10"/>
    <meta name="citation_reference" content="citation_journal_title=Diabetes; citation_title=Thiazolidinediones in the treatment of insulin resistance and type II diabetes; citation_author=AR Saltiel, JM Olefsky; citation_volume=45; citation_publication_date=1996; citation_pages=1661-1669; citation_doi=10.2337/diab.45.12.1661; citation_id=CR11"/>
    <meta name="citation_reference" content="citation_journal_title=Nature; citation_title=Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma; citation_author=RT Nolte; citation_volume=395; citation_publication_date=1998; citation_pages=137-143; citation_doi=10.1038/25931; citation_id=CR12"/>
    <meta name="citation_reference" content="citation_journal_title=JAMA; citation_title=Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials; citation_author=AM Lincoff, K Wolski, SJ Nicholls, SE Nissen; citation_volume=298; citation_publication_date=2007; citation_pages=1180-1188; citation_doi=10.1001/jama.298.10.1180; citation_id=CR13"/>
    <meta name="citation_reference" content="citation_journal_title=Cancer Med.; citation_title=Pioglitazone and bladder cancer risk: a systematic review and meta-analysis; citation_author=H Tang; citation_volume=7; citation_publication_date=2018; citation_pages=1070-1080; citation_doi=10.1002/cam4.1354; citation_id=CR14"/>
    <meta name="citation_reference" content="Tuccori, M. et al. Pioglitazone use and risk of bladder cancer: population based cohort study. BMJ. 352 (2016)."/>
    <meta name="citation_reference" content="citation_journal_title=Biochim. Et Biophys. Acta (BBA) - Mol. Cell. Biology Lipids; citation_title=Molecular basis of selective PPAR&#947; modulation for the treatment of type 2 diabetes; citation_author=L Gelman, JN Feige, B Desvergne; citation_volume=1771; citation_publication_date=2007; citation_pages=1094-1107; citation_id=CR16"/>
    <meta name="citation_reference" content="citation_journal_title=Am. J. Clin. Nutr.; citation_title=Selective peroxisome proliferator-activated receptor &#947; (PPAR&#947;) modulation as a strategy for safer therapeutic PPAR&#947; activation; citation_author=LS Higgins, AM Depaoli; citation_volume=91; citation_publication_date=2010; citation_pages=267S-270S; citation_doi=10.3945/ajcn.2009.28449E; citation_id=CR17"/>
    <meta name="citation_reference" content="citation_journal_title=J. Mol. Biol.; citation_title=INT131: a selective modulator of PPAR gamma; citation_author=A Motani; citation_volume=386; citation_publication_date=2009; citation_pages=1301-1311; citation_doi=10.1016/j.jmb.2009.01.025; citation_id=CR18"/>
    <meta name="citation_reference" content="citation_journal_title=J. Phys. Chem. A; citation_title=S-oxidation of thiazolidinedione with hydrogen peroxide, peroxynitrous acid, and c4a-hydroperoxyflavin: A theoretical study; citation_author=N Taxak, V Parmar, DS Patel, A Kotasthane, PV Bharatam; citation_volume=115; citation_publication_date=2011; citation_pages=891-898; citation_doi=10.1021/jp109935k; citation_id=CR19"/>
    <meta name="citation_reference" content="citation_journal_title=Drug Metab. Dispos.; citation_title=New poglitazone metabolites and absence of opened-ring metabolites in new N-substituted thiazolidinedione; citation_author=ML Campos; citation_volume=46; citation_publication_date=2018; citation_pages=879-887; citation_doi=10.1124/dmd.117.079012; citation_id=CR20"/>
    <meta name="citation_reference" content="citation_journal_title=RSC Adv.; citation_title=Molecular targets and anticancer activity of quinoline&#8211;chalcone hybrids: literature review; citation_author=MFA Mohamed, GEDA Abuo-Rahma; citation_volume=10; citation_publication_date=2020; citation_pages=31139-31155; citation_doi=10.1039/D0RA05594H; citation_id=CR21"/>
    <meta name="citation_reference" content="citation_journal_title=Eur. J. Org. Chem.; citation_title=Chemistry and applications of functionalized 2,4-thiazolidinediones; citation_author=AM Ibrahim; citation_volume=26; citation_publication_date=2023; citation_pages=e202300184; citation_doi=10.1002/ejoc.202300184; citation_id=CR22"/>
    <meta name="citation_reference" content="citation_journal_title=Chem. Pharm. Bull. (Tokyo); citation_title=Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives; citation_author=T Sohda; citation_volume=30; citation_publication_date=1982; citation_pages=3580-3600; citation_doi=10.1248/cpb.30.3580; citation_id=CR23"/>
    <meta name="citation_reference" content="citation_journal_title=Org. Process. Res. Dev.; citation_title=An improved process for pioglitazone and its pharmaceutically acceptable salt; citation_author=LR Madivada; citation_volume=13; citation_publication_date=2009; citation_pages=1190-1194; citation_doi=10.1021/op900131m; citation_id=CR24"/>
    <meta name="citation_reference" content="citation_journal_title=Eur. J. Med. Chem.; citation_title=Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-&#947; agonists; citation_author=S Nazreen; citation_volume=87; citation_publication_date=2014; citation_pages=175-185; citation_doi=10.1016/j.ejmech.2014.09.010; citation_id=CR25"/>
    <meta name="citation_reference" content="citation_journal_title=Arch. Pharm. (Weinheim); citation_title=Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-&#947; modulators; citation_author=MJ Naim; citation_volume=351; citation_publication_date=2018; citation_pages=e1700223; citation_doi=10.1002/ardp.201700223; citation_id=CR26"/>
    <meta name="citation_reference" content="Kroker, A. J. &amp; Bruning, J. B. Review of the structural and dynamic mechanisms of PPAR&#947; partial agonism. PPAR Res. 2015 (2015)."/>
    <meta name="citation_reference" content="citation_journal_title=Chem. Res. Toxicol.; citation_title=Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols; citation_author=VBG Reddy; citation_volume=18; citation_publication_date=2005; citation_pages=880-888; citation_doi=10.1021/tx0500373; citation_id=CR28"/>
    <meta name="citation_reference" content="citation_journal_title=Xenobiotica; citation_title=Identification of novel metabolites of pioglitazone in rat and dog; citation_author=Z Shen; citation_volume=33; citation_publication_date=2008; citation_pages=499-509; citation_doi=10.1080/0049825031000085951; citation_id=CR29"/>
    <meta name="citation_reference" content="citation_journal_title=Chem. Res. Toxicol.; citation_title=Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and Pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry; citation_author=R Alvarez-S&#225;nchez, F Montavon, T Hartung, A P&#228;hler; citation_volume=19; citation_publication_date=2006; citation_pages=1106-1116; citation_doi=10.1021/tx050353h; citation_id=CR30"/>
    <meta name="citation_reference" content="citation_journal_title=Chem. Res. Toxicol.; citation_title=GLORYx: Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics; citation_author=C Bruyn Kops, M &#352;&#237;cho, A Mazzolari, J Kirchmair; citation_volume=34; citation_publication_date=2021; citation_pages=286-299; citation_doi=10.1021/acs.chemrestox.0c00224; citation_id=CR31"/>
    <meta name="citation_reference" content="Ramadan, B. K., Schaalan, M. F. &amp; Tolba, A. M. Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats. BMC Complement. Altern. Med 17, (2017)."/>
    <meta name="citation_reference" content="citation_journal_title=Med. (B Aires); citation_title=Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies; citation_author=OM Ighodaro, AM Adeosun, OA Akinloye; citation_volume=53; citation_publication_date=2017; citation_pages=365-374; citation_id=CR33"/>
    <meta name="citation_reference" content="citation_journal_title=Mol. Cell. Endocrinol.; citation_title=Protective effects of pioglitazone and/or liraglutide on pancreatic &#946;-cells in Db/db mice: comparison of their effects between in an early and advanced stage of diabetes; citation_author=T Kimura; citation_volume=400; citation_publication_date=2015; citation_pages=78-89; citation_doi=10.1016/j.mce.2014.11.018; citation_id=CR34"/>
    <meta name="citation_reference" content="citation_journal_title=Mol. Cell.; citation_title=Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors; citation_author=RT Gampe; citation_volume=5; citation_publication_date=2000; citation_pages=545-555; citation_doi=10.1016/S1097-2765(00)80448-7; citation_id=CR35"/>
    <meta name="citation_reference" content="Daina, A., Michielin, O. &amp; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 1&#8211;13 (2017)."/>
    <meta name="citation_reference" content="citation_journal_title=Med. Chem. Res.; citation_title=Synthesis, antibacterial and anticancer evaluation of 5-substituted (1,3,4-oxadiazol-2-yl)quinoline; citation_author=A Salahuddin, Mazumder, M Shaharyar; citation_volume=24; citation_publication_date=2015; citation_pages=2514-2528; citation_doi=10.1007/s00044-014-1308-2; citation_id=CR37"/>
    <meta name="citation_reference" content="citation_journal_title=Bioorg. Med. Chem. Lett.; citation_title=Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents; citation_author=FRB Bokosi; citation_volume=38; citation_publication_date=2021; citation_pages=127855; citation_doi=10.1016/j.bmcl.2021.127855; citation_id=CR38"/>
    <meta name="citation_reference" content="citation_journal_title=Chem. Biol. Drug Des.; citation_title=Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands; citation_author=N Elkholy; citation_volume=100; citation_publication_date=2022; citation_pages=25-40; citation_doi=10.1111/cbdd.14047; citation_id=CR39"/>
    <meta name="citation_reference" content="citation_journal_title=J. Org. Chem.; citation_title=Diverse 3-methylthio-4-substituted maleimides through a novel rearrangement reaction: synthesis and selective cell imaging; citation_author=LV Meirelles; citation_volume=87; citation_publication_date=2022; citation_pages=2809-2820; citation_doi=10.1021/acs.joc.1c02714; citation_id=CR40"/>
    <meta name="citation_reference" content="citation_journal_title=Sci. Rep.; citation_title=Evaluation of the appropriateness of using glucometers for measuring the blood glucose levels in mice; citation_author=Y Togashi; citation_volume=6; citation_publication_date=2016; citation_pages=25465; citation_doi=10.1038/srep25465; citation_id=CR41"/>
    <meta name="citation_reference" content="citation_journal_title=J. Basic. Clin. Pharm.; citation_title=Alteration of glucose lowering effect of glibenclamide on single and multiple treatments with fenofibrate in experimental rats and rabbit models; citation_author=M Candasamy, TEGK Murthy, KS Gubiyappa, DK Chellappan, G Gupta; citation_volume=5; citation_publication_date=2014; citation_pages=62; citation_doi=10.4103/0976-0105.139728; citation_id=CR42"/>
    <meta name="citation_reference" content="citation_journal_title=Bioorg. Chem.; citation_title=Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives; citation_author=MJ Naim; citation_volume=73; citation_publication_date=2017; citation_pages=24-36; citation_doi=10.1016/j.bioorg.2017.05.007; citation_id=CR43"/>
    <meta name="citation_reference" content="citation_journal_title=Food Chem. Toxicol.; citation_title=Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice; citation_author=JD Lambert; citation_volume=48; citation_publication_date=2010; citation_pages=409; citation_doi=10.1016/j.fct.2009.10.030; citation_id=CR44"/>
    <meta name="citation_reference" content="citation_journal_title=Sci. Rep.; citation_title=Structures of PPAR&#947; complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs; citation_author=MA Lee, L Tan, H Yang, YG Im, YJ Im; citation_volume=7; citation_publication_date=2017; citation_pages=16837; citation_doi=10.1038/s41598-017-17082-x; citation_id=CR45"/>
    <meta name="citation_author" content="Ibrahim, Ayman M."/>
    <meta name="citation_author_institution" content="Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt"/>
    <meta name="citation_author" content="Shoman, Mai E."/>
    <meta name="citation_author_institution" content="Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, Egypt"/>
    <meta name="citation_author" content="el-dien, Radwa Taher Mohie"/>
    <meta name="citation_author_institution" content="Department of Pharmacognosy, Faculty of Pharmacy, New Valley University, El-kharga City, Egypt"/>
    <meta name="citation_author" content="Saber, Entesar Ali"/>
    <meta name="citation_author_institution" content="Department of Medical science, Histology and Cell Biology, Faculty of Pharmacy, Deraya University, New Minia, Egypt"/>
    <meta name="citation_author" content="Abdelnaser, Mahmoud"/>
    <meta name="citation_author_institution" content="Department of Biochemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt"/>
    <meta name="citation_author" content="Maher, Sherif A."/>
    <meta name="citation_author_institution" content="Department of Biochemistry, Faculty of pharmacy, New Valley University, El-kharga City, Egypt"/>
    <meta name="citation_author" content="Hayallah, Alaa M."/>
    <meta name="citation_author_institution" content="Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt"/>
    <meta name="citation_author_institution" content="Pharmaceutical Chemistry Department, Faculty of Pharmacy, Sphinx University, New Assiut, Egypt"/>
    <meta name="citation_author" content="El-Rehany, Mahmoud Abdul-Aziz"/>
    <meta name="citation_author_institution" content="Department of Biochemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt"/>
    <meta name="citation_author" content="Abuo-Rahma, Gamal El-Din A."/>
    <meta name="citation_author_institution" content="Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, Egypt"/>
    <meta name="citation_author_institution" content="Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, Egypt"/>
    <meta name="access_endpoint" content="https://www.nature.com/platform/readcube-access"/>
    <meta name="twitter:site" content="@SciReports"/>
    <meta name="twitter:card" content="summary_large_image"/>
    <meta name="twitter:image:alt" content="Content cover image"/>
    <meta name="twitter:title" content="Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator"/>
    <meta name="twitter:description" content="Scientific Reports - Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPAR&#947; modulator"/>
    <meta name="twitter:image" content="https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig1_HTML.png"/>
    

    
    
    <meta property="og:url" content="https://www.nature.com/articles/s41598-025-03387-9"/>
    <meta property="og:type" content="article"/>
    <meta property="og:site_name" content="Nature"/>
    <meta property="og:title" content="Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator - Scientific Reports"/>
    <meta property="og:image" content="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig1_HTML.png"/>
    

    <script>
        window.eligibleForRa21 = 'false'; 
    </script>
</head>
<body class="article-page">

<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-MRVXSHQ"
                  height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>



<div class="position-relative cleared z-index-50 background-white" data-test="top-containers">
    <a class="c-skip-link" href="#content">Skip to main content</a>



<div class="c-grade-c-banner u-hide">
    <div class="c-grade-c-banner__container">
        
        <p>Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
            the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
            Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
            and JavaScript.</p>

    </div>
</div>

    

    

    
    
        <div class="u-hide u-show-following-ad"></div>

    <aside class="c-ad c-ad--728x90">
        <div class="c-ad__inner" data-container-type="banner-advert">
            <p class="c-ad__label">Advertisement</p>
            
        
            
    <div id="div-gpt-ad-top-1"
         class="div-gpt-ad advert leaderboard js-ad text-center hide-print grade-c-hide"
         data-ad-type="top"
         data-test="top-ad"
         data-pa11y-ignore
         data-gpt
         data-gpt-unitpath="/285/scientific_reports/article"
         data-gpt-sizes="728x90"
         data-gpt-targeting="type=article;pos=top;artid=s41598-025-03387-9;doi=10.1038/s41598-025-03387-9;subjmeta=154,45,631,638,639,92;kwrd=Biochemistry,Chemical+biology,Chemistry,Drug+discovery">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/scientific_reports/article&amp;sz=728x90&amp;c=1364709243&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41598-025-03387-9%26doi%3D10.1038/s41598-025-03387-9%26subjmeta%3D154,45,631,638,639,92%26kwrd%3DBiochemistry,Chemical+biology,Chemistry,Drug+discovery">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/scientific_reports/article&amp;sz=728x90&amp;c=1364709243&amp;t=pos%3Dtop%26type%3Darticle%26artid%3Ds41598-025-03387-9%26doi%3D10.1038/s41598-025-03387-9%26subjmeta%3D154,45,631,638,639,92%26kwrd%3DBiochemistry,Chemical+biology,Chemistry,Drug+discovery"
                     alt="Advertisement"
                     width="728"
                     height="90"></a>
        </noscript>
    </div>

        
    
        </div>
    </aside>


    <header class="c-header" id="header" data-header data-track-component="nature-150-split-header" style="border-color:#cedde4">
        <div class="c-header__row">
            <div class="c-header__container">
                <div class="c-header__split">
                    
                    
                    <div class="c-header__logo-container">
                        
                        <a href="/srep"
                           data-track="click" data-track-action="home" data-track-label="image">
                            <picture class="c-header__logo">
                                <source srcset="https://media.springernature.com/full/nature-cms/uploads/product/srep/header-d3c533c187c710c1bedbd8e293815d5f.svg" media="(min-width: 875px)">
                                <img src="https://media.springernature.com/full/nature-cms/uploads/product/srep/header-d3c533c187c710c1bedbd8e293815d5f.svg" height="32" alt="Scientific Reports">
                            </picture>
                        </a>
                    
                    </div>
                    
                    <ul class="c-header__menu c-header__menu--global">
                        <li class="c-header__item c-header__item--padding c-header__item--hide-md-max">
                            <a class="c-header__link" href="https://www.nature.com/siteindex" data-test="siteindex-link"
                               data-track="click" data-track-action="open nature research index" data-track-label="link">
                                <span>View all journals</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--pipe">
                            <a class="c-header__link c-header__link--search"
                                href="#search-menu"
                                data-header-expander
                                data-test="search-link" data-track="click" data-track-action="open search tray" data-track-label="button">
                                <svg role="img" aria-hidden="true" focusable="false" height="22" width="22" viewBox="0 0 18 18" xmlns="http://www.w3.org/2000/svg"><path d="M16.48 15.455c.283.282.29.749.007 1.032a.738.738 0 01-1.032-.007l-3.045-3.044a7 7 0 111.026-1.026zM8 14A6 6 0 108 2a6 6 0 000 12z"/></svg><span>Search</span>
                            </a>
                        </li>
                        <li class="c-header__item c-header__item--padding c-header__item--snid-account-widget c-header__item--pipe">
                            
                                <a class="c-header__link eds-c-header__link" id="identity-account-widget" data-track="click_login" data-track-context="header" href='https://idp.nature.com/auth/personal/springernature?redirect_uri=https://www.nature.com/articles/s41598-025-03387-9'><span class="eds-c-header__widget-fragment-title">Log in</span></a>
                            
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        
            <div class="c-header__row">
                <div class="c-header__container" data-test="navigation-row">
                    <div class="c-header__split">
                        <ul class="c-header__menu c-header__menu--journal">
                            
                                <li class="c-header__item c-header__item--dropdown-menu" data-test="explore-content-button">
                                    <a href="#explore"
                                       class="c-header__link"
                                       data-header-expander
                                       data-test="menu-button--explore"
                                       data-track="click" data-track-action="open explore expander" data-track-label="button">
                                        <span><span class="c-header__show-text">Explore</span> content</span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"/></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--dropdown-menu">
                                    <a href="#about-the-journal"
                                       class="c-header__link"
                                       data-header-expander
                                       data-test="menu-button--about-the-journal"
                                       data-track="click" data-track-action="open about the journal expander" data-track-label="button">
                                        <span>About <span class="c-header__show-text">the journal</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"/></svg>
                                    </a>
                                </li>
                                
                                    <li class="c-header__item c-header__item--dropdown-menu" data-test="publish-with-us-button">
                                        <a href="#publish-with-us"
                                           class="c-header__link c-header__link--dropdown-menu"
                                           data-header-expander
                                           data-test="menu-button--publish"
                                           data-track="click" data-track-action="open publish with us expander" data-track-label="button">
                                            <span>Publish <span class="c-header__show-text">with us</span></span><svg role="img" aria-hidden="true" focusable="false" height="16" viewBox="0 0 16 16" width="16" xmlns="http://www.w3.org/2000/svg"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" transform="matrix(0 1 -1 0 11 3)"/></svg>
                                        </a>
                                    </li>
                                
                            
                            
                        </ul>
                        <ul class="c-header__menu c-header__menu--hide-lg-max">
                            
                                <li class="c-header__item" data-test="alert-link">
                                    <a class="c-header__link"
                                       href="https://journal-alerts.springernature.com/subscribe?journal_id&#x3D;41598"
                                       rel="nofollow"
                                       data-track="nav_sign_up_for_alerts"
                                       data-track-action="Sign up for alerts"
                                       data-track-label="link (desktop site header)"
                                       data-track-external>
                                        <span>Sign up for alerts</span><svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#222"/></svg>
                                    </a>
                                </li>
                            
                            
                                <li class="c-header__item c-header__item--pipe">
                                    <a class="c-header__link"
                                       href="https://www.nature.com/srep.rss"
                                       data-track="click"
                                       data-track-action="rss feed"
                                       data-track-label="link">
                                            <span>RSS feed</span>
                                    </a>
                                </li>
                            
                        </ul>
                    </div>
                </div>
            </div>
        
    </header>


    
    
        <nav class="u-mb-16" aria-label="breadcrumbs">
            <div class="u-container">
                <ol class="c-breadcrumbs" itemscope itemtype="https://schema.org/BreadcrumbList">
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link"
                               href="/" itemprop="item"
                               data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:nature"><span itemprop="name">nature</span></a><meta itemprop="position" content="1">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10"
                                         xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z"
                                              fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link"
                               href="/srep" itemprop="item"
                               data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:scientific reports"><span itemprop="name">scientific reports</span></a><meta itemprop="position" content="2">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10"
                                         xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z"
                                              fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem"><a class="c-breadcrumbs__link"
                               href="/srep/articles?type&#x3D;article" itemprop="item"
                               data-track="click" data-track-action="breadcrumb" data-track-category="header" data-track-label="link:articles"><span itemprop="name">articles</span></a><meta itemprop="position" content="3">
                                    <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" height="10" viewBox="0 0 10 10" width="10"
                                         xmlns="http://www.w3.org/2000/svg">
                                        <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z"
                                              fill="#666" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                                    </svg>
                                </li><li class="c-breadcrumbs__item" id="breadcrumb3" itemprop="itemListElement" itemscope itemtype="https://schema.org/ListItem">
                                    <span itemprop="name">article</span><meta itemprop="position" content="4"></li>
                </ol>
            </div>
        </nav>
    



    

</div>


<div class="u-container u-mt-32 u-mb-32 u-clearfix" id="content" data-component="article-container"  data-container-type="article">
    <main class="c-article-main-column u-float-left js-main-column" data-track-component="article body">
        
            
                <div class="c-context-bar u-hide"
                     id="js-enable-context-bar"
                     data-test="context-bar"
                     data-context-bar
                     aria-hidden="true">
                    <div class="c-context-bar__container u-container" data-track-context="sticky banner">
                        <div class="c-context-bar__title">
                            Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator
                        </div>
                        
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41598-025-03387-9.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external download>
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"/></svg>
            </a>
        </div>
    

                    </div>
                </div>
            
        
        <article lang="en">
            
                <div class="c-pdf-button__container u-mb-16 u-hide-at-lg js-context-bar-sticky-point-mobile">
                    <div class="c-pdf-container" data-track-context="article body">
                        
                            
                                
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41598-025-03387-9.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external download>
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"/></svg>
            </a>
        </div>
    

                            
                        
                    </div>
                </div>
            
            <div class="c-article-header">
                <header>
                    <ul class="c-article-identifiers" data-test="article-identifier">
                        
        <li class="c-article-identifiers__item" data-test="article-category">Article</li>
    
        <li class="c-article-identifiers__item">
            <a href="https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access">Open access</a>
        </li>
    
    

                        <li class="c-article-identifiers__item">Published: <time datetime="2025-06-01">01 June 2025</time></li>
                    </ul>

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator</h1>
                    <ul class="c-article-author-list c-article-author-list--short" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Ayman_M_-Ibrahim-Aff1" data-author-popup="auth-Ayman_M_-Ibrahim-Aff1" data-author-search="Ibrahim, Ayman M.">Ayman M. Ibrahim</a><sup class="u-js-hide"><a href="#Aff1">1</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Mai_E_-Shoman-Aff2" data-author-popup="auth-Mai_E_-Shoman-Aff2" data-author-search="Shoman, Mai E.">Mai E. Shoman</a><sup class="u-js-hide"><a href="#Aff2">2</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Radwa_Taher_Mohie-el_dien-Aff3" data-author-popup="auth-Radwa_Taher_Mohie-el_dien-Aff3" data-author-search="el-dien, Radwa Taher Mohie">Radwa Taher Mohie el-dien</a><sup class="u-js-hide"><a href="#Aff3">3</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Entesar_Ali-Saber-Aff4" data-author-popup="auth-Entesar_Ali-Saber-Aff4" data-author-search="Saber, Entesar Ali">Entesar Ali Saber</a><sup class="u-js-hide"><a href="#Aff4">4</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Mahmoud-Abdelnaser-Aff5" data-author-popup="auth-Mahmoud-Abdelnaser-Aff5" data-author-search="Abdelnaser, Mahmoud">Mahmoud Abdelnaser</a><sup class="u-js-hide"><a href="#Aff5">5</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Sherif_A_-Maher-Aff6" data-author-popup="auth-Sherif_A_-Maher-Aff6" data-author-search="Maher, Sherif A.">Sherif A. Maher</a><sup class="u-js-hide"><a href="#Aff6">6</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Alaa_M_-Hayallah-Aff7-Aff8" data-author-popup="auth-Alaa_M_-Hayallah-Aff7-Aff8" data-author-search="Hayallah, Alaa M." data-corresp-id="c1">Alaa M. Hayallah<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><sup class="u-js-hide"><a href="#Aff7">7</a>,<a href="#Aff8">8</a></sup>, </li><li class="c-article-author-list__item c-article-author-list__item--hide-small-screen"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Mahmoud_Abdul_Aziz-El_Rehany-Aff5" data-author-popup="auth-Mahmoud_Abdul_Aziz-El_Rehany-Aff5" data-author-search="El-Rehany, Mahmoud Abdul-Aziz">Mahmoud Abdul-Aziz El-Rehany</a><sup class="u-js-hide"><a href="#Aff5">5</a></sup> &amp; </li><li class="c-article-author-list__show-more" aria-label="Show all 9 authors for this article" title="Show all 9 authors for this article">…</li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" href="#auth-Gamal_El_Din_A_-Abuo_Rahma-Aff1-Aff2" data-author-popup="auth-Gamal_El_Din_A_-Abuo_Rahma-Aff1-Aff2" data-author-search="Abuo-Rahma, Gamal El-Din A." data-corresp-id="c2">Gamal El-Din A. Abuo-Rahma<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a></sup> </li></ul><button aria-expanded="false" class="c-article-author-list__button"><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-down-medium"></use></svg><span>Show authors</span></button>

                    

                    <p class="c-article-info-details" data-container-section="info">
                        
    <a data-test="journal-link" href="/srep" data-track="click" data-track-action="journal homepage" data-track-category="article body" data-track-label="link"><i data-test="journal-title">Scientific Reports</i></a>

                        <b data-test="journal-volume"><span class="u-visually-hidden">volume</span> 15</b>, Article number: <span data-test="article-number">19207</span> (<span data-test="article-publication-year">2025</span>)
            <a href="#citeas" class="c-article-info-details__cite-as u-hide-print" data-track="click" data-track-action="cite this article" data-track-label="link">Cite this article</a>
                    </p>
                    
        <div class="c-article-metrics-bar__wrapper u-clear-both">
            <ul class="c-article-metrics-bar u-list-reset">
                
                    <li class=" c-article-metrics-bar__item" data-test="access-count">
                        <p class="c-article-metrics-bar__count">392 <span class="c-article-metrics-bar__label">Accesses</span></p>
                    </li>
                
                
                
                    
                        <li class="c-article-metrics-bar__item" data-test="altmetric-score">
                            <p class="c-article-metrics-bar__count">6 <span class="c-article-metrics-bar__label">Altmetric</span></p>
                        </li>
                    
                
                <li class="c-article-metrics-bar__item">
                    <p class="c-article-metrics-bar__details"><a href="/articles/s41598-025-03387-9/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Metrics <span class="u-visually-hidden">details</span></a></p>
                </li>
            </ul>
        </div>
    
                    
                </header>

                
    <div class="u-js-hide" data-component="article-subject-links">
        <h3 class="c-article__sub-heading">Subjects</h3>
        <ul class="c-article-subject-list">
            <li class="c-article-subject-list__subject"><a href="/subjects/biochemistry" data-track="click" data-track-action="view subject" data-track-label="link">Biochemistry</a></li><li class="c-article-subject-list__subject"><a href="/subjects/chemical-biology" data-track="click" data-track-action="view subject" data-track-label="link">Chemical biology</a></li><li class="c-article-subject-list__subject"><a href="/subjects/chemistry" data-track="click" data-track-action="view subject" data-track-label="link">Chemistry</a></li><li class="c-article-subject-list__subject"><a href="/subjects/drug-discovery" data-track="click" data-track-action="view subject" data-track-label="link">Drug discovery</a></li>
        </ul>
    </div>

                
    
    

    
    

                
            </div>

        <div class="c-article-body">
            <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><p>Peroxisome proliferator-activated receptor γ (PPARγ) remains a critical target for antidiabetic drug development due to its role in glucose and lipid metabolism. However, the adverse effects associated with full agonists of the thiazolidinedione (TZD) class, such as weight gain and hepatotoxicity, limit their clinical utility. Herein, we report the design and synthesis of (<i>Z</i>)-5-benzylidene-3-((2-chloroquinolin-3-yl)methyl)thiazolidine-2,4-dione (compound <b>7</b>), a novel TZD derivative that functions as a potential PPARγ modulator. Compound <b>7</b> reduced blood glucose level (BGL) by 22.33% after 15 days of treatment with a daily single oral dose, demonstrating an antidiabetic effect comparable to TZDs. Additionally, it elevated PPARγ expression to 75% of the activation level induced by Pioglitazone (PIO). Further characterization of its safety profile reveals that compound <b>7</b> is safer on the liver compared to PIO, as alanine transaminase (ALT) and aspartate transaminase (AST) levels remained significantly lower (147.4 ± 4.2 IU/L and 229.9 ± 2.7 IU/L, respectively). Moreover, compound <b>7</b> exerts a protective effect on hepatic and pancreatic tissues. Computational metabolic studies predict that compound <b>7</b> does not produce toxic metabolites or undergo hydrolysis of the TZD ring, contributing to its improved safety. The docking of Compound <b>7</b> into the PPARγ ligand-binding domain (LBD) demonstrates a unique binding mode, positioning it centrally within the LBD and interacting with key amino acids critical for selective modulation. These findings emphasize the potential of compound <b>7</b> as a selective PPARγ modulator to dissociate insulin-sensitizing effects from adverse side effects, offering a safer alternative to current TZD-based therapies.</p></div></div></section>

            
                
            

            
                
                    
        
            <section aria-labelledby="inline-recommendations" data-title="Inline Recommendations" class="c-article-recommendations" data-track-component="inline-recommendations">
                <h3 class="c-article-recommendations-title" id="inline-recommendations">Similar content being viewed by others</h3>
                <div class="c-article-recommendations-list">
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-023-47157-x/MediaObjects/41598_2023_47157_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link"
                                           itemprop="url"
                                           href="https://www.nature.com/articles/s41598-023-47157-x?fromPaywallRec=false"
                                           data-track="select_recommendations_1"
                                           data-track-context="inline recommendations"
                                           data-track-action="click recommendations inline - 1"
                                           data-track-label="10.1038/s41598-023-47157-x">Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">14 November 2023</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-020-70689-5/MediaObjects/41598_2020_70689_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link"
                                           itemprop="url"
                                           href="https://www.nature.com/articles/s41598-020-70689-5?fromPaywallRec=false"
                                           data-track="select_recommendations_2"
                                           data-track-context="inline recommendations"
                                           data-track-action="click recommendations inline - 2"
                                           data-track-label="10.1038/s41598-020-70689-5">Administration of small-molecule guanabenz acetate attenuates fatty liver and hyperglycemia associated with obesity
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">13 August 2020</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-024-82765-1/MediaObjects/41598_2024_82765_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link"
                                           itemprop="url"
                                           href="https://www.nature.com/articles/s41598-024-82765-1?fromPaywallRec=false"
                                           data-track="select_recommendations_3"
                                           data-track-context="inline recommendations"
                                           data-track-action="click recommendations inline - 3"
                                           data-track-label="10.1038/s41598-024-82765-1">Exploring dihydropyrimidone derivatives as modulators of carbohydrate catabolic enzyme to mitigate diabetes
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">30 December 2024</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                </div>
            </section>
        
            <script>
                window.dataLayer = window.dataLayer || [];
                window.dataLayer.push({
                    recommendations: {
                        recommender: 'semantic',
                        model: 'specter',
                        policy_id: 'NA',
                        timestamp: 1749027026,
                        embedded_user: 'null'
                    }
                });
            </script>
        
    
                
                
                <div class="main-content">
                    
                        <section data-title="Introduction"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1">Introduction</h2><div class="c-article-section__content" id="Sec1-content"><p>Type II diabetes mellitus (T2DM) stands as a chronic metabolic disorder characterized by insulin resistance and impaired glucose homeostasis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers. 1, 15019 (2015)." href="/articles/s41598-025-03387-9#ref-CR1" id="ref-link-section-d113436912e1141">1</a></sup> The therapeutic management of T2DM involves various drug classes, each targeting distinct aspects of glucose regulation. Among them, glitazones (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig1">1</a>), or thiazolidinediones (TZDs), have emerged as pharmacological agents that modulate insulin sensitivity and improve glycemic control<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Yki-Järvinen, H. Thiazolidinediones. N. Engl. J. Med. 351, 1106–1118 (2004)." href="/articles/s41598-025-03387-9#ref-CR2" id="ref-link-section-d113436912e1148">2</a></sup>.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Fig. 1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/1" rel="nofollow"><picture><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="290"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>Chemical structures of glitazones.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>TZDs effectively lower hemoglobin A1c by approximately 1% as monotherapy in T2DM without causing hypoglycemia, unlike insulin or insulin secretagogues such as sulfonylureas; this makes them suitable for combination therapy with other antidiabetic agents<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Yau, H., Rivera, K., Lomonaco, R. &amp; Cusi, K. The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus. Curr. Diab Rep. 13, 329–341 (2013)." href="/articles/s41598-025-03387-9#ref-CR3" id="ref-link-section-d113436912e1174">3</a></sup> Studies have shown that TZDs improved insulin sensitivity, where the randomized controlled trial has demonstrated that Rosiglitazone is more durable glycemic control compared to metformin or sulfonylurea<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Kahn, S. E. et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl. J. Med. 355, 2427–2443 (2006)." href="/articles/s41598-025-03387-9#ref-CR4" id="ref-link-section-d113436912e1178">4</a></sup> Current practice guidelines approved PIO for biopsy-proven nonalcoholic steatohepatitis (NASH), while guidelines recommend TZDs to decrease androgen levels, enhance ovulation, and improve glucose tolerance in women with polycystic ovarian syndrome (PCOS), though not for first-line use in treating hirsutism or infertility<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Soccio, R. E., Chen, E. R. &amp; Lazar, M. A. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell. Metab. 20, 573–591 (2014)." href="/articles/s41598-025-03387-9#ref-CR5" id="ref-link-section-d113436912e1182">5</a></sup>.</p><p>The primary molecular target of glitazones in antidiabetic action is the PPARγ<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 6" title="Bansal, G., Thanikachalam, P. V., Maurya, R. K., Chawla, P. &amp; Ramamurthy, S. An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes. J. Adv. Res. 23, 163–205 (2020)." href="/articles/s41598-025-03387-9#ref-CR6" id="ref-link-section-d113436912e1189">6</a></sup> PPARγ is a nuclear receptor that plays a crucial role in regulating glucose and lipid metabolism in various tissues, including adipose tissue, skeletal muscles, and liver<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 7" title="Ahmadian, M. et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557–566 (2013)." href="/articles/s41598-025-03387-9#ref-CR7" id="ref-link-section-d113436912e1193">7</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Rosen, E. D. &amp; Spiegelman, B. M. PPARγ: A nuclear regulator of metabolism, differentiation, and cell growth. J. Biol. Chem. 276, 37731–37734 (2001)." href="/articles/s41598-025-03387-9#ref-CR8" id="ref-link-section-d113436912e1196">8</a></sup> Upon activation by TZDs, PPARγ forms a heterodimer with Retinoid X Receptor (RXR) and binds to specific PPAR response elements (PPREs) in the promoter region of target genes<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Mangelsdorf, D. J. &amp; Evans, R. M. The RXR heterodimers and orphan receptors. Cell 83, 841–850 (1995)." href="/articles/s41598-025-03387-9#ref-CR9" id="ref-link-section-d113436912e1200">9</a></sup> This activation results in the transcriptional regulation of pathways involved in insulin sensitivity, adipogenesis, and lipid metabolism, leading to improved glucose homeostasis<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="Schoonjans, K., Staels, B. &amp; Auwerx, J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta. 1302, 93–109 (1996)." href="/articles/s41598-025-03387-9#ref-CR10" id="ref-link-section-d113436912e1204">10</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Saltiel, A. R. &amp; Olefsky, J. M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45, 1661–1669 (1996)." href="/articles/s41598-025-03387-9#ref-CR11" id="ref-link-section-d113436912e1207">11</a></sup> TZDs are full agonists of PPARγ that form hydrogen bonds between their TZD head group and the ligand-binding domain (LBD) of PPARγ, specifically with the side chains of key residues His323, His449, and Tyr473 (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig2">2</a>). These interactions play a crucial role in stabilizing helix 12 (H12) in the active conformation leading to the formation of the activation function 2 (AF2) surface, which is necessary for full receptor activation<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Nolte, R. T. et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature 395, 137–143 (1998)." href="/articles/s41598-025-03387-9#ref-CR12" id="ref-link-section-d113436912e1215">12</a></sup>.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-2" data-title="Fig. 2"><figure><figcaption><b id="Fig2" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 2</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/2" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig2_HTML.png?as=webp"><img aria-describedby="Fig2" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig2_HTML.png" alt="figure 2" loading="lazy" width="685" height="209"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-2-desc"><p>(<b>A</b>) Binding mode of PIO with key residues of PPARγ LBD. (<b>B</b>) Structure-activity relationship (SAR) of TZDs as PPARγ full agonists.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/2" data-track-dest="link:Figure2 Full size image" aria-label="Full size image figure 2" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Despite their efficacy, glitazones are associated with a range of adverse effects, including weight gain and fluid retention. Long-term use of PIO raises concerns about cardiovascular safety, particularly an increased risk of heart failure and myocardial infarction<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Lincoff, A. M., Wolski, K., Nicholls, S. J. &amp; Nissen, S. E. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298, 1180–1188 (2007)." href="/articles/s41598-025-03387-9#ref-CR13" id="ref-link-section-d113436912e1249">13</a></sup> PIO may elevate the risk of bone fractures and has been linked to cases of liver toxicity. Moreover, long-term use of PIO has also been linked to an increased risk of bladder cancer, raising concerns about safety profile<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Tang, H. et al. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis. Cancer Med. 7, 1070–1080 (2018)." href="/articles/s41598-025-03387-9#ref-CR14" id="ref-link-section-d113436912e1253">14</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="Tuccori, M. et al. Pioglitazone use and risk of bladder cancer: population based cohort study. BMJ. 352 (2016)." href="/articles/s41598-025-03387-9#ref-CR15" id="ref-link-section-d113436912e1256">15</a></sup> Three TZDs received FDA approval: Troglitazone, Rosiglitazone, and PIO. Troglitazone was introduced in 1997 but withdrawn in 2000 due to liver toxicity concerns. Rosiglitazone and Pioglitazone were both approved in 1999, but Rosiglitazone faced restrictions due to cardiovascular concerns that were later lifted<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Soccio, R. E., Chen, E. R. &amp; Lazar, M. A. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. Cell. Metab. 20, 573–591 (2014)." href="/articles/s41598-025-03387-9#ref-CR5" id="ref-link-section-d113436912e1260">5</a></sup>.</p><p>Thus, a new prospective class of compounds appeared for the treatment of diabetes as selective PPARγ modulators (SPPARMs) (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig3">3</a>). These compounds have been demonstrated to retain favorable insulin-sensitizing effects while exhibiting little to no adverse effects. SPPARMs induce selective receptor conformations, engaging distinct signaling pathways, which leads to a more targeted and balanced activation of PPARγ<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Gelman, L., Feige, J. N. &amp; Desvergne, B. Molecular basis of selective PPARγ modulation for the treatment of type 2 diabetes. Biochim. Et Biophys. Acta (BBA) - Mol. Cell. Biology Lipids. 1771, 1094–1107 (2007)." href="/articles/s41598-025-03387-9#ref-CR16" id="ref-link-section-d113436912e1270">16</a></sup> This selective modulation enhances insulin sensitivity while minimizing common side effects such as weight gain, fluid retention, and cardiovascular risks, making them a safer alternative to traditional TZDs<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Higgins, L. S. &amp; Depaoli, A. M. Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation. Am. J. Clin. Nutr. 91, 267S–270S (2010)." href="/articles/s41598-025-03387-9#ref-CR17" id="ref-link-section-d113436912e1274">17</a></sup>.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-3" data-title="Fig. 3"><figure><figcaption><b id="Fig3" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 3</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/3" rel="nofollow"><picture><img aria-describedby="Fig3" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig3_HTML.png" alt="figure 3" loading="lazy" width="685" height="390"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-3-desc"><p>Chemical structures of SPPARMs.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/3" data-track-dest="link:Figure3 Full size image" aria-label="Full size image figure 3" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>SPPARMs, as shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig3">3</a>, do not share a general structure. However, they exhibit common binding features within the PPARγ LBD (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig4">4</a>). For example, <b>INT131</b>, a well-characterized SPPARM, binds to the LBD in a manner representative of this class<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Motani, A. et al. INT131: a selective modulator of PPAR gamma. J. Mol. Biol. 386, 1301–1311 (2009)." href="/articles/s41598-025-03387-9#ref-CR18" id="ref-link-section-d113436912e1309">18</a></sup> Like other SPPARMs, <b>INT131</b> interacts hydrophobically with Cys285 of H3, a critical residue for partial activation, and engages Arg288 <i>via</i> hydrophobic/van der Waals forces (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig4">4</a>A). These interactions are often mediated by aromatic groups present within the SPPARM structure, as shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig4">4</a>B. This contrasts with full agonists like PIO, which stabilize the AF2 domain through strong electrostatic interactions with His323, Tyr473, and His449. The distinct binding mode of <b>INT131</b> (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig4">4</a>A) exemplifies the SPPARM signature: retention of key interactions with Cys285 and Arg288, coupled with the absence of direct stabilization of the AF2 domain. These features collectively contribute to the unique partial activation profile and reduced adverse effects associated with SPPARMs.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-4" data-title="Fig. 4"><figure><figcaption><b id="Fig4" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 4</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/4" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig4_HTML.png?as=webp"><img aria-describedby="Fig4" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig4_HTML.png" alt="figure 4" loading="lazy" width="685" height="309"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-4-desc"><p>(<b>A</b>) Binding mode of <b>INT131</b> with key residues of PPAR LBDγ. (<b>B</b>) General structure features of SPPARMs.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/4" data-track-dest="link:Figure4 Full size image" aria-label="Full size image figure 4" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Therefore, motivated by the advantages of the SPPARMs, a novel derivative of the TZD scaffold has been designed with improved pharmacological properties. The design of this compound was based on several considerations. The investigations showed that toxicity of TZDs is most likely due to the hydrolysis of the TZD ring leading to formation of reactive intermediates, and hence TZD toxicity<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Taxak, N., Parmar, V., Patel, D. S., Kotasthane, A. &amp; Bharatam, P. V. S-oxidation of thiazolidinedione with hydrogen peroxide, peroxynitrous acid, and c4a-hydroperoxyflavin: A theoretical study. J. Phys. Chem. A. 115, 891–898 (2011)." href="/articles/s41598-025-03387-9#ref-CR19" id="ref-link-section-d113436912e1365">19</a></sup> Additionally, it was observed that substitution at the nitrogen atom of the TZD ring in <b>GQ-11</b> prevents the cleavage of the TZD moiety, rendering it non-toxic to the liver<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Campos, M. L. et al. New pioglitazone metabolites and absence of opened-ring metabolites in new N-substituted thiazolidinedione. Drug Metab. Dispos. 46, 879–887 (2018)." href="/articles/s41598-025-03387-9#ref-CR20" id="ref-link-section-d113436912e1372">20</a></sup> Based on these observations, the first consideration was to modify the TZD ring in the desired compound by introducing a substitution at the nitrogen atom.</p><p>The other consideration is to enhance the designed compound’s binding with its target. A quinoline ring was selected as the nitrogen substituent. The aromatic nature of quinoline, characterized by its π-electron system, enables π-π stacking interactions with aromatic residues in the binding sites of biomolecules. Within the LBD of PPARγ, these interactions possible to occur with aromatic residues, including Phe282, Phe363, and His449. Additionally, the nitrogen atom within the quinoline ring contributes to hydrogen bonding, enhancing specificity and affinity for target binding sites<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="Mohamed, M. F. A. &amp; Abuo-Rahma, G. E. D. A. Molecular targets and anticancer activity of quinoline–chalcone hybrids: literature review. RSC Adv. 10, 31139–31155 (2020)." href="/articles/s41598-025-03387-9#ref-CR21" id="ref-link-section-d113436912e1379">21</a></sup>.</p><p>The final point depends on the selection of 5-benzylidene-2,4-thiazolidinedione moiety over 5-benzyl counterpart. The presence of the exocyclic double bond eliminates concerns regarding stereochemical instability and potential racemization. This structural preference facilitates access to the target compound without complexities associated with reduction methods of double bond as non-selectivity over other functional groups, toxicity, catalyst poisoning, and low to moderate yield. Combining these structural features, compound <b>7</b> was developed to achieve an optimized balance of safety, efficacy, and drug-like properties (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig5">5</a>)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Ibrahim, A. M. et al. Chemistry and applications of functionalized 2,4-thiazolidinediones. Eur. J. Org. Chem. 26, e202300184 (2023)." href="/articles/s41598-025-03387-9#ref-CR22" id="ref-link-section-d113436912e1392">22</a></sup>.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-5" data-title="Fig. 5"><figure><figcaption><b id="Fig5" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 5</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/5" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig5_HTML.png?as=webp"><img aria-describedby="Fig5" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig5_HTML.png" alt="figure 5" loading="lazy" width="685" height="209"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-5-desc"><p>The design of the target molecule.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/5" data-track-dest="link:Figure5 Full size image" aria-label="Full size image figure 5" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div></div></section><section data-title="Results and discussion"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2">Results and discussion</h2><div class="c-article-section__content" id="Sec2-content"><h3 class="c-article__sub-heading" id="Sec3">Chemistry</h3><p>The titled compound <b>7</b> was synthesized as per the route outlined in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig6">6</a>. Acetanilide was treated with Vilsmeier–Haack reagent (POCl<sub>3</sub> and <i>N</i>,<i>N</i>-dimethyl formamide (DMF)) to form intermediate <b>1</b>. Intermediate <b>1</b> was then treated with solid NaBH<sub>4</sub> in ethanol to afford 2-chloro-3-hydroxymethylquinoline <b>2</b>, followed by chlorination with SOCl<sub>2</sub> in dichloromethane to obtain intermediate <b>3</b>. Heating intermediate <b>3</b> in acetonitrile under reflux with the potassium salt of (<i>Z</i>)-5-benzylidenethiazolidine-2,4-dione <b>6</b> formed the target compound <b>7</b>. The structure of TZD derivatives <b>7</b> was confirmed by<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers. 1, 15019 (2015)." href="/articles/s41598-025-03387-9#ref-CR1" id="ref-link-section-d113436912e1474">1</a></sup>H and<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Lincoff, A. M., Wolski, K., Nicholls, S. J. &amp; Nissen, S. E. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298, 1180–1188 (2007)." href="/articles/s41598-025-03387-9#ref-CR13" id="ref-link-section-d113436912e1479">13</a></sup>C NMR. For instance, the<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers. 1, 15019 (2015)." href="/articles/s41598-025-03387-9#ref-CR1" id="ref-link-section-d113436912e1483">1</a></sup>H NMR spectrum of compound <b>7</b> was characterized by a singlet signal assigned to the methylene protons (CH<sub>2</sub>) which experienced a downfield shift from δ 4.82 to 5.00 ppm (Figure <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41598-025-03387-9#MOESM1">S1</a>). Notably, a characteristic signal for the methylene group appeared at δ 42.60 ppm. Moreover, the chemical shift of the methine proton shifted from δ 7.79 to 7.97 ppm. Also, the spectrum included a singlet at δ 8.40 ppm, corresponding to the H4 of the quinoline moiety. Another signal at δ 8.03 ppm represents the proton H5 of the quinoline nucleus. Additionally, a signal at δ 7.94 ppm corresponds to H8 of the quinoline moiety. The spectrum also exhibited a triplet at δ 7.79 ppm, representing H7 of the quinoline group. Furthermore, multiple resonances were observed for the phenyl group, including a multiplet at the range δ 7.54–7.64 ppm. DEPTQ-135 <sup>13</sup>C NMR spectrum of compound 8a displayed 18 distinct signals (Figure S2). Among these signals, 9 signals were observed exhibiting a phase shift of 180° compared to the other 9 signals arising from CH and CH<sub>3</sub> carbons. Notably, a characteristic signal originating from the methylene group appeared at δ 42.60 ppm. The peaks observed at 167.41 and 165.50 ppm were attributed to the two carbonyl groups present in the TZD ring. The molecular structure was further confirmed by mass spectrometry (ESI-MS, water), showing the molecular ion peak [M + H] + at m/z 380.5, consistent with the calculated molecular mass (Figure S3). The peak at <i>m/z</i> 434 could potentially be attributed to an adduct with the solvent, specifically [M + Na + MeOH]+. Crucially, the expected chlorine isotope peak at <i>m/z</i> 382.5 was also observed, with an intensity of approximately 32% relative to the [M + H] + 380.5 peak, confirming the presence of the chlorine atom in the molecule. HPLC analysis of compound <b>7</b> revealed a purity level of 95% (Figure S4). The synthesis of compound <b>7</b> is notably simpler and more straightforward, with a higher yield compared to the synthesis of PIO<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Sohda, T. et al. Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives. Chem. Pharm. Bull. (Tokyo). 30, 3580–3600 (1982)." href="/articles/s41598-025-03387-9#ref-CR23" id="ref-link-section-d113436912e1512">23</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Madivada, L. R. et al. An improved process for pioglitazone and its pharmaceutically acceptable salt. Org. Process. Res. Dev. 13, 1190–1194 (2009)." href="/articles/s41598-025-03387-9#ref-CR24" id="ref-link-section-d113436912e1515">24</a></sup> It involves fewer steps and relies on inexpensive and commercially available starting materials, making it a cost-effective and practical approach for large-scale production.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-6" data-title="Fig. 6"><figure><figcaption><b id="Fig6" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 6</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/6" rel="nofollow"><picture><img aria-describedby="Fig6" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig6_HTML.png" alt="figure 6" loading="lazy" width="685" height="419"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-6-desc"><p>Synthetic pathway of target compound <b>7</b>.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/6" data-track-dest="link:Figure6 Full size image" aria-label="Full size image figure 6" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec4">Biological investigation</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec5">In vivo antidiabetic activity</h4><p>Compound <b>7</b> was evaluated on alloxan-induced diabetic rats for its blood glucose lowering effect. Besides control and diabetic groups, PIO was used as a reference drug with a single oral dose (36 mg/kg) to group III<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Nazreen, S. et al. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists. Eur. J. Med. Chem. 87, 175–185 (2014)." href="/articles/s41598-025-03387-9#ref-CR25" id="ref-link-section-d113436912e1557">25</a></sup> Compound <b>7</b> was also orally administered as an equimolar (1 mmole) single dose (38 mg/kg) to group IV. PIO and <b>7</b> were given in the form of a 0.25% carboxymethylcellulose (CMC) suspension and the fasting BGLs were monitored as per standard protocols on the 0-day, 1st, 7th, and 15th day of the commencement of the experiment<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="Nazreen, S. et al. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists. Eur. J. Med. Chem. 87, 175–185 (2014)." href="/articles/s41598-025-03387-9#ref-CR25" id="ref-link-section-d113436912e1567">25</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Naim, M. J. et al. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators. Arch. Pharm. (Weinheim). 351, e1700223 (2018)." href="/articles/s41598-025-03387-9#ref-CR26" id="ref-link-section-d113436912e1570">26</a></sup> The results are outlined in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig7">7</a>.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-7" data-title="Fig. 7"><figure><figcaption><b id="Fig7" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 7</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/7" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig7_HTML.png?as=webp"><img aria-describedby="Fig7" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig7_HTML.png" alt="figure 7" loading="lazy" width="685" height="416"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-7-desc"><p>Antidiabetic activity of compound <b>7</b> in alloxan-induced diabetic rats. Data are analyzed by one-way ANOVA followed by Bonferroni <i>t</i>-test and expressed as mean ± SD from five observations; *<i>p</i> &lt; 0.05 <i>versus</i> normal control; and #<i>p</i> &lt; 0.05 <i>versus</i> diabetic control.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/7" data-track-dest="link:Figure7 Full size image" aria-label="Full size image figure 7" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>The data analysis showed that compound <b>7</b> and PIO effectively reduced blood glucose levels. On the 15th day, compound <b>7</b> demonstrated a decrease in BGL from 300 ± 2.23 mg/dL to 233 ± 5.05 mg/dL, while PIO exhibited a BGL reduction from 260 ± 3.5 mg/dL to 134 ± 7.74 mg/dL, in comparison to the diabetic group. Thus, compound <b>7</b> showed a promising blood glucose lowering effect with 22.33% along with the reference drug, PIO (48.46%).</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec6">PPARγ gene expression study</h4><p>PPAR<b>γ</b> gene expression analysis was done to evaluate the impact of compound <b>7</b> on modulating PPARγ gene. As shown in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig8">8</a>, diabetes significantly downregulated the expression of PPARγ gene, compared to the normal control group. However, in both <b>7</b>-treated group and PIO-treated group, the expression of PPARγ gene was markedly elevated, in contrast to the diabetic group. Thus, the increase in gene expression exerted by compound <b>7</b> supports its blood glucose lowering effect and its potential PPARγ activation. The transcriptional activity induced by SPPARMs is lower than that of full agonists. For instance, some partial agonists show transcriptional outputs ranging from 20 to 80% of full agonists like Rosiglitazone in reporter assays<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Kroker, A. J. &amp; Bruning, J. B. Review of the structural and dynamic mechanisms of PPARγ partial agonism. PPAR Res. 2015 (2015)." href="/articles/s41598-025-03387-9#ref-CR27" id="ref-link-section-d113436912e1653">27</a></sup> This partial activation modulates a subset of PPARγ-regulated genes, focusing on those involved in insulin sensitization while minimizing the activation of genes linked to adverse effects.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-8" data-title="Fig. 8"><figure><figcaption><b id="Fig8" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 8</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/8" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig8_HTML.png?as=webp"><img aria-describedby="Fig8" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig8_HTML.png" alt="figure 8" loading="lazy" width="685" height="854"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-8-desc"><p>Effect of compound <b>7</b> on pancreatic PPARγ mRNA levels. Data are analyzed by one-way ANOVA followed by Bonferroni <i>t</i>-test and expressed as mean ± SD from five observations; *<i>p</i> &lt; 0.05 <i>versus</i> normal control; and #<i>p</i> &lt; 0.05 <i>versus</i> diabetic control.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/8" data-track-dest="link:Figure8 Full size image" aria-label="Full size image figure 8" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec7">Body weight gain study</h4><p>Due to the earlier association of PPARγ full agonists with weight gain among treated animals, compound <b>7</b> was further analyzed for body weight gain (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig9">9</a>). In the diabetic control group, the body weight was decreased which may be attributed to the underlying diabetic condition. Administration of compound <b>7</b> resulted in a slight increase in body weight indicating that compound <b>7</b> has no significant effect on body weight compared to both the normal and diabetic control groups. In comparison, treatment with PIO induced a significant weight gain, which was notably higher than the changes observed with compound <b>7</b> and the normal control group.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-9" data-title="Fig. 9"><figure><figcaption><b id="Fig9" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 9</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/9" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig9_HTML.png?as=webp"><img aria-describedby="Fig9" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig9_HTML.png" alt="figure 9" loading="lazy" width="685" height="783"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-9-desc"><p>Effect of compound <b>7</b> on body weight gain in rats. Data are analyzed by one-way ANOVA followed by Bonferroni <i>t</i>-test and expressed as mean ± SD from five observations; *<i>p</i> &lt; 0.05 <i>versus</i> normal control; and #<i>p</i> &lt; 0.05 <i>versus</i> diabetic control.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/9" data-track-dest="link:Figure9 Full size image" aria-label="Full size image figure 9" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec8">Hepatotoxicity studies</h4><p>Compound <b>7</b> was further analyzed for an increase or decrease in the levels of ALT and AST (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig10">10</a>). Normal control group showed ALT and AST levels of 113.2 ± 3.2 and 124.8 ± 4.4 IU/L, respectively. The diabetic control group served as a model for evaluating the impact of diabetes on liver function. The levels of ALT and AST were significantly elevated to 147.4 ± 4.2 IU/L and 229.9 ± 2.7 IU/L, respectively. This increase indicates impaired liver function associated with diabetes. Compound <b>7</b> was effective in bringing down the levels of ALT and AST to the normal range, with 124.3 ± 5.3 IU/L and 123.3 ± 7.6 IU/L, respectively. Treatment with PIO resulted in an elevated level of AST (154.7 ± 4.8 IU/L) when compared to the normal control group.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-10" data-title="Fig. 10"><figure><figcaption><b id="Fig10" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 10</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/10" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig10_HTML.png?as=webp"><img aria-describedby="Fig10" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig10_HTML.png" alt="figure 10" loading="lazy" width="685" height="448"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-10-desc"><p>Effect of compound <b>7</b> on serum AST and ALT levels. Data are analyzed by one-way ANOVA followed by Bonferroni <i>t</i>-test and expressed as mean ± SD from five observations; *<i>p</i> &lt; 0.05 <i>versus</i> normal control; and #<i>p</i> &lt; 0.05 <i>versus</i> diabetic control.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/10" data-track-dest="link:Figure10 Full size image" aria-label="Full size image figure 10" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Histopathological examination of liver sections from the normal control group demonstrated normal hepatic architecture with characteristic hexagonal lobules. The tissue showed well-organized hepatic cords radiating from central veins, with intact portal triads at the periphery. Hepatocytes exhibited normal polyhedral morphology with vesicular nuclei and acidophilic cytoplasm, separated by clear sinusoidal spaces (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig11">11</a>A1, A2).</p><p>Liver sections from the diabetic control group exhibited severe disruption of hepatic architecture with disorganized hepatic cords and prominent sinusoidal dilation. Hepatocytes displayed extensive degenerative changes, including cytoplasmic vacuolation and nuclear abnormalities (pyknosis, fragmentation, and karyolysis). Dilated sinusoids, steatosis, glycogen depletion, and enlarged Kupffer cells were present. Notable features included marked central vein congestion, patchy necrosis, and perivenular inflammatory cell infiltration extending toward portal areas. These pathological changes indicate the severity of diabetes-induced hepatic injury (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig11">11</a>B1, B2).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-11" data-title="Fig. 11"><figure><figcaption><b id="Fig11" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 11</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/11" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig11_HTML.png?as=webp"><img aria-describedby="Fig11" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig11_HTML.png" alt="figure 11" loading="lazy" width="685" height="514"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-11-desc"><p>Photomicrographs of rat liver tissue for normal group (A1 &amp; A2), and diabetic group (B1 &amp; B2). (<b>A1</b>) Normal liver architecture with central veins (CV) and blood sinusoids in-between rows of hepatocytes (arrows). (<b>A2</b>) Hepatocytes are large polyhedral cells with vesicular nuclei and vacuolated and acidophilic cytoplasm. (<b>B1</b>) marked congestion of CV, vessels of the portal areas (PA) and blood sinusoids. Widely distributed patchy inflammation and necrosis mainly concentrated around the central veins (empty circle); (<b>B2</b>) Hepatic cord disorganization and dissolution. Varying degrees of cytoplasmic vacuolation (empty rectangles) and some nuclei showing pyknosis (arrows).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/11" data-track-dest="link:Figure11 Full size image" aria-label="Full size image figure 11" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>Treatment with compound <b>7</b> demonstrated notable amelioration of diabetes-induced hepatic changes. The liver sections showed improvement in hepatic architecture, with partially restored hexagonal lobular structure and organized central veins. Hepatocytes exhibited improved cellular integrity, radiating in well-defined cords from the central axis. The hepatic tissue displayed reduced inflammatory infiltration compared to the diabetic control group, with only mild collagen deposition in the interlobular septa and around sinusoids, indicating attenuation of diabetes-induced liver damage (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig12">12</a>A1-A3).</p><p>PIO treatment demonstrated moderate amelioration of alloxan-induced hepatic changes. The liver sections showed partial restoration of hepatic architecture, with hepatocytes arranged in radiating cords and relatively normal portal areas. While most hepatocytes displayed normal acidophilic cytoplasm and vesicular nuclei, scattered cells exhibited mild vacuolation. The tissue showed reduced inflammatory infiltration compared to diabetic controls, with minimal fibrous tissue surrounding hepatic lobules, central veins, and portal areas. Notable features included prominent Kupffer cells along sinusoidal linings and visible bile canaliculi in portal tracts (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig12">12</a>B1, B2).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-12" data-title="Fig. 12"><figure><figcaption><b id="Fig12" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 12</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/12" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig12_HTML.png?as=webp"><img aria-describedby="Fig12" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig12_HTML.png" alt="figure 12" loading="lazy" width="685" height="522"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-12-desc"><p>Photomicrographs of rat liver tissue of <b>7</b>-treated group (A1-A3) and PIO-treated group (B1 &amp; B2). (<b>A1</b>) Hepatocytes have normal appearance but few hepatocytes appeared slightly vacuolated (tailed arrows). (<b>A2</b>) Kupffer cells appear inserted in the endothelial lining of hepatic sinusoids detected by particles of brown containing pigments (double arrows). (<b>A3</b>) Branching bile canaliculi (BC) seen in portal tracts. (<b>B1</b>) Classic hepatic lobules were roughly hexagonal in shape with CV forming their central axis from which cords of hepatocytes radiating like sun rays and surrounded at each corner by PA. (<b>B2</b>) Delicate collagen fibers in the interlobular septa and surrounding the liver cells and the blood sinusoids.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/12" data-track-dest="link:Figure12 Full size image" aria-label="Full size image figure 12" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>It has been proposed that the oxidative cleavage of the TZD ring is a convinced metabolic pathway leading to the formation of reactive intermediates, and hence TZD toxicity. Metabolic studies confirmed this perception by the presence of <i>S</i>-oxidized metabolites of Troglitazone, PIO, and Rosiglitazone<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Reddy, V. B. G. et al. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols. Chem. Res. Toxicol. 18, 880–888 (2005)." href="#ref-CR28" id="ref-link-section-d113436912e1919">28</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Shen, Z. et al. Identification of novel metabolites of pioglitazone in rat and dog. Xenobiotica 33, 499–509 (2008)." href="#ref-CR29" id="ref-link-section-d113436912e1919_1">29</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Alvarez-Sánchez, R., Montavon, F., Hartung, T. &amp; Pähler, A. Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and Pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. Chem. Res. Toxicol. 19, 1106–1116 (2006)." href="/articles/s41598-025-03387-9#ref-CR30" id="ref-link-section-d113436912e1922">30</a></sup> The proposed mechanism from these studies depicted by initial CYP450-mediated <i>S</i>-oxidation of TZD leading to formation of an unstable TZD sulfoxide. Then, the formed intermediate undergoes spontaneous cleavage to a reactive α-keto isocyanate intermediate. This isocyanate intermediate is more likely to covalently bind to hepatic proteins such as glutathione (GSH) and consequently cause hepatic failure<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="Ibrahim, A. M. et al. Chemistry and applications of functionalized 2,4-thiazolidinediones. Eur. J. Org. Chem. 26, e202300184 (2023)." href="/articles/s41598-025-03387-9#ref-CR22" id="ref-link-section-d113436912e1929">22</a></sup> In order to predict the metabolic positions on the TZD ring in <b>7</b>, it was submitted to GLORYx server, a reliable tool for forecasting the metabolites resulting from both phase I and phase II biotransformations<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="De Bruyn Kops, C., Šícho, M., Mazzolari, A. &amp;  Kirchmair, J. GLORYx: Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics. Chem. Res. Toxicol. 34, 286–299 (2021)." href="/articles/s41598-025-03387-9#ref-CR31" id="ref-link-section-d113436912e1937">31</a></sup> The results provided the atom positions of <b>7</b> where metabolic reactions are most likely to initiate by CYP450, ranked by probability of occurrence from highest to lowest (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig13">13</a>; Table <a data-track="click" data-track-label="link" data-track-action="table anchor" href="/articles/s41598-025-03387-9#Tab1">1</a>).</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-13" data-title="Fig. 13"><figure><figcaption><b id="Fig13" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 13</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/13" rel="nofollow"><picture><img aria-describedby="Fig13" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig13_HTML.png" alt="figure 13" loading="lazy" width="685" height="404"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-13-desc"><p>Chemical structure of compound <b>7</b> with its numbering by GLORYx.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/13" data-track-dest="link:Figure13 Full size image" aria-label="Full size image figure 13" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><div class="c-article-table" data-test="inline-table" data-container-section="table" id="table-1"><figure><figcaption class="c-article-table__figcaption"><b id="Tab1" data-test="table-caption">Table 1 The probability of metabolic biotransformation at each position of compound <b>7</b> proposed by GLORYx.</b></figcaption><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="table-link" data-track="click" data-track-action="view table" data-track-label="button" rel="nofollow" href="/articles/s41598-025-03387-9/tables/1" aria-label="Full size table 1"><span>Full size table</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>These results indicated that the sulfur atom would be the primary site of metabolism, with a P of 0.584, while all other atom positions within the TZD exhibited significantly lower probabilities, each falling below 0.1. Other carbons within the quinoline and phenyl rings exhibited a substantially higher probability for metabolic reactions than the TZD moiety. This suggests that the TZD of compound <b>7</b> may be less susceptible to metabolic transformations, except sulfur atom.</p><p>Furthermore, the investigation extended to the structural elucidation of the predicted metabolites using GLORYx server, depicted in Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig14">14</a>. These predictions revealed that the foremost metabolic transformation involved the oxidation of the sulfur atom <b>M</b>-<b>I</b>, while there were no observed metabolites with a cleaved TZD ring. Subsequently, the second-highest probabilities were associated with hydroxylation reactions at C5, C7, and C8 of the quinoline <b>M</b>-<b>II</b>: <b>M</b>-<b>IV</b>, each possessing an equal likelihood of 0.26, followed by hydroxylation of phenyl group <b>M-V</b>: <b>M-VII</b> (P: 0.25). Interestingly, the analysis also observed the glutathionation process in phase II metabolism <i>via</i> conjugation at the methine group <b>M</b>-<b>VIII</b>, which served as a Michael acceptor, along with C2 of the quinoline moiety <b>M</b>-<b>IX</b>. These results indicated the high possibility of metabolic reactions to locate at sulfur atom through <i>S</i>-oxidation without ring cleavage. This observation may be attributed to the substitution at the nitrogen atom of the TZD moiety, which likely prevents hydrolysis of TZD and consequently the formation of reactive metabolites that could potentially induce toxicity<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="Campos, M. L. et al. New pioglitazone metabolites and absence of opened-ring metabolites in new N-substituted thiazolidinedione. Drug Metab. Dispos. 46, 879–887 (2018)." href="/articles/s41598-025-03387-9#ref-CR20" id="ref-link-section-d113436912e2435">20</a></sup> These findings reveal that <b>7</b> could be less toxic than the current glitazones.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-14" data-title="Fig. 14"><figure><figcaption><b id="Fig14" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 14</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/14" rel="nofollow"><picture><img aria-describedby="Fig14" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig14_HTML.png" alt="figure 14" loading="lazy" width="685" height="787"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-14-desc"><p>Predicted metabolic structures of compound <b>7</b> through phase I and II using GLORYx.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/14" data-track-dest="link:Figure14 Full size image" aria-label="Full size image figure 14" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec9">Morphological changes in pancreatic tissue</h4><p>Histopathological studies were performed to evaluate the effect of <b>7</b> and PIO on pancreatic islets. The normal histological structure of the pancreatic tissue appeared in the form of lobules packed with acini that were separated from each other by very little connective tissue septa (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig15">15</a>A1-A4). It was reported that alloxan causes degeneration and necrosis of pancreatic β-cells<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Ramadan, B. K., Schaalan, M. F. &amp; Tolba, A. M. Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats. BMC Complement. Altern. Med 17, (2017)." href="/articles/s41598-025-03387-9#ref-CR32" id="ref-link-section-d113436912e2480">32</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Ighodaro, O. M., Adeosun, A. M. &amp; Akinloye, O. A. Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies. Med. (B Aires). 53, 365–374 (2017)." href="/articles/s41598-025-03387-9#ref-CR33" id="ref-link-section-d113436912e2483">33</a></sup> The results showed that diabetic pancreatic tissue was characterized by marked morphological changes in the form of widening of the interlobular connective tissue containing numerous congested blood vessels loaded with RBCs (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig15">15</a>B1-B5). The inflammatory cells, mainly neutrophils, and eosinophils, were also seen surrounding ducts.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-15" data-title="Fig. 15"><figure><figcaption><b id="Fig15" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 15</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/15" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig15_HTML.png?as=webp"><img aria-describedby="Fig15" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig15_HTML.png" alt="figure 15" loading="lazy" width="685" height="798"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-15-desc"><p>Photomicrograph of rat pancreatic tissue obtained from normal and diabetic groups and stained with hematoxylin and eosin (H &amp; E). (<b>A1-A4</b>) Control group showing pancreatic acini with its basal basophilia and apical acidophilia (AC), Islets of Langerhans (IL) containing cells that form cords separated by a network of blood capillaries. α-Cells at the periphery (thick arrows) and β-cells at the center (thin arrows). (<b>B1-B3</b>) Diabetic group showing some islet’s cells with pyknotic and/or fragmented nuclei. The degenerated cells surrounded by empty spaces were filled with amyloid-like material. Some islets appear completely devoid of cells (black star). (<b>B4-B5</b>) Intralobular and interlobular ducts showed stratification of their epithelial lining (LD &amp; ILD).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/15" data-track-dest="link:Figure15 Full size image" aria-label="Full size image figure 15" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>However, the pancreatic tissue of diabetic group treated with PIO showed signs of improvement in tissue organization (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig16">16</a>A1-A2). The pancreatic lobules appeared more organized with intervening connective tissue. The remaining islets demonstrated better preservation with reduced inflammatory cellular infiltration compared to the diabetic control group. These results agree with studies that demonstrated the protective effects on pancreatic β-cells exerted by PIO<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Kimura, T. et al. Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in Db/db mice: comparison of their effects between in an early and advanced stage of diabetes. Mol. Cell. Endocrinol. 400, 78–89 (2015)." href="/articles/s41598-025-03387-9#ref-CR34" id="ref-link-section-d113436912e2525">34</a></sup> The pancreatic tissue of <b>7</b>-treated group showed marked improvement which was observed in the morphological features (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig16">16</a>B1-B2). The overall tissue architecture appeared more preserved compared to the diabetic control group, except some blood vessels remained congested, and certain ducts showed dilation with retained secretions. The reduction in inflammatory infiltration and better preservation of tissue architecture suggest that compound <b>7</b> may exert protective effects on pancreatic tissue similar to PIO, possibly through anti-inflammatory and antioxidant mechanisms. These protective effects could help maintain pancreatic function during the diabetic state, though longer-term studies would be needed to evaluate any potential effects on tissue regeneration.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-16" data-title="Fig. 16"><figure><figcaption><b id="Fig16" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 16</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/16" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig16_HTML.png?as=webp"><img aria-describedby="Fig16" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig16_HTML.png" alt="figure 16" loading="lazy" width="685" height="337"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-16-desc"><p>Photomicrograph of rat pancreatic tissue obtained from PIO- and <b>7</b>-treated groups and stained with H&amp;E. (<b>A1-A2</b>) PIO-treated group showing scattered areas of small lobules separated by abundant connective tissue. Many islets showed an increase in cellular density, reduction of the inflammatory cellular infiltration, and more numerous β-cells occupying the center of the islets (empty circle), LDs were dilated and lined with flat cells and filled with accumulated secretion. (<b>B1-B2</b>) <b>7</b>-treated group showing normal pancreatic tissue. The islet cells appeared normal with fibroblast-like cells infiltrating the islets (stripped arrows). An islet showing connection by a stream of cells to the nearby duct that showed nearly normal lining epithelium (yellow arrows).</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/16" data-track-dest="link:Figure16 Full size image" aria-label="Full size image figure 16" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec10">Molecular docking study</h3><p>Molecular docking studies were performed to investigate the binding mode of compound <b>7</b> within the PPARγ LBD, and to compare it with the reference drug PIO. The PPARγ LBD has a large Y-shaped ligand binding pocket. PIO adopts a U-shaped conformation within the binding site with the hydrophobic chains wrapping around H3. TZD of PIO is reported to exist adjacent to H12 where the nitrogen atom makes a hydrogen bond with the hydroxyl group of Tyr473 in H12, stabilizing the active conformation of H12. Additionally, two carbonyl groups of the TZD head group make hydrogen bonds with the side chains of His323, Ser289, and His449. The phenyl group of the PIO engaged in hydrophobic interaction with amino acid Cys285<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Gampe, R. T. et al. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell. 5, 545–555 (2000)." href="/articles/s41598-025-03387-9#ref-CR35" id="ref-link-section-d113436912e2582">35</a></sup>.</p><p>Docking studies of compound <b>7</b> on PPARγ, complexed with PIO as a co-crystallized ligand (PDB code: 5Y2O), were performed using AutoDock software. To validate the docking protocol, PIO was re-docked onto the binding domain of PPARγ. PIO docked at almost the same position with a binding score of -9.62 kcal/mol with RMSD equals 1.73 Å.</p><p>The docking results also revealed a high binding score for <b>7</b> (-9.66 Kcal/mol). The analysis revealed that the binding pose of compound <b>7</b> typically lies between arm I and arm II of the PPARγ binding pocket (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig17">17</a>). The phenyl ring of compound <b>7</b> showed the same interactions with key amino acid Cys285 (arm I), similar to the co-crystallized ligand. The quinoline ring of compound <b>7</b> played a critical role in stabilizing the molecule through multiple interactions (arm II). The quinoline ring itself established a π-π stacking interaction with Arg288, while the nitrogen atom of the quinoline moiety formed a hydrogen bond with Glu343. Furthermore, the chloro substituent of the quinoline ring participated in hydrophobic interactions with Leu333, enhancing the compound’s affinity in this region of the binding pocket (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig17">17</a>). Finally, TZD ring formed a network of π-sigma interactions with Leu330 and Arg288, further reinforcing the compound’s positioning within the binding pocket.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-17" data-title="Fig. 17"><figure><figcaption><b id="Fig17" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 17</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/17" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig17_HTML.png?as=webp"><img aria-describedby="Fig17" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig17_HTML.png" alt="figure 17" loading="lazy" width="685" height="968"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-17-desc"><p>(<b>A</b>) Overall structure of the PPARγ LBD complexed with compound <b>7</b> (green); (<b>B</b>) 3D and (<b>C</b>) 2D binding mode of <b>7</b> with PPARγ LBD.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/17" data-track-dest="link:Figure17 Full size image" aria-label="Full size image figure 17" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec11">In silico ADME prediction</h3><p>The ADME properties of compound <b>7</b> were evaluated using the SwissADME server and compared with PIO as a reference drug<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Daina, A., Michielin, O. &amp; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 1–13 (2017)." href="/articles/s41598-025-03387-9#ref-CR36" id="ref-link-section-d113436912e2660">36</a></sup> The results (Table <a data-track="click" data-track-label="link" data-track-action="supplementary material anchor" href="/articles/s41598-025-03387-9#MOESM1">S1</a>) confirmed that compound <b>7</b> complies with Lipinski’s rule of five, with no violations, suggesting favorable oral bioavailability. The pharmacokinetic predictions indicate high gastrointestinal (GI) absorption, further supporting the compound’s suitability for oral administration. The blood-brain barrier (BBB) permeability is predicted to be low, suggesting that compound 7 is unlikely to cause central nervous system (CNS)-related side effects. Moreover, compound <b>7</b> is not a P-glycoprotein (P-gp) substrate, indicating it is not actively effluxed, which may contribute to improved bioavailability. Furthermore, compound <b>7</b> does not trigger any PAINS (Pan-Assay Interference Compounds) alerts. Additionally, the synthetic accessibility score of 3.29 suggests that compound <b>7</b> is relatively straightforward to synthesize, supporting its feasibility for synthesis.</p><p>Overall, compound <b>7</b> shares the same biological profile and binding mode as SPPARMs, offering the benefits of partial receptor activation with reduced adverse effects (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/articles/s41598-025-03387-9#Fig18">18</a>). Compound <b>7</b> represents a novel and safer alternative to PIO, providing a strong foundation for the future development of improved PPARγ modulators for diabetes treatment.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-18" data-title="Fig. 18"><figure><figcaption><b id="Fig18" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 18</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/18" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig18_HTML.png?as=webp"><img aria-describedby="Fig18" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_Fig18_HTML.png" alt="figure 18" loading="lazy" width="685" height="490"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-18-desc"><p>Comparative summary of biological and synthetic profiles of PIO and compound 7.</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/articles/s41598-025-03387-9/figures/18" data-track-dest="link:Figure18 Full size image" aria-label="Full size image figure 18" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div></div></div></section><section data-title="Experimental"><div class="c-article-section" id="Sec12-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec12">Experimental</h2><div class="c-article-section__content" id="Sec12-content"><h3 class="c-article__sub-heading" id="Sec13">Chemistry</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec14">Materials and methods</h4><p>All required chemicals, solvents, and reagents were purchased from Sigma–Aldrich and Merck. Reaction progress was monitored using thin layer chromatography (TLC) on pre-coated Silica Gel Merck 60 F254 aluminum sheets, using hexane/ethyl acetate (2:8) as the mobile phase. TLC spots were visualized under UV light (254/365 nm). Melting points of the synthesized compounds were determined by open glass capillary tubes and are uncorrected. The<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="DeFronzo, R. A. et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Primers. 1, 15019 (2015)." href="/articles/s41598-025-03387-9#ref-CR1" id="ref-link-section-d113436912e2728">1</a></sup>H NMR and<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Lincoff, A. M., Wolski, K., Nicholls, S. J. &amp; Nissen, S. E. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 298, 1180–1188 (2007)." href="/articles/s41598-025-03387-9#ref-CR13" id="ref-link-section-d113436912e2732">13</a></sup>C NMR spectra were recorded on Bruker model DRX-500 and 100 MHz, respectively, in DMSO-<i>d</i><sub>6</sub> using tetramethylsilane (TMS) as the internal standard. Chemical shift values are given in δ (ppm) and the signals are described as s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet) whereas coupling constants (<i>J</i>) are expressed in Hz. Mass spectra were recorded on an Advion Compact Mass Spectrometer (CMS) using electrospray ionization (ESI) with amlodipine as standard. HPLC analysis was performed on an Agilent 1260 Infinity II system using 100% acetonitrile as the mobile phase.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec15">Synthesis of 2-chloroquinoline-3-carbaldehyde 1</h4><p>Yellow crystals, (4.1 gm) 42% yield, m.p.: 144–146 °C (lit. m.p.: 146–148 °C)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Salahuddin, Mazumder, A. &amp; Shaharyar, M. Synthesis, antibacterial and anticancer evaluation of 5-substituted (1,3,4-oxadiazol-2-yl)quinoline. Med. Chem. Res. 24, 2514–2528 (2015)." href="/articles/s41598-025-03387-9#ref-CR37" id="ref-link-section-d113436912e2751">37</a></sup>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec16">Synthesis of (2-chloroquinolin-3-yl)methanol 2</h4><p>White powder, (0.35 gm) 91% yield, m.p.: 166–167 °C (lit. m.p.: 166–168 °C)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Bokosi, F. R. B. et al. Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents. Bioorg. Med. Chem. Lett. 38, 127855 (2021)." href="/articles/s41598-025-03387-9#ref-CR38" id="ref-link-section-d113436912e2763">38</a></sup>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec17">Synthesis of 2-chloro-3-(chloromethyl)quinoline 3</h4><p>Light brown crystals, (0.293 gm) 92% yield; m.p.: 115–116 °C (lit. m.p.: 116–117 °C)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="Bokosi, F. R. B. et al. Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents. Bioorg. Med. Chem. Lett. 38, 127855 (2021)." href="/articles/s41598-025-03387-9#ref-CR38" id="ref-link-section-d113436912e2775">38</a></sup>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec18">Synthesis of 1,<b>3-thiazolidine-2</b>,<b>4-dione 4</b>
                           </h4><p>White crystals, (5.69 gm) 81% yield, m.p.: 126–127 °C (lit. m.p.: 125–127 °C)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Elkholy, N. et al. Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands. Chem. Biol. Drug Des. 100, 25–40 (2022)." href="/articles/s41598-025-03387-9#ref-CR39" id="ref-link-section-d113436912e2795">39</a></sup>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec19">
                              <b>Synthesis of (</b>
                              <b><i>Z</i></b>
                              <b>)-5-benzylidenethiazolidine-2</b>,<b>4-diones 5</b>
                           </h4><p>Pale yellow powder, (0.32 gm) 78% yield, m.p.: 237–238 °C (lit. m.p.: 237–238 °C)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Meirelles, L. V. et al. Diverse 3-methylthio-4-substituted maleimides through a novel rearrangement reaction: synthesis and selective cell imaging. J. Org. Chem. 87, 2809–2820 (2022)." href="/articles/s41598-025-03387-9#ref-CR40" id="ref-link-section-d113436912e2820">40</a></sup>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec20">Synthesis of (<i>Z</i>)-5-benzylidene-1,3-thiazolidine-2,4-dione potassium salt 6</h4><p>White powder, (0.276 gm) 76% yield, m.p.: &gt;300 °C.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec21">Synthesis of (<i>Z</i>) 5-benzylidene-3-[(2-chloroquinolin-3-yl)methyl]thiazolidine-2,4-diones 7</h4><p>Potassium salt of (<i>Z</i>)-5-benzylidenethiazolidine-2,4-dione <b>6</b> (1 mmol, 0.243 gm) was added to a stirred solution of intermediate <b>3</b> (1 mmol, 0.212 gm) in acetonitrile (50 mL) and heated under reflux. The progress of the reaction was monitored by TLC using 3:7 hexane : ethyl acetate as eluent. After the completion of the reaction, the solvent was evaporated under reduced pressure. Then, the residue was added to water, the formed precipitate was filtered off, washed with water, dried, and recrystallized from acetonitrile. White crystals, (0.239 gm) 63% yield, m.p.:235–236 °C; <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (s, 1 H, quinoline H4), 8.03 (d, <i>J</i> = 8.1 Hz, 1 H, quinoline H5), 7.97 (s, 1 H, methine C-H), 7.94 (d, <i>J</i> = 8.4 Hz, 1 H, quinoline H8), 7.79 (m, 1 H, quinoline H7), 7.64 (m, 3 H, phenyl 2 H and quinoline H6), 7.54 (m, 2 H, phenyl), 7.49 (m, 1 H, phenyl), 5.00 (s, 2 H, CH<sub>2</sub>); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.41, 165.50, 148.25, 146.28, 137.31, 133.38, 132.95, 130.96, 130.78, 130.19, 129.45, 127.99, 127.62, 127.51, 126.88, 126.50, 121.38, 42.60; HPLC analysis: Mobile phase: 100% MeCN, Retention Time (RT): 2.395 min, peak area: 94.89% at λ<sup>max</sup> 236 nm; ESI-MS m/z: 380.5 [M + H]+ (calcd. for C<sub>21</sub>H<sub>14</sub>ClN<sub>2</sub>O<sub>2</sub>S, 380.86).</p><h3 class="c-article__sub-heading" id="Sec22">Biological investigation</h3><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec23">In vivo antidiabetic activity</h4><p>In vivo antidiabetic study was determined by studying the effect of orally administered compound <b>7</b> on glucose tolerance on alloxan-induced non-insulin-dependent diabetes mellitus (NIDDM) in rats<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Ighodaro, O. M., Adeosun, A. M. &amp; Akinloye, O. A. Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies. Med. (B Aires). 53, 365–374 (2017)." href="/articles/s41598-025-03387-9#ref-CR33" id="ref-link-section-d113436912e2905">33</a></sup> Twenty adult healthy male Albino Wistar rats (170–200 gm) were acquired from Deraya University, Minia, Egypt, and kept at room temperature with food and water <i>ad libitum</i>. Alloxan was freshly prepared in normal saline solution for inducing diabetes at a dose of 120 mg/kg body weight intraperitoneally to fifteen overnight-fasted rats, after 3 days of acclimatization. To overcome drug-induced hypoglycemia, the animals were permitted to drink only 5% glucose solution the whole night. The remaining five rats were injected with an equivalent volume of CMC as the normal control group (Group I). BGL was measured after 72 h for all rats using glucometer. Rats were considered diabetic when their BGL was found to be at least 250 mg/dL.<sup>26</sup> Diabetic rats were then divided into three groups (five rats each). Diabetic control group (Group II) was only given the vehicle (0.25% CMC) orally. Diabetic rats were orally fed with PIO (Diabetin tablets, Unipharma<sup>®</sup>) as 0.25% CMC suspension at a dose of 36 mg/kg (Group III). Diabetic rats were orally fed with synthesized compound <b>7</b> (as 0.25% CMC suspension) at an equimolar dose (38 mg/kg) of the reference drug PIO (Group IV). BGLs were then measured at 0, 1, 7, and 15 days by collecting blood samples from the tail vein (caudal vein)<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Togashi, Y. et al. Evaluation of the appropriateness of using glucometers for measuring the blood glucose levels in mice. Sci. Rep. 6, 25465 (2016)." href="/articles/s41598-025-03387-9#ref-CR41" id="ref-link-section-d113436912e2920">41</a></sup> The percentage of change in blood glucose level was calculated using the following formula<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Candasamy, M., Murthy, T. E. G. K., Gubiyappa, K. S., Chellappan, D. K. &amp; Gupta, G. Alteration of glucose lowering effect of glibenclamide on single and multiple treatments with fenofibrate in experimental rats and rabbit models. J. Basic. Clin. Pharm. 5, 62 (2014)." href="/articles/s41598-025-03387-9#ref-CR42" id="ref-link-section-d113436912e2924">42</a></sup>.</p><p>% lowering of blood glucose level = (C<sub>F</sub> – C<sub>L</sub>) / C<sub>F</sub> × 100.</p><p>C<sub>F</sub> is the blood glucose concentration on day 0, and C<sub>L</sub> is the blood glucose concentration after 15 days.</p><p>Overnight-fasted rats were weighed using an electric balance prior to the commencement of the study, and their weights were recorded on day 15 for body weight gain study.</p><p>After the end of the experiment, animals were euthanized using an overdose of Ketamine-Xylazine (300 mg/kg and 36 mg/kg, respectively) administered intraperitoneally. This method ensured that the animals were rendered unconscious and insensible to pain prior to sacrifice. Following confirmation of deep anesthesia through absence of pedal reflex and the induction of anesthesia, the animals were humanely sacrificed, and terminal blood collection was performed <i>via</i> cardiac puncture. Plasma samples were then collected for biochemical analysis. Pancreas was collected and divided into two portions. One portion for studying morphological changes in pancreatic tissue. The other portion of pancreas was freshly extracted with TRIzol™ reagent for total RNA. All animal experiments were approved by the Institutional Animal Ethics Committee (Approval No. 12/2023) at Deraya university. The study was conducted in accordance with the relevant guidelines and regulations, including National Institutes of Health (NIH) guidelines. Additionally, all procedures followed the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines to ensure proper reporting of in vivo studies.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec24">PPARγ gene expression study</h4><p>An ultrasonic homogenizer (Sonics-Vibracell, Sonics &amp; Materials Inc., Newtown, USA) was used to homogenize 100 mg of pancreatic tissue in 1 mL of TRIzol™ solution (Amresco, Solon, USA). Total RNA was isolated from pancreatic tissues using the TRIzol™ RNA extraction reagent (Amresco, Solon, USA) according to the manufacturer’s instructions. The total RNA concentration was assessed at A<sub>260</sub> nm, and the purity was computed using the A<sub>260</sub>/A<sub>280</sub> ratio. When purity of the samples ≥ 1.7, samples were used for qRT-PCR utilizing GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) as a reference housekeeping gene for determining the relative expression of PPARγ.</p><p>The RevertAid H Minus First Strand cDNA Synthesis kit (#K1632, Thermo Scientific Fermentas, St. Leon-Ro, Germany) was used to synthesize cDNA for equivalent amounts of total RNA in all samples, according to the manufacturer’s instructions. Single-stranded cDNAs were used in real-time PCR. SYBER Green [#K0251, Thermo Scientific Fermentas St. Leon-Ro, Germany-Maxima SYBER Green qPCR Master Mix (2X)] was used for PCR reactions and the StepOne Real-Time PCR Detection System (Applied Biosystems) was also used. Real-time polymerase chain reaction (qRT-PCR) was performed with 20 µL of RealMOD Green qRT-PCR Mix kit (iNtRON biotechnology) containing 0.02 µg RNA per reaction and 10 Pmol of specified primers for 30 cycles of 95 °C for 10 s. and 60 °C for 1 min. To assess the relative quantities of the products, the comparative threshold cycle (Ct) approach was utilized. The formula 2 <sup>(−ΔΔCt)</sup> was used to determine the relative expression. They were scaled in relation to controls, with control samples set to a value of one. The PPARγ primers used for rat-specific PPARγ were (forward: 5′- GCA TGG TGC CTT CGC TGA TG -3′; reverse: 5′- AGA ATA ATA AGG CGG GGA CGC − 3′) and GenBank accession number is NM_013124.3.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec25">Hepatotoxicity studies</h4><p>The collected samples of serum ALT and AST of the mice were quantified with ALT assay kits, according to the manufacturers’ protocols<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Naim, M. J. et al. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives. Bioorg. Chem. 73, 24–36 (2017)." href="/articles/s41598-025-03387-9#ref-CR43" id="ref-link-section-d113436912e2981">43</a></sup>.</p><p>Predicted metabolites of <b>7</b> were generated using the web-based GLORYx tool (<a href="https://nerdd.univie.ac.at/gloryx/">https://nerdd.univie.ac.at/gloryx/</a><i>)</i>, University of Hamburg, Germany, simulating phase I and phase II metabolic reactions in humans using machine learning and site-of-reaction-based prediction models<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="De Bruyn Kops, C., Šícho, M., Mazzolari, A. &amp;  Kirchmair, J. GLORYx: Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics. Chem. Res. Toxicol. 34, 286–299 (2021)." href="/articles/s41598-025-03387-9#ref-CR31" id="ref-link-section-d113436912e3000">31</a></sup> This was achieved by using the “phase I and II metabolism” option following the generation of SMILE notation using ChemDraw. Results from phase I and II metabolites with a corresponding score equal to or greater than 25% were selected.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec26">Morphological changes in pancreatic tissue</h4><p>One portion of pancreas was collected and stored in 10% neutral-buffered formalin, dehydrated in a graded ethanol series, cleared in xylene, and embedded in paraffin wax. Five Sects. (3–5 μm thickness) were stained with H&amp;E and then examined under microscope at 400x and 1000x magnification<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Lambert, J. D. et al. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem. Toxicol. 48, 409 (2010)." href="/articles/s41598-025-03387-9#ref-CR44" id="ref-link-section-d113436912e3012">44</a></sup>.</p><h4 class="c-article__sub-heading c-article__sub-heading--small" id="Sec27">Statistical analysis</h4><p>The data was encoded and entered using the Graph Pad Prism version 9 statistical package (Graph Pad, La Jolla, CA, USA). Statistical variations between groups were evaluated using one-way analysis of variance (ANOVA) followed by Bonferroni <i>t</i>-test. Results of all biological studies were expressed as means ± SD. P-values less than 0.05, was considered statistically significant, *<i>p</i> &lt; 0.05.</p><h3 class="c-article__sub-heading" id="Sec28">Molecular docking study</h3><p>Molecular docking was performed using AutoDock. The crystal structure of PPARγ was obtained from RCSB Protein Data Bank (<a href="http://www.rcsb.org/">http://www.rcsb.org/</a><i>).</i> The crystal structure 5Y2O was selected for docking studies as it met the criteria of high-resolution data, well-defined binding sites, and their association with the specific ligand of interest in our research<sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Lee, M. A., Tan, L., Yang, H., Im, Y. G. &amp; Im, Y. J. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs. Sci. Rep. 7, 16837 (2017)." href="/articles/s41598-025-03387-9#ref-CR45" id="ref-link-section-d113436912e3049">45</a></sup> The input files for molecular docking were prepared using Discovery Studio (DS) 2016 client and AutoDock tools 4.2.6 bundled with MGL tools (version 1.5.7). Prior to docking, the protein structure was subjected to necessary cleaning procedures, which involved removing small molecular ligands, heteroatoms, non-standard residues, and water molecules. The 3D structures of ligands were retrieved from ChemDraw as a single file in 3D-spatial data file (SDF) format. The structures of ligands were energy-minimized using a universal force field and saved in PDB format. Then, these files were imported to Autodock, the Gasteiger charges and polar hydrogens were added, and the ligands were set up for the rotatable bond. The prepared protein and ligand files were then converted into PDBQT format, which serves as an input file for AutoDock for molecular docking. The binding site of the ligand was chosen according to a literature survey and selected as the active grid center. The dimensions of grid box were chosen to include all atoms of the ligands, default parameters were utilized with a grid box (74 × 60 × 82) Å which centered at (-47.217 × -1.288 × 77.334) Å with 0.375 Å of grid spacing. Additionally, the docking process was validated using co-crystallized ligand to ensure its quality and reliability for subsequent docking studies and the RMSD was calculated using LigRMSD server (<a href="https://ligrmsd.appsbio.utalca.cl/">https://ligrmsd.appsbio.utalca.cl/</a>). The molecular docking was proceeded using tested ligand and the protein-ligand conformation with the lowest binding energy was chosen and visualized by DS 2016 client.</p><h3 class="c-article__sub-heading" id="Sec29">In silico ADME prediction</h3><p>The ADME properties of compound <b>7</b> were predicted using the SwissADME online tool (<a href="http://swissadme.ch/)">http://swissadme.ch/)</a><sup><a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Daina, A., Michielin, O. &amp; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 1–13 (2017)." href="/articles/s41598-025-03387-9#ref-CR36" id="ref-link-section-d113436912e3077">36</a></sup>. Molecular descriptors, pharmacokinetics, lipophilicity, and water solubility were analyzed to assess oral drug-likeness.</p></div></div></section><section data-title="Conclusion"><div class="c-article-section" id="Sec30-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec30">Conclusion</h2><div class="c-article-section__content" id="Sec30-content"><p>In this study, we successfully designed, synthesized, and evaluated compound <b>7</b>, a novel quinoline-thiazolidinedione hybrid, as a potential SPPARM with improved safety and therapeutic potential for diabetes management. Compound <b>7</b> demonstrated effective antidiabetic activity, effectively lowering blood glucose levels while exhibiting a safer metabolic and histopathological profile compared to PIO. Notably, compound <b>7</b> showed lower hepatotoxicity, minimal weight gain, and enhanced metabolic stability, addressing key safety concerns associated with traditional thiazolidinediones. Furthermore, its protective effects on liver and pancreatic tissues highlight its potential as a safer therapeutic option.</p><p>Molecular docking studies confirmed the strong binding affinity of compound <b>7</b> to PPARγ, interacting with key amino acid residues within the PPARγ LBD. These findings support its role as a potential selective PPARγ modulator, capable of dissociating insulin-sensitizing effects from adverse side effects. Additionally, ADME predictions indicated that compound <b>7</b> complies with Lipinski’s rule of five, with no violations, suggesting favorable oral bioavailability and high gastrointestinal GI absorption, making it suitable for oral administration.</p><p>While our findings demonstrate the promising potential of compound <b>7</b>, certain limitations should be acknowledged. Direct PPARγ binding assays are essential for measuring its efficacy and comparing it with other partial agonists. Moreover, while computational ADME predictions provide valuable insights into compound <b>7</b>’s pharmacokinetic profile, further experimental pharmacokinetic studies are important to validate these findings and fully characterize ADME properties. These studies are planned as part of our future work to further explore its pharmacological potential.</p></div></div></section>
                    
                </div>
            

            <div class="u-mt-32">
                <section data-title="Data availability"><div class="c-article-section" id="data-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content" id="data-availability-content">
              
              <p>The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request. All relevant data supporting the findings of this study, including synthetic procedures, in vivo experimental results, NMR spectra, and HPLC chromatograms are included in the manuscript and its supplementary information files. Additional raw data such as molecular docking files, can be provided by the corresponding author upon request.</p>
            </div></div></section><section data-title="Abbreviations"><div class="c-article-section" id="abbreviations-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="abbreviations">Abbreviations</h2><div class="c-article-section__content" id="abbreviations-content"><dl class="c-abbreviation_list"><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>AC:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Apical acidophilia</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>AF2:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Activation function 2</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>ALT:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Alanine transaminase</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>AST:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Aspartate transaminase</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>BBB:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Blood brain barrier</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>BC:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Bile canaliculi</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>BGL:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Blood glucose level</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>CMC:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Carboxy methyl cellulose</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>CNS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Central nervous system</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>Ct:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Threshold cycle</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>CV:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Central veins</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>CYP:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Cytochrome</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>CYP450:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Cytochrome P450</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>DS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Discovery Studio</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>ESI:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Electrospray ionization</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>GAPDH:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Glyceraldehyde-3-phosphate dehydrogenase</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>GI:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Gastrointestinal</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>GSH:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Glutathione</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>H:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Helix</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>H&amp;E:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Hematoxylin and eosin</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>IL:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Islets of Langerhans</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>ILD:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Interlobular ducts</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>LBD:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Ligand-binding domain</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>LD:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Intralobular ducts</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>NASH:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Nonalcoholic steatohepatitis</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>NIDDM:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Non-insulin-dependent diabetes mellitus</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>NIH:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>National Institutes of Health</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>P:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Probability</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>PA:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Portal areas</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>PAINS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Pan-assay interference compounds</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>PCOS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Polycystic ovarian syndrome</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>P-gp:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>P-glycoprotein</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>PIO:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Pioglitazone</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>PPARγ:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Peroxisome proliferator-activated receptor γ</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>PPREs:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>PPAR response elements</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>qRT-PCR:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Real-time polymerase chain reaction</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>RMSD:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Root mean square deviation</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>RXR:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Retinoid X receptor</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>SAR:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Structure–activity relationship</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>SPPARMs:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Selective PPARγ modulators</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>T2DM:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Type II diabetes mellitus</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>TLC:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Thin layer chromatography</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>TMS:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Tetramethylsilane</p>
                  </dd><dt class="c-abbreviation_list__term u-text-bold u-float-left u-pr-16" style="min-width:50px;"><dfn>TZD:</dfn></dt><dd class="c-abbreviation_list__description u-mb-24">
                    <p>Thiazolidinedione</p>
                  </dd></dl></div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">DeFronzo, R. A. et al. Type 2 diabetes mellitus. <i>Nat. Rev. Dis. Primers</i>. <b>1</b>, 15019 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nrdp.2015.19" data-track-item_id="10.1038/nrdp.2015.19" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnrdp.2015.19" aria-label="Article reference 1" data-doi="10.1038/nrdp.2015.19">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27189025" aria-label="PubMed reference 1">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=Type%202%20diabetes%20mellitus&amp;journal=Nat.%20Rev.%20Dis.%20Primers&amp;doi=10.1038%2Fnrdp.2015.19&amp;volume=1&amp;publication_year=2015&amp;author=DeFronzo%2CRA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Yki-Järvinen, H. Thiazolidinediones. <i>N. Engl. J. Med.</i> <b>351</b>, 1106–1118 (2004).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMra041001" data-track-item_id="10.1056/NEJMra041001" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMra041001" aria-label="Article reference 2" data-doi="10.1056/NEJMra041001">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15356308" aria-label="PubMed reference 2">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Thiazolidinediones&amp;journal=N.%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMra041001&amp;volume=351&amp;pages=1106-1118&amp;publication_year=2004&amp;author=Yki-J%C3%A4rvinen%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Yau, H., Rivera, K., Lomonaco, R. &amp; Cusi, K. The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus. <i>Curr. Diab Rep.</i> <b>13</b>, 329–341 (2013).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s11892-013-0378-8" data-track-item_id="10.1007/s11892-013-0378-8" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s11892-013-0378-8" aria-label="Article reference 3" data-doi="10.1007/s11892-013-0378-8">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXnsFSntrk%3D" aria-label="CAS reference 3">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23625197" aria-label="PubMed reference 3">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20future%20of%20thiazolidinedione%20therapy%20in%20the%20management%20of%20type%202%20diabetes%20mellitus&amp;journal=Curr.%20Diab%20Rep.&amp;doi=10.1007%2Fs11892-013-0378-8&amp;volume=13&amp;pages=329-341&amp;publication_year=2013&amp;author=Yau%2CH&amp;author=Rivera%2CK&amp;author=Lomonaco%2CR&amp;author=Cusi%2CK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Kahn, S. E. et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. <i>N Engl. J. Med.</i> <b>355</b>, 2427–2443 (2006).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1056/NEJMoa066224" data-track-item_id="10.1056/NEJMoa066224" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1056%2FNEJMoa066224" aria-label="Article reference 4" data-doi="10.1056/NEJMoa066224">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD28Xht12ntrzF" aria-label="CAS reference 4">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17145742" aria-label="PubMed reference 4">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Glycemic%20durability%20of%20rosiglitazone%2C%20metformin%2C%20or%20glyburide%20monotherapy&amp;journal=N%20Engl.%20J.%20Med.&amp;doi=10.1056%2FNEJMoa066224&amp;volume=355&amp;pages=2427-2443&amp;publication_year=2006&amp;author=Kahn%2CSE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Soccio, R. E., Chen, E. R. &amp; Lazar, M. A. Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes. <i>Cell. Metab.</i> <b>20</b>, 573–591 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cmet.2014.08.005" data-track-item_id="10.1016/j.cmet.2014.08.005" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cmet.2014.08.005" aria-label="Article reference 5" data-doi="10.1016/j.cmet.2014.08.005">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhsFyrtbbN" aria-label="CAS reference 5">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25242225" aria-label="PubMed reference 5">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192012" aria-label="PubMed Central reference 5">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Thiazolidinediones%20and%20the%20promise%20of%20insulin%20sensitization%20in%20type%202%20diabetes&amp;journal=Cell.%20Metab.&amp;doi=10.1016%2Fj.cmet.2014.08.005&amp;volume=20&amp;pages=573-591&amp;publication_year=2014&amp;author=Soccio%2CRE&amp;author=Chen%2CER&amp;author=Lazar%2CMA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Bansal, G., Thanikachalam, P. V., Maurya, R. K., Chawla, P. &amp; Ramamurthy, S. An overview on medicinal perspective of thiazolidine-2,4-dione: A remarkable scaffold in the treatment of type 2 diabetes. <i>J. Adv. Res.</i> <b>23</b>, 163–205 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jare.2020.01.008" data-track-item_id="10.1016/j.jare.2020.01.008" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jare.2020.01.008" aria-label="Article reference 6" data-doi="10.1016/j.jare.2020.01.008">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXmsl2ntLY%3D" aria-label="CAS reference 6">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32154036" aria-label="PubMed reference 6">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052407" aria-label="PubMed Central reference 6">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20overview%20on%20medicinal%20perspective%20of%20thiazolidine-2%2C4-dione%3A%20A%20remarkable%20scaffold%20in%20the%20treatment%20of%20type%202%20diabetes&amp;journal=J.%20Adv.%20Res.&amp;doi=10.1016%2Fj.jare.2020.01.008&amp;volume=23&amp;pages=163-205&amp;publication_year=2020&amp;author=Bansal%2CG&amp;author=Thanikachalam%2CPV&amp;author=Maurya%2CRK&amp;author=Chawla%2CP&amp;author=Ramamurthy%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Ahmadian, M. et al. PPARγ signaling and metabolism: the good, the bad and the future. <i>Nat. Med.</i> <b>19</b>, 557–566 (2013).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/nm.3159" data-track-item_id="10.1038/nm.3159" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnm.3159" aria-label="Article reference 7" data-doi="10.1038/nm.3159">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXntF2kurs%3D" aria-label="CAS reference 7">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=23652116" aria-label="PubMed reference 7">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=PPAR%CE%B3%20signaling%20and%20metabolism%3A%20the%20good%2C%20the%20bad%20and%20the%20future&amp;journal=Nat.%20Med.&amp;doi=10.1038%2Fnm.3159&amp;volume=19&amp;pages=557-566&amp;publication_year=2013&amp;author=Ahmadian%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Rosen, E. D. &amp; Spiegelman, B. M. PPARγ: A nuclear regulator of metabolism, differentiation, and cell growth. <i>J. Biol. Chem.</i> <b>276</b>, 37731–37734 (2001).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1074/jbc.R100034200" data-track-item_id="10.1074/jbc.R100034200" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1074%2Fjbc.R100034200" aria-label="Article reference 8" data-doi="10.1074/jbc.R100034200">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3MXotFOrsbo%3D" aria-label="CAS reference 8">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=11459852" aria-label="PubMed reference 8">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=PPAR%CE%B3%3A%20A%20nuclear%20regulator%20of%20metabolism%2C%20differentiation%2C%20and%20cell%20growth&amp;journal=J.%20Biol.%20Chem.&amp;doi=10.1074%2Fjbc.R100034200&amp;volume=276&amp;pages=37731-37734&amp;publication_year=2001&amp;author=Rosen%2CED&amp;author=Spiegelman%2CBM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Mangelsdorf, D. J. &amp; Evans, R. M. The RXR heterodimers and orphan receptors. <i>Cell</i> <b>83</b>, 841–850 (1995).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/0092-8674(95)90200-7" data-track-item_id="10.1016/0092-8674(95)90200-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2F0092-8674%2895%2990200-7" aria-label="Article reference 9" data-doi="10.1016/0092-8674(95)90200-7">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK2MXhtVSnu7nK" aria-label="CAS reference 9">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8521508" aria-label="PubMed reference 9">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20RXR%20heterodimers%20and%20orphan%20receptors&amp;journal=Cell&amp;doi=10.1016%2F0092-8674%2895%2990200-7&amp;volume=83&amp;pages=841-850&amp;publication_year=1995&amp;author=Mangelsdorf%2CDJ&amp;author=Evans%2CRM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">Schoonjans, K., Staels, B. &amp; Auwerx, J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. <i>Biochim. Biophys. Acta</i>. <b>1302</b>, 93–109 (1996).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/0005-2760(96)00066-5" data-track-item_id="10.1016/0005-2760(96)00066-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2F0005-2760%2896%2900066-5" aria-label="Article reference 10" data-doi="10.1016/0005-2760(96)00066-5">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DyaK28zhtlygsA%3D%3D" aria-label="CAS reference 10">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8695669" aria-label="PubMed reference 10">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 10" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20peroxisome%20proliferator%20activated%20receptors%20%28PPARS%29%20and%20their%20effects%20on%20lipid%20metabolism%20and%20adipocyte%20differentiation&amp;journal=Biochim.%20Biophys.%20Acta&amp;doi=10.1016%2F0005-2760%2896%2900066-5&amp;volume=1302&amp;pages=93-109&amp;publication_year=1996&amp;author=Schoonjans%2CK&amp;author=Staels%2CB&amp;author=Auwerx%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">Saltiel, A. R. &amp; Olefsky, J. M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. <i>Diabetes</i> <b>45</b>, 1661–1669 (1996).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2337/diab.45.12.1661" data-track-item_id="10.2337/diab.45.12.1661" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2337%2Fdiab.45.12.1661" aria-label="Article reference 11" data-doi="10.2337/diab.45.12.1661">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK28XntlCmtL4%3D" aria-label="CAS reference 11">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=8922349" aria-label="PubMed reference 11">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Thiazolidinediones%20in%20the%20treatment%20of%20insulin%20resistance%20and%20type%20II%20diabetes&amp;journal=Diabetes&amp;doi=10.2337%2Fdiab.45.12.1661&amp;volume=45&amp;pages=1661-1669&amp;publication_year=1996&amp;author=Saltiel%2CAR&amp;author=Olefsky%2CJM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Nolte, R. T. et al. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. <i>Nature</i> <b>395</b>, 137–143 (1998).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/25931" data-track-item_id="10.1038/25931" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2F25931" aria-label="Article reference 12" data-doi="10.1038/25931">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaK1cXmtVekt7k%3D" aria-label="CAS reference 12">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=9744270" aria-label="PubMed reference 12">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Ligand%20binding%20and%20co-activator%20assembly%20of%20the%20peroxisome%20proliferator-activated%20receptor-gamma&amp;journal=Nature&amp;doi=10.1038%2F25931&amp;volume=395&amp;pages=137-143&amp;publication_year=1998&amp;author=Nolte%2CRT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">Lincoff, A. M., Wolski, K., Nicholls, S. J. &amp; Nissen, S. E. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. <i>JAMA</i> <b>298</b>, 1180–1188 (2007).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1001/jama.298.10.1180" data-track-item_id="10.1001/jama.298.10.1180" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1001%2Fjama.298.10.1180" aria-label="Article reference 13" data-doi="10.1001/jama.298.10.1180">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXhtVGmtL3J" aria-label="CAS reference 13">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=17848652" aria-label="PubMed reference 13">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Pioglitazone%20and%20risk%20of%20cardiovascular%20events%20in%20patients%20with%20type%202%20diabetes%20mellitus%3A%20a%20meta-analysis%20of%20randomized%20trials&amp;journal=JAMA&amp;doi=10.1001%2Fjama.298.10.1180&amp;volume=298&amp;pages=1180-1188&amp;publication_year=2007&amp;author=Lincoff%2CAM&amp;author=Wolski%2CK&amp;author=Nicholls%2CSJ&amp;author=Nissen%2CSE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">Tang, H. et al. Pioglitazone and bladder cancer risk: a systematic review and meta-analysis. <i>Cancer Med.</i> <b>7</b>, 1070–1080 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/cam4.1354" data-track-item_id="10.1002/cam4.1354" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fcam4.1354" aria-label="Article reference 14" data-doi="10.1002/cam4.1354">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXotlygsrw%3D" aria-label="CAS reference 14">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29476615" aria-label="PubMed reference 14">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911601" aria-label="PubMed Central reference 14">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Pioglitazone%20and%20bladder%20cancer%20risk%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=Cancer%20Med.&amp;doi=10.1002%2Fcam4.1354&amp;volume=7&amp;pages=1070-1080&amp;publication_year=2018&amp;author=Tang%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">Tuccori, M. et al. Pioglitazone use and risk of bladder cancer: population based cohort study. <i>BMJ</i>. <b>352</b> (2016).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">Gelman, L., Feige, J. N. &amp; Desvergne, B. Molecular basis of selective PPARγ modulation for the treatment of type 2 diabetes. <i>Biochim. Et Biophys. Acta (BBA) - Mol. Cell. Biology Lipids</i>. <b>1771</b>, 1094–1107 (2007).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2sXovFensrw%3D" aria-label="CAS reference 16">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20basis%20of%20selective%20PPAR%CE%B3%20modulation%20for%20the%20treatment%20of%20type%202%20diabetes&amp;journal=Biochim.%20Et%20Biophys.%20Acta%20%28BBA%29%20-%20Mol.%20Cell.%20Biology%20Lipids&amp;volume=1771&amp;pages=1094-1107&amp;publication_year=2007&amp;author=Gelman%2CL&amp;author=Feige%2CJN&amp;author=Desvergne%2CB">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Higgins, L. S. &amp; Depaoli, A. M. Selective peroxisome proliferator-activated receptor γ (PPARγ) modulation as a strategy for safer therapeutic PPARγ activation. <i>Am. J. Clin. Nutr.</i> <b>91</b>, 267S–270S (2010).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3945/ajcn.2009.28449E" data-track-item_id="10.3945/ajcn.2009.28449E" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3945%2Fajcn.2009.28449E" aria-label="Article reference 17" data-doi="10.3945/ajcn.2009.28449E">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhs1WlsbfL" aria-label="CAS reference 17">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19906796" aria-label="PubMed reference 17">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Selective%20peroxisome%20proliferator-activated%20receptor%20%CE%B3%20%28PPAR%CE%B3%29%20modulation%20as%20a%20strategy%20for%20safer%20therapeutic%20PPAR%CE%B3%20activation&amp;journal=Am.%20J.%20Clin.%20Nutr.&amp;doi=10.3945%2Fajcn.2009.28449E&amp;volume=91&amp;pages=267S-270S&amp;publication_year=2010&amp;author=Higgins%2CLS&amp;author=Depaoli%2CAM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Motani, A. et al. INT131: a selective modulator of PPAR gamma. <i>J. Mol. Biol.</i> <b>386</b>, 1301–1311 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jmb.2009.01.025" data-track-item_id="10.1016/j.jmb.2009.01.025" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jmb.2009.01.025" aria-label="Article reference 18" data-doi="10.1016/j.jmb.2009.01.025">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXisFamsr0%3D" aria-label="CAS reference 18">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19452630" aria-label="PubMed reference 18">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=INT131%3A%20a%20selective%20modulator%20of%20PPAR%20gamma&amp;journal=J.%20Mol.%20Biol.&amp;doi=10.1016%2Fj.jmb.2009.01.025&amp;volume=386&amp;pages=1301-1311&amp;publication_year=2009&amp;author=Motani%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Taxak, N., Parmar, V., Patel, D. S., Kotasthane, A. &amp; Bharatam, P. V. S-oxidation of thiazolidinedione with hydrogen peroxide, peroxynitrous acid, and c4a-hydroperoxyflavin: A theoretical study. <i>J. Phys. Chem. A</i>. <b>115</b>, 891–898 (2011).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/jp109935k" data-track-item_id="10.1021/jp109935k" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Fjp109935k" aria-label="Article reference 19" data-doi="10.1021/jp109935k">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXivFertQ%3D%3D" aria-label="CAS reference 19">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=21214231" aria-label="PubMed reference 19">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=S-oxidation%20of%20thiazolidinedione%20with%20hydrogen%20peroxide%2C%20peroxynitrous%20acid%2C%20and%20c4a-hydroperoxyflavin%3A%20A%20theoretical%20study&amp;journal=J.%20Phys.%20Chem.%20A&amp;doi=10.1021%2Fjp109935k&amp;volume=115&amp;pages=891-898&amp;publication_year=2011&amp;author=Taxak%2CN&amp;author=Parmar%2CV&amp;author=Patel%2CDS&amp;author=Kotasthane%2CA&amp;author=Bharatam%2CPV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">Campos, M. L. et al. New pioglitazone metabolites and absence of opened-ring metabolites in new N-substituted thiazolidinedione. <i>Drug Metab. Dispos.</i> <b>46</b>, 879–887 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1124/dmd.117.079012" data-track-item_id="10.1124/dmd.117.079012" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1124%2Fdmd.117.079012" aria-label="Article reference 20" data-doi="10.1124/dmd.117.079012">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhvVWlsbrE" aria-label="CAS reference 20">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29618574" aria-label="PubMed reference 20">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 20" href="http://scholar.google.com/scholar_lookup?&amp;title=New%20poglitazone%20metabolites%20and%20absence%20of%20opened-ring%20metabolites%20in%20new%20N-substituted%20thiazolidinedione&amp;journal=Drug%20Metab.%20Dispos.&amp;doi=10.1124%2Fdmd.117.079012&amp;volume=46&amp;pages=879-887&amp;publication_year=2018&amp;author=Campos%2CML">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">Mohamed, M. F. A. &amp; Abuo-Rahma, G. E. D. A. Molecular targets and anticancer activity of quinoline–chalcone hybrids: literature review. <i>RSC Adv.</i> <b>10</b>, 31139–31155 (2020).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1039/D0RA05594H" data-track-item_id="10.1039/D0RA05594H" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1039%2FD0RA05594H" aria-label="Article reference 21" data-doi="10.1039/D0RA05594H">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3cXhs1Cis7%2FK" aria-label="CAS reference 21">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35520674" aria-label="PubMed reference 21">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9056499" aria-label="PubMed Central reference 21">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 21" href="http://scholar.google.com/scholar_lookup?&amp;title=Molecular%20targets%20and%20anticancer%20activity%20of%20quinoline%E2%80%93chalcone%20hybrids%3A%20literature%20review&amp;journal=RSC%20Adv.&amp;doi=10.1039%2FD0RA05594H&amp;volume=10&amp;pages=31139-31155&amp;publication_year=2020&amp;author=Mohamed%2CMFA&amp;author=Abuo-Rahma%2CGEDA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">Ibrahim, A. M. et al. Chemistry and applications of functionalized 2,4-thiazolidinediones. <i>Eur. J. Org. Chem.</i> <b>26</b>, e202300184 (2023).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/ejoc.202300184" data-track-item_id="10.1002/ejoc.202300184" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fejoc.202300184" aria-label="Article reference 22" data-doi="10.1002/ejoc.202300184">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXpt1SisrY%3D" aria-label="CAS reference 22">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 22" href="http://scholar.google.com/scholar_lookup?&amp;title=Chemistry%20and%20applications%20of%20functionalized%202%2C4-thiazolidinediones&amp;journal=Eur.%20J.%20Org.%20Chem.&amp;doi=10.1002%2Fejoc.202300184&amp;volume=26&amp;publication_year=2023&amp;author=Ibrahim%2CAM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Sohda, T. et al. Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives. <i>Chem. Pharm. Bull. (Tokyo)</i>. <b>30</b>, 3580–3600 (1982).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1248/cpb.30.3580" data-track-item_id="10.1248/cpb.30.3580" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1248%2Fcpb.30.3580" aria-label="Article reference 23" data-doi="10.1248/cpb.30.3580">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DyaL3sXht1Gqtrs%3D" aria-label="CAS reference 23">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=7160012" aria-label="PubMed reference 23">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=Studies%20on%20antidiabetic%20agents.%20II.%20Synthesis%20of%205-%5B4-%281-methylcyclohexylmethoxy%29-benzyl%5Dthiazolidine-2%2C4-dione%20%28ADD-3878%29%20and%20its%20derivatives&amp;journal=Chem.%20Pharm.%20Bull.%20%28Tokyo%29&amp;doi=10.1248%2Fcpb.30.3580&amp;volume=30&amp;pages=3580-3600&amp;publication_year=1982&amp;author=Sohda%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">Madivada, L. R. et al. An improved process for pioglitazone and its pharmaceutically acceptable salt. <i>Org. Process. Res. Dev.</i> <b>13</b>, 1190–1194 (2009).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/op900131m" data-track-item_id="10.1021/op900131m" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Fop900131m" aria-label="Article reference 24" data-doi="10.1021/op900131m">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhtF2lurfO" aria-label="CAS reference 24">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=An%20improved%20process%20for%20pioglitazone%20and%20its%20pharmaceutically%20acceptable%20salt&amp;journal=Org.%20Process.%20Res.%20Dev.&amp;doi=10.1021%2Fop900131m&amp;volume=13&amp;pages=1190-1194&amp;publication_year=2009&amp;author=Madivada%2CLR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">Nazreen, S. et al. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists. <i>Eur. J. Med. Chem.</i> <b>87</b>, 175–185 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ejmech.2014.09.010" data-track-item_id="10.1016/j.ejmech.2014.09.010" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ejmech.2014.09.010" aria-label="Article reference 25" data-doi="10.1016/j.ejmech.2014.09.010">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhsFyrtLnK" aria-label="CAS reference 25">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25255433" aria-label="PubMed reference 25">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 25" href="http://scholar.google.com/scholar_lookup?&amp;title=Design%2C%20synthesis%2C%20in%20silico%20molecular%20docking%20and%20biological%20evaluation%20of%20novel%20oxadiazole%20based%20thiazolidine-2%2C4-diones%20bis-heterocycles%20as%20PPAR-%CE%B3%20agonists&amp;journal=Eur.%20J.%20Med.%20Chem.&amp;doi=10.1016%2Fj.ejmech.2014.09.010&amp;volume=87&amp;pages=175-185&amp;publication_year=2014&amp;author=Nazreen%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Naim, M. J. et al. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators. <i>Arch. Pharm. (Weinheim)</i>. <b>351</b>, e1700223 (2018).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/ardp.201700223" data-track-item_id="10.1002/ardp.201700223" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fardp.201700223" aria-label="Article reference 26" data-doi="10.1002/ardp.201700223">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29400412" aria-label="PubMed reference 26">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=Synthesis%2C%20docking%2C%20in%20vitro%20and%20in%20vivo%20antidiabetic%20activity%20of%20pyrazole-based%202%2C4-thiazolidinedione%20derivatives%20as%20PPAR-%CE%B3%20modulators&amp;journal=Arch.%20Pharm.%20%28Weinheim%29&amp;doi=10.1002%2Fardp.201700223&amp;volume=351&amp;publication_year=2018&amp;author=Naim%2CMJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">Kroker, A. J. &amp; Bruning, J. B. Review of the structural and dynamic mechanisms of PPARγ partial agonism. <i>PPAR Res</i>. <b>2015</b> (2015).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Reddy, V. B. G. et al. Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols. <i>Chem. Res. Toxicol.</i> <b>18</b>, 880–888 (2005).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/tx0500373" data-track-item_id="10.1021/tx0500373" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Ftx0500373" aria-label="Article reference 28" data-doi="10.1021/tx0500373">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXjtFGhtr8%3D" aria-label="CAS reference 28">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=15892582" aria-label="PubMed reference 28">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanistic%20studies%20on%20the%20metabolic%20scission%20of%20thiazolidinedione%20derivatives%20to%20acyclic%20thiols&amp;journal=Chem.%20Res.%20Toxicol.&amp;doi=10.1021%2Ftx0500373&amp;volume=18&amp;pages=880-888&amp;publication_year=2005&amp;author=Reddy%2CVBG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">Shen, Z. et al. Identification of novel metabolites of pioglitazone in rat and dog. <i>Xenobiotica</i> <b>33</b>, 499–509 (2008).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1080/0049825031000085951" data-track-item_id="10.1080/0049825031000085951" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1080%2F0049825031000085951" aria-label="Article reference 29" data-doi="10.1080/0049825031000085951">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 29" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20of%20novel%20metabolites%20of%20pioglitazone%20in%20rat%20and%20dog&amp;journal=Xenobiotica&amp;doi=10.1080%2F0049825031000085951&amp;volume=33&amp;pages=499-509&amp;publication_year=2008&amp;author=Shen%2CZ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Alvarez-Sánchez, R., Montavon, F., Hartung, T. &amp; Pähler, A. Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and Pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry. <i>Chem. Res. Toxicol.</i> <b>19</b>, 1106–1116 (2006).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/tx050353h" data-track-item_id="10.1021/tx050353h" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Ftx050353h" aria-label="Article reference 30" data-doi="10.1021/tx050353h">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16918252" aria-label="PubMed reference 30">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=Thiazolidinedione%20bioactivation%3A%20A%20comparison%20of%20the%20bioactivation%20potentials%20of%20troglitazone%2C%20rosiglitazone%2C%20and%20Pioglitazone%20using%20stable%20isotope-labeled%20analogues%20and%20liquid%20chromatography%20tandem%20mass%20spectrometry&amp;journal=Chem.%20Res.%20Toxicol.&amp;doi=10.1021%2Ftx050353h&amp;volume=19&amp;pages=1106-1116&amp;publication_year=2006&amp;author=Alvarez-S%C3%A1nchez%2CR&amp;author=Montavon%2CF&amp;author=Hartung%2CT&amp;author=P%C3%A4hler%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">De Bruyn Kops, C., Šícho, M., Mazzolari, A. &amp;  Kirchmair, J. GLORYx: Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics. <i>Chem. Res. Toxicol.</i> <b>34</b>, 286–299 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/acs.chemrestox.0c00224" data-track-item_id="10.1021/acs.chemrestox.0c00224" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Facs.chemrestox.0c00224" aria-label="Article reference 31" data-doi="10.1021/acs.chemrestox.0c00224">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32786543" aria-label="PubMed reference 31">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=GLORYx%3A%20Prediction%20of%20the%20metabolites%20resulting%20from%20phase%201%20and%20phase%202%20biotransformations%20of%20xenobiotics&amp;journal=Chem.%20Res.%20Toxicol.&amp;doi=10.1021%2Facs.chemrestox.0c00224&amp;volume=34&amp;pages=286-299&amp;publication_year=2021&amp;author=Bruyn%20Kops%2CC&amp;author=%C5%A0%C3%ADcho%2CM&amp;author=Mazzolari%2CA&amp;author=Kirchmair%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Ramadan, B. K., Schaalan, M. F. &amp; Tolba, A. M. Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats. <i>BMC Complement. Altern. Med</i> <b>17</b>, (2017).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">Ighodaro, O. M., Adeosun, A. M. &amp; Akinloye, O. A. Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies. <i>Med. (B Aires)</i>. <b>53</b>, 365–374 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=Alloxan-induced%20diabetes%2C%20a%20common%20model%20for%20evaluating%20the%20glycemic-control%20potential%20of%20therapeutic%20compounds%20and%20plants%20extracts%20in%20experimental%20studies&amp;journal=Med.%20%28B%20Aires%29&amp;volume=53&amp;pages=365-374&amp;publication_year=2017&amp;author=Ighodaro%2COM&amp;author=Adeosun%2CAM&amp;author=Akinloye%2COA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Kimura, T. et al. Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in Db/db mice: comparison of their effects between in an early and advanced stage of diabetes. <i>Mol. Cell. Endocrinol.</i> <b>400</b>, 78–89 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.mce.2014.11.018" data-track-item_id="10.1016/j.mce.2014.11.018" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.mce.2014.11.018" aria-label="Article reference 34" data-doi="10.1016/j.mce.2014.11.018">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXitVWhtb%2FI" aria-label="CAS reference 34">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25463759" aria-label="PubMed reference 34">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=Protective%20effects%20of%20pioglitazone%20and%2For%20liraglutide%20on%20pancreatic%20%CE%B2-cells%20in%20Db%2Fdb%20mice%3A%20comparison%20of%20their%20effects%20between%20in%20an%20early%20and%20advanced%20stage%20of%20diabetes&amp;journal=Mol.%20Cell.%20Endocrinol.&amp;doi=10.1016%2Fj.mce.2014.11.018&amp;volume=400&amp;pages=78-89&amp;publication_year=2015&amp;author=Kimura%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Gampe, R. T. et al. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. <i>Mol. Cell.</i> <b>5</b>, 545–555 (2000).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S1097-2765(00)80448-7" data-track-item_id="10.1016/S1097-2765(00)80448-7" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS1097-2765%2800%2980448-7" aria-label="Article reference 35" data-doi="10.1016/S1097-2765(00)80448-7">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3cXisVWrs7s%3D" aria-label="CAS reference 35">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=10882139" aria-label="PubMed reference 35">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Asymmetry%20in%20the%20PPARgamma%2FRXRalpha%20crystal%20structure%20reveals%20the%20molecular%20basis%20of%20heterodimerization%20among%20nuclear%20receptors&amp;journal=Mol.%20Cell.&amp;doi=10.1016%2FS1097-2765%2800%2980448-7&amp;volume=5&amp;pages=545-555&amp;publication_year=2000&amp;author=Gampe%2CRT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Daina, A., Michielin, O. &amp; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. <i>Sci. Rep.</i> <b>7</b>(1), 1–13 (2017).</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Salahuddin, Mazumder, A. &amp; Shaharyar, M. Synthesis, antibacterial and anticancer evaluation of 5-substituted (1,3,4-oxadiazol-2-yl)quinoline. <i>Med. Chem. Res.</i> <b>24</b>, 2514–2528 (2015).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s00044-014-1308-2" data-track-item_id="10.1007/s00044-014-1308-2" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00044-014-1308-2" aria-label="Article reference 37" data-doi="10.1007/s00044-014-1308-2">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Synthesis%2C%20antibacterial%20and%20anticancer%20evaluation%20of%205-substituted%20%281%2C3%2C4-oxadiazol-2-yl%29quinoline&amp;journal=Med.%20Chem.%20Res.&amp;doi=10.1007%2Fs00044-014-1308-2&amp;volume=24&amp;pages=2514-2528&amp;publication_year=2015&amp;author=Salahuddin%2C%20Mazumder%2CA&amp;author=Shaharyar%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">Bokosi, F. R. B. et al. Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents. <i>Bioorg. Med. Chem. Lett.</i> <b>38</b>, 127855 (2021).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bmcl.2021.127855" data-track-item_id="10.1016/j.bmcl.2021.127855" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bmcl.2021.127855" aria-label="Article reference 38" data-doi="10.1016/j.bmcl.2021.127855">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXlsVyrt7Y%3D" aria-label="CAS reference 38">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33609655" aria-label="PubMed reference 38">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 38" href="http://scholar.google.com/scholar_lookup?&amp;title=Design%2C%20synthesis%20and%20biological%20evaluation%20of%20mono-%20and%20bisquinoline%20methanamine%20derivatives%20as%20potential%20antiplasmodial%20agents&amp;journal=Bioorg.%20Med.%20Chem.%20Lett.&amp;doi=10.1016%2Fj.bmcl.2021.127855&amp;volume=38&amp;publication_year=2021&amp;author=Bokosi%2CFRB">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">Elkholy, N. et al. Discovery of 3-(2-aminoethyl)-thiazolidine-2,4-diones as a novel chemotype of sigma-1 receptor ligands. <i>Chem. Biol. Drug Des.</i> <b>100</b>, 25–40 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/cbdd.14047" data-track-item_id="10.1111/cbdd.14047" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fcbdd.14047" aria-label="Article reference 39" data-doi="10.1111/cbdd.14047">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XhtFWitbfM" aria-label="CAS reference 39">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35353926" aria-label="PubMed reference 39">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Discovery%20of%203-%282-aminoethyl%29-thiazolidine-2%2C4-diones%20as%20a%20novel%20chemotype%20of%20sigma-1%20receptor%20ligands&amp;journal=Chem.%20Biol.%20Drug%20Des.&amp;doi=10.1111%2Fcbdd.14047&amp;volume=100&amp;pages=25-40&amp;publication_year=2022&amp;author=Elkholy%2CN">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Meirelles, L. V. et al. Diverse 3-methylthio-4-substituted maleimides through a novel rearrangement reaction: synthesis and selective cell imaging. <i>J. Org. Chem.</i> <b>87</b>, 2809–2820 (2022).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1021/acs.joc.1c02714" data-track-item_id="10.1021/acs.joc.1c02714" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1021%2Facs.joc.1c02714" aria-label="Article reference 40" data-doi="10.1021/acs.joc.1c02714">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XisFyqt7g%3D" aria-label="CAS reference 40">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35108004" aria-label="PubMed reference 40">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Diverse%203-methylthio-4-substituted%20maleimides%20through%20a%20novel%20rearrangement%20reaction%3A%20synthesis%20and%20selective%20cell%20imaging&amp;journal=J.%20Org.%20Chem.&amp;doi=10.1021%2Facs.joc.1c02714&amp;volume=87&amp;pages=2809-2820&amp;publication_year=2022&amp;author=Meirelles%2CLV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">Togashi, Y. et al. Evaluation of the appropriateness of using glucometers for measuring the blood glucose levels in mice. <i>Sci. Rep.</i> <b>6</b>, 25465 (2016).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/srep25465" data-track-item_id="10.1038/srep25465" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fsrep25465" aria-label="Article reference 41" data-doi="10.1038/srep25465">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XnsV2jsbo%3D" aria-label="CAS reference 41">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27151424" aria-label="PubMed reference 41">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858715" aria-label="PubMed Central reference 41">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Evaluation%20of%20the%20appropriateness%20of%20using%20glucometers%20for%20measuring%20the%20blood%20glucose%20levels%20in%20mice&amp;journal=Sci.%20Rep.&amp;doi=10.1038%2Fsrep25465&amp;volume=6&amp;publication_year=2016&amp;author=Togashi%2CY">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Candasamy, M., Murthy, T. E. G. K., Gubiyappa, K. S., Chellappan, D. K. &amp; Gupta, G. Alteration of glucose lowering effect of glibenclamide on single and multiple treatments with fenofibrate in experimental rats and rabbit models. <i>J. Basic. Clin. Pharm.</i> <b>5</b>, 62 (2014).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.4103/0976-0105.139728" data-track-item_id="10.4103/0976-0105.139728" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4103%2F0976-0105.139728" aria-label="Article reference 42" data-doi="10.4103/0976-0105.139728">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvFOnsr3N" aria-label="CAS reference 42">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25278668" aria-label="PubMed reference 42">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160721" aria-label="PubMed Central reference 42">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=Alteration%20of%20glucose%20lowering%20effect%20of%20glibenclamide%20on%20single%20and%20multiple%20treatments%20with%20fenofibrate%20in%20experimental%20rats%20and%20rabbit%20models&amp;journal=J.%20Basic.%20Clin.%20Pharm.&amp;doi=10.4103%2F0976-0105.139728&amp;volume=5&amp;publication_year=2014&amp;author=Candasamy%2CM&amp;author=Murthy%2CTEGK&amp;author=Gubiyappa%2CKS&amp;author=Chellappan%2CDK&amp;author=Gupta%2CG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">Naim, M. J. et al. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives. <i>Bioorg. Chem.</i> <b>73</b>, 24–36 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.bioorg.2017.05.007" data-track-item_id="10.1016/j.bioorg.2017.05.007" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.bioorg.2017.05.007" aria-label="Article reference 43" data-doi="10.1016/j.bioorg.2017.05.007">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsVOhu7bM" aria-label="CAS reference 43">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28582649" aria-label="PubMed reference 43">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Synthesis%2C%20molecular%20docking%20and%20anti-diabetic%20evaluation%20of%202%2C4-thiazolidinedione%20based%20amide%20derivatives&amp;journal=Bioorg.%20Chem.&amp;doi=10.1016%2Fj.bioorg.2017.05.007&amp;volume=73&amp;pages=24-36&amp;publication_year=2017&amp;author=Naim%2CMJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">Lambert, J. D. et al. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. <i>Food Chem. Toxicol.</i> <b>48</b>, 409 (2010).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.fct.2009.10.030" data-track-item_id="10.1016/j.fct.2009.10.030" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.fct.2009.10.030" aria-label="Article reference 44" data-doi="10.1016/j.fct.2009.10.030">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXhs1Wntr7F" aria-label="CAS reference 44">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19883714" aria-label="PubMed reference 44">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=Hepatotoxicity%20of%20high%20oral%20dose%20%28-%29-epigallocatechin-3-gallate%20in%20mice&amp;journal=Food%20Chem.%20Toxicol.&amp;doi=10.1016%2Fj.fct.2009.10.030&amp;volume=48&amp;publication_year=2010&amp;author=Lambert%2CJD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45">Lee, M. A., Tan, L., Yang, H., Im, Y. G. &amp; Im, Y. J. Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs. <i>Sci. Rep.</i> <b>7</b>, 16837 (2017).</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/s41598-017-17082-x" data-track-item_id="10.1038/s41598-017-17082-x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fs41598-017-17082-x" aria-label="Article reference 45" data-doi="10.1038/s41598-017-17082-x">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29203903" aria-label="PubMed reference 45">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715099" aria-label="PubMed Central reference 45">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=Structures%20of%20PPAR%CE%B3%20complexed%20with%20lobeglitazone%20and%20pioglitazone%20reveal%20key%20determinants%20for%20the%20recognition%20of%20antidiabetic%20drugs&amp;journal=Sci.%20Rep.&amp;doi=10.1038%2Fs41598-017-17082-x&amp;volume=7&amp;publication_year=2017&amp;author=Lee%2CMA&amp;author=Tan%2CL&amp;author=Yang%2CH&amp;author=Im%2CYG&amp;author=Im%2CYJ">
                    Google Scholar</a> 
                </p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41598-025-03387-9?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>I would like to thank my colleague: Sara Nabil Shokrany, Medical Biochemistry Department, Faculty of Postgraduates Studies for Advanced Science, Beni-Suef University, for providing me with the PPARγ qRT-PCR primers for the completion of PPARγ gene expression study.</p></div></div></section><section data-title="Funding"><div class="c-article-section" id="Fun-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Fun">Funding</h2><div class="c-article-section__content" id="Fun-content"><p>Open access funding provided by The Science, Technology &amp; Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Authors and Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Deraya University, New Minia, 61111, Egypt</p><p class="c-article-author-affiliation__authors-list">Ayman M. Ibrahim &amp; Gamal El-Din A. Abuo-Rahma</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, Minia, 61519, Egypt</p><p class="c-article-author-affiliation__authors-list">Mai E. Shoman &amp; Gamal El-Din A. Abuo-Rahma</p></li><li id="Aff3"><p class="c-article-author-affiliation__address">Department of Pharmacognosy, Faculty of Pharmacy, New Valley University, El-kharga City, Egypt</p><p class="c-article-author-affiliation__authors-list">Radwa Taher Mohie el-dien</p></li><li id="Aff4"><p class="c-article-author-affiliation__address">Department of Medical science, Histology and Cell Biology, Faculty of Pharmacy, Deraya University, New Minia, 61111, Egypt</p><p class="c-article-author-affiliation__authors-list">Entesar Ali Saber</p></li><li id="Aff5"><p class="c-article-author-affiliation__address">Department of Biochemistry, Faculty of Pharmacy, Deraya University, New Minia, 61111, Egypt</p><p class="c-article-author-affiliation__authors-list">Mahmoud Abdelnaser &amp; Mahmoud Abdul-Aziz El-Rehany</p></li><li id="Aff6"><p class="c-article-author-affiliation__address">Department of Biochemistry, Faculty of pharmacy, New Valley University, El-kharga City, Egypt</p><p class="c-article-author-affiliation__authors-list">Sherif A. Maher</p></li><li id="Aff7"><p class="c-article-author-affiliation__address">Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, 71526, Egypt</p><p class="c-article-author-affiliation__authors-list">Alaa M. Hayallah</p></li><li id="Aff8"><p class="c-article-author-affiliation__address">Pharmaceutical Chemistry Department, Faculty of Pharmacy, Sphinx University, New Assiut, Egypt</p><p class="c-article-author-affiliation__authors-list">Alaa M. Hayallah</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Ayman_M_-Ibrahim-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Ayman M. Ibrahim</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Ayman%20M.%20Ibrahim" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Ayman%20M.%20Ibrahim" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Ayman%20M.%20Ibrahim%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Mai_E_-Shoman-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Mai E. Shoman</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Mai%20E.%20Shoman" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Mai%20E.%20Shoman" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Mai%20E.%20Shoman%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Radwa_Taher_Mohie-el_dien-Aff3"><span class="c-article-authors-search__title u-h3 js-search-name">Radwa Taher Mohie el-dien</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Radwa%20Taher%20Mohie%20el-dien" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Radwa%20Taher%20Mohie%20el-dien" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Radwa%20Taher%20Mohie%20el-dien%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Entesar_Ali-Saber-Aff4"><span class="c-article-authors-search__title u-h3 js-search-name">Entesar Ali Saber</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Entesar%20Ali%20Saber" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Entesar%20Ali%20Saber" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Entesar%20Ali%20Saber%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Mahmoud-Abdelnaser-Aff5"><span class="c-article-authors-search__title u-h3 js-search-name">Mahmoud Abdelnaser</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Mahmoud%20Abdelnaser" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Mahmoud%20Abdelnaser" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Mahmoud%20Abdelnaser%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Sherif_A_-Maher-Aff6"><span class="c-article-authors-search__title u-h3 js-search-name">Sherif A. Maher</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Sherif%20A.%20Maher" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Sherif%20A.%20Maher" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Sherif%20A.%20Maher%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Alaa_M_-Hayallah-Aff7-Aff8"><span class="c-article-authors-search__title u-h3 js-search-name">Alaa M. Hayallah</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Alaa%20M.%20Hayallah" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Alaa%20M.%20Hayallah" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Alaa%20M.%20Hayallah%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Mahmoud_Abdul_Aziz-El_Rehany-Aff5"><span class="c-article-authors-search__title u-h3 js-search-name">Mahmoud Abdul-Aziz El-Rehany</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Mahmoud%20Abdul-Aziz%20El-Rehany" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Mahmoud%20Abdul-Aziz%20El-Rehany" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Mahmoud%20Abdul-Aziz%20El-Rehany%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Gamal_El_Din_A_-Abuo_Rahma-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Gamal El-Din A. Abuo-Rahma</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?author=Gamal%20El-Din%20A.%20Abuo-Rahma" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">You can also search for this author in</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Gamal%20El-Din%20A.%20Abuo-Rahma" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Gamal%20El-Din%20A.%20Abuo-Rahma%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="contributions">Contributions</h3><p>Ayman M. Ibrahim: Methodology, Investigation, Formal Analysis, Writing – Original Draft, Visualization.Mai E. Shoman: Writing – Review &amp; Editing.Radwa Taher Mohie el-dien: Investigation, Formal Analysis (HPLC).Entesar Ali Saber: Investigation, Formal Analysis (Histopathology).Mahmoud Abdelnaser: Investigation, Formal Analysis (PPARγ gene expression and liver enzymes).Sherif A. Maher: Formal Analysis (Statistical Analysis), Validation.Alaa M. Hayallah: Conceptualization, Supervision, Project Administration, Writing – Review &amp; Editing.Mahmoud Abdul-Aziz El-Rehany: Conceptualization, Supervision, Review &amp; Editing (Biological evaluation).Gamal El-Din A. Abuo-Rahma: Conceptualization, Supervision, Project Administration, Writing – Review &amp; Editing.</p><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding authors</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" href="mailto:alaa_hayalah@yahoo.com">Alaa M. Hayallah</a> or <a id="corresp-c2" href="mailto:gamal.aborahma@mu.edu.eg">Gamal El-Din A. Abuo-Rahma</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
              
                <h3 class="c-article__sub-heading" id="FPar1">Competing interests</h3>
                <p>The authors declare no competing interests.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><h3 class="c-article__sub-heading">Publisher’s note</h3><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Electronic supplementary material"><div class="c-article-section" id="Sec31-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec31">Electronic supplementary material</h2><div class="c-article-section__content" id="Sec31-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div><p>Below is the link to the electronic supplementary material.</p><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary material 1" href="https://static-content.springer.com/esm/art%3A10.1038%2Fs41598-025-03387-9/MediaObjects/41598_2025_3387_MOESM1_ESM.docx" data-supp-info-image="">Supplementary Material 1</a></h3></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="http://creativecommons.org/licenses/by/4.0/" rel="license">http://creativecommons.org/licenses/by/4.0/</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=Design%20and%20synthesis%20of%20a%20novel%20quinoline%20thiazolidinedione%20hybrid%20as%20a%20potential%20antidiabetic%20PPAR%CE%B3%20modulator&amp;author=Ayman%20M.%20Ibrahim%20et%20al&amp;contentID=10.1038%2Fs41598-025-03387-9&amp;copyright=The%20Author%28s%29&amp;publication=2045-2322&amp;publicationDate=2025-06-01&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1038/s41598-025-03387-9" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1038/s41598-025-03387-9" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img loading="lazy" width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Ibrahim, A.M., Shoman, M.E., el-dien, R.T.M. <i>et al.</i> Design and synthesis of a novel quinoline thiazolidinedione hybrid as a potential antidiabetic PPARγ modulator.
                    <i>Sci Rep</i> <b>15</b>, 19207 (2025). https://doi.org/10.1038/s41598-025-03387-9</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1038/s41598-025-03387-9?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2025-02-04">04 February 2025</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2025-05-20">20 May 2025</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2025-06-01">01 June 2025</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1038/s41598-025-03387-9</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-none" hidden=""><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><h3 class="c-article__sub-heading">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span><a href="/search?query=Quinoline&amp;facet-discipline=&#34;Science%2C%20Humanities%20and%20Social%20Sciences%2C%20multidisciplinary&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Quinoline</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Thiazolidinedione&amp;facet-discipline=&#34;Science%2C%20Humanities%20and%20Social%20Sciences%2C%20multidisciplinary&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Thiazolidinedione</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=PPAR%CE%B3&amp;facet-discipline=&#34;Science%2C%20Humanities%20and%20Social%20Sciences%2C%20multidisciplinary&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">PPARγ</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Antidiabetic&amp;facet-discipline=&#34;Science%2C%20Humanities%20and%20Social%20Sciences%2C%20multidisciplinary&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Antidiabetic</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=SPPARMs&amp;facet-discipline=&#34;Science%2C%20Humanities%20and%20Social%20Sciences%2C%20multidisciplinary&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">SPPARMs</a></span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>
            </div>

            

        </div>
</article>
</main>

<aside class="c-article-extras u-hide-print" aria-label="Article navigation" data-component-reading-companion data-container-type="reading-companion" data-track-component="reading companion">
    <div class="js-context-bar-sticky-point-desktop" data-track-context="reading companion">
        

        
            
                
                    
    
        <div class="c-pdf-download u-clear-both js-pdf-download">
            <a href="/articles/s41598-025-03387-9.pdf" class="u-button u-button--full-width u-button--primary u-justify-content-space-between c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="download-pdf" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="link" data-track-external download>
                <span class="c-pdf-download__text">Download PDF</span>
                <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-download"/></svg>
            </a>
        </div>
    

                
            
        
    </div>

    
        
    

    
    

    <div class="c-reading-companion">
        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky" data-test="reading-companion-sticky">
            <div class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active" id="tabpanel-sections">
                <div class="u-lazy-ad-wrapper u-mt-16 u-hide" data-component-mpu>
                    <div class="c-ad c-ad--300x250">
                        <div class="c-ad__inner">
                            <p class="c-ad__label">Advertisement</p>
                            
    <div id="div-gpt-ad-right-2"
         class="div-gpt-ad advert medium-rectangle js-ad text-center hide-print grade-c-hide"
         data-ad-type="right"
         data-test="right-ad"
         data-pa11y-ignore
         data-gpt
         data-gpt-unitpath="/285/scientific_reports/article"
         data-gpt-sizes="300x250"
         data-gpt-targeting="type=article;pos=right;artid=s41598-025-03387-9;doi=10.1038/s41598-025-03387-9;subjmeta=154,45,631,638,639,92;kwrd=Biochemistry,Chemical+biology,Chemistry,Drug+discovery">
        <noscript>
            <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/285/scientific_reports/article&amp;sz=300x250&amp;c=1174274527&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41598-025-03387-9%26doi%3D10.1038/s41598-025-03387-9%26subjmeta%3D154,45,631,638,639,92%26kwrd%3DBiochemistry,Chemical+biology,Chemistry,Drug+discovery">
                <img data-test="gpt-advert-fallback-img"
                     src="//pubads.g.doubleclick.net/gampad/ad?iu=/285/scientific_reports/article&amp;sz=300x250&amp;c=1174274527&amp;t=pos%3Dright%26type%3Darticle%26artid%3Ds41598-025-03387-9%26doi%3D10.1038/s41598-025-03387-9%26subjmeta%3D154,45,631,638,639,92%26kwrd%3DBiochemistry,Chemical+biology,Chemistry,Drug+discovery"
                     alt="Advertisement"
                     width="300"
                     height="250"></a>
        </noscript>
    </div>

                        </div>
                    </div>
                </div>
            </div>
            <div class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width" id="tabpanel-figures"></div>
            <div class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width" id="tabpanel-references"></div>
        </div>
    </div>
</aside>
</div>


    
        <nav class="c-header__dropdown" aria-labelledby="Explore-content" data-test="Explore-content" id="explore" data-track-component="nature-150-split-header">
            <div class="c-header__container">
                <h2 id="Explore-content" class="c-header__heading c-header__heading--js-hide">Explore content</h2>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/research-articles"
                                   data-track="click"
                                   data-track-action="research articles"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    Research articles
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/news-and-comment"
                                   data-track="click"
                                   data-track-action="news &amp; comment"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    News &amp; Comment
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/collections"
                                   data-track="click"
                                   data-track-action="collections"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    Collections
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/browse-subjects"
                                   data-track="click"
                                   data-track-action="subjects"
                                   data-track-label="link"
                                   data-test="explore-nav-item">
                                    Subjects
                                </a>
                            </li>
                        
                    
                </ul>
                <ul class="c-header__list c-header__list--js-stack">
                    
                        <li class="c-header__item">
                            <a class="c-header__link"
                               href="https://www.facebook.com/scientificreports"
                               data-track="click"
                               data-track-action="facebook"
                               data-track-label="link">Follow us on Facebook
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item">
                            <a class="c-header__link"
                               href="https://twitter.com/SciReports"
                               data-track="click"
                               data-track-action="twitter"
                               data-track-label="link">Follow us on Twitter
                            </a>
                        </li>
                    
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link"
                               href="https://www.nature.com/my-account/alerts/subscribe-journal?list-id&#x3D;288"
                               rel="nofollow"
                               data-track="nav_sign_up_for_alerts"
                               data-track-action="Sign up for alerts"
                               data-track-external
                               data-track-label="link (mobile dropdown)">Sign up for alerts<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill="#fff"/></svg>
                            </a>
                        </li>
                    
                    
                        <li class="c-header__item c-header__item--hide-lg">
                            <a class="c-header__link"
                               href="https://www.nature.com/srep.rss"
                               data-track="click"
                               data-track-action="rss feed"
                               data-track-label="link">
                                <span>RSS feed</span>
                            </a>
                        </li>
                    
                </ul>
            </div>
        </nav>
    
    
        
            <nav class="c-header__dropdown" aria-labelledby="About-the-journal" id="about-the-journal" data-test="about-the-journal" data-track-component="nature-150-split-header">
                <div class="c-header__container">
                    <h2 id="About-the-journal" class="c-header__heading c-header__heading--js-hide">About the journal</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/about"
                                   data-track="click"
                                   data-track-action="about scientific reports"
                                   data-track-label="link">
                                    About Scientific Reports
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/contact"
                                   data-track="click"
                                   data-track-action="contact"
                                   data-track-label="link">
                                    Contact
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/journal-policies"
                                   data-track="click"
                                   data-track-action="journal policies"
                                   data-track-label="link">
                                    Journal policies
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/guide-to-referees"
                                   data-track="click"
                                   data-track-action="guide to referees"
                                   data-track-label="link">
                                    Guide to referees
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/calls-for-papers"
                                   data-track="click"
                                   data-track-action="calls for papers"
                                   data-track-label="link">
                                    Calls for Papers
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/editorschoice"
                                   data-track="click"
                                   data-track-action="editor&#x27;s choice"
                                   data-track-label="link">
                                    Editor&#x27;s Choice
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/highlights"
                                   data-track="click"
                                   data-track-action="journal highlights"
                                   data-track-label="link">
                                    Journal highlights
                                </a>
                            </li>
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/open-access"
                                   data-track="click"
                                   data-track-action="open access fees and funding"
                                   data-track-label="link">
                                    Open Access Fees and Funding
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
        

        
            <nav class="c-header__dropdown" aria-labelledby="Publish-with-us-label" id="publish-with-us" data-test="publish-with-us" data-track-component="nature-150-split-header">
                <div class="c-header__container">
                    <h2 id="Publish-with-us-label" class="c-header__heading c-header__heading--js-hide">Publish with us</h2>
                    <ul class="c-header__list c-header__list--js-stack">
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/author-instructions"
                                   data-track="click"
                                   data-track-action="for authors"
                                   data-track-label="link">
                                    For authors
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link" data-test="nature-author-services"
                                   data-track="nav_language_services"
                                   data-track-context="header publish with us dropdown menu"
                                   data-track-action="manuscript author services"
                                   data-track-label="link manuscript author services"
                                   href="https://authorservices.springernature.com/go/sn/?utm_source=For+Authors&utm_medium=Website_Nature&utm_campaign=Platform+Experimentation+2022&utm_id=PE2022">
                                    Language editing services
                                </a>
                            </li>
                        
                        
                            <li class="c-header__item">
                                <a class="c-header__link"
                                   href="/srep/open-access-funding"
                                   data-test="funding-eligibility-link"
                                   data-track="click_explore_funding"
                                   data-track-context="header publish with us"
                                   data-track-action="funding eligibility">Open access funding</a>
                            </li>
                        
                        
                            <li class="c-header__item c-header__item--keyline">
                                <a class="c-header__link"
                                   href="https://author-welcome.nature.com/41598"
                                   data-track="click_submit_manuscript"
                                   data-track-context="submit link in Nature header dropdown menu"
                                   data-track-action="submit manuscript"
                                   data-track-label="link (publish with us dropdown menu)"
                                   data-track-external
                                   data-gtm-criteo="submit-manuscript">Submit manuscript<svg role="img" aria-hidden="true" focusable="false" height="18" viewBox="0 0 18 18" width="18" xmlns="http://www.w3.org/2000/svg"><path d="m15 0c1.1045695 0 2 .8954305 2 2v5.5c0 .27614237-.2238576.5-.5.5s-.5-.22385763-.5-.5v-5.5c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-9v3c0 1.1045695-.8954305 2-2 2h-3v10c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h7.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-7.5c-1.1045695 0-2-.8954305-2-2v-10.17157288c0-.53043297.21071368-1.0391408.58578644-1.41421356l3.82842712-3.82842712c.37507276-.37507276.88378059-.58578644 1.41421356-.58578644zm-.5442863 8.18867991 3.3545404 3.35454039c.2508994.2508994.2538696.6596433.0035959.909917-.2429543.2429542-.6561449.2462671-.9065387-.0089489l-2.2609825-2.3045251.0010427 7.2231989c0 .3569916-.2898381.6371378-.6473715.6371378-.3470771 0-.6473715-.2852563-.6473715-.6371378l-.0010428-7.2231995-2.2611222 2.3046654c-.2531661.2580415-.6562868.2592444-.9065605.0089707-.24295423-.2429542-.24865597-.6576651.0036132-.9099343l3.3546673-3.35466731c.2509089-.25090888.6612706-.25227691.9135302-.00001728zm-.9557137-3.18867991c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm-8.5-3.587-3.587 3.587h2.587c.55228475 0 1-.44771525 1-1zm8.5 1.587c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill="#fff"/></svg>
                                </a>
                            </li>
                        
                    </ul>
                </div>
            </nav>
        
    
    <script>
        window.dataLayer = window.dataLayer || [];
        window.dataLayer.push({
            page: {
                content: {
                    fundingWidget: "true",
                        }
                    }
                });
    </script>


<div id="search-menu" class="c-header__dropdown c-header__dropdown--full-width" data-track-component="nature-150-split-header">
    <div class="c-header__container">
        <h2 class="c-header__visually-hidden">Search</h2>
        <form class="c-header__search-form" action="/search" method="get" role="search" autocomplete="off" data-test="inline-search">
            <label class="c-header__heading" for="keywords">Search articles by subject, keyword or author</label>
            <div class="c-header__search-layout c-header__search-layout--max-width">
                <div>
                    <input type="text" required="" class="c-header__input" id="keywords" name="q" value="">
                </div>
                <div class="c-header__search-layout">
                    <div>
                        <label for="results-from" class="c-header__visually-hidden">Show results from</label>
                        <select id="results-from" name="journal" class="c-header__select">
                            
                                
                                    <option value="" selected>All journals</option>
                                    <option value="srep">This journal</option>
                                
                            
                        </select>
                    </div>
                    <div>
                        <button type="submit" class="c-header__search-button">Search</button>
                    </div>
                </div>

            </div>
        </form>

        <div class="c-header__flush">
            <a class="c-header__link" href="/search/advanced"
               data-track="click" data-track-action="advanced search" data-track-label="link">
                Advanced search
            </a>
        </div>

        <h3 class="c-header__heading c-header__heading--keyline">Quick links</h3>
        <ul class="c-header__list">
            <li><a class="c-header__link" href="/subjects" data-track="click" data-track-action="explore articles by subject" data-track-label="link">Explore articles by subject</a></li>
            <li><a class="c-header__link" href="/naturecareers" data-track="click" data-track-action="find a job" data-track-label="link">Find a job</a></li>
            <li><a class="c-header__link" href="/authors/index.html" data-track="click" data-track-action="guide to authors" data-track-label="link">Guide to authors</a></li>
            <li><a class="c-header__link" href="/authors/editorial_policies/" data-track="click" data-track-action="editorial policies" data-track-label="link">Editorial policies</a></li>
        </ul>
    </div>
</div>

<footer class="composite-layer" itemscope itemtype="http://schema.org/Periodical">
        <meta itemprop="publisher" content="Springer Nature">
        

        <div class="u-mt-16 u-mb-16">
    <div class="u-container">
        <div class="u-display-flex u-flex-wrap u-justify-content-space-between">
            

            <div class="c-meta u-ma-0 u-flex-shrink">
                <p class="c-meta__item c-meta__type u-mt-0">
                    <span itemprop="name">
                        Scientific Reports
                    </span>
                    (<i itemprop="alternateName">Sci Rep</i>)
                </p>
                
    
        <p class="c-meta__item u-mt-0">
            <abbr title="International Standard Serial Number">ISSN</abbr> <span itemprop="issn">2045-2322</span> (online)
        </p>
    

                
    

            </div>
        </div>
    </div>
</div>

    <div class="c-footer">
        <div class="u-hide-print" data-track-component="footer">
    <h2 class="u-visually-hidden">nature.com sitemap</h2>
    <div class="c-footer__container">
        <div class="c-footer__grid c-footer__group--separator">
            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">About Nature Portfolio</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.nature.com/npg_/company_info/index.html"
                                                  data-track="click" data-track-action="about us"
                                                  data-track-label="link">About us</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.nature.com/npg_/press_room/press_releases.html"
                                                  data-track="click" data-track-action="press releases"
                                                  data-track-label="link">Press releases</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://press.nature.com/"
                                                  data-track="click" data-track-action="press office"
                                                  data-track-label="link">Press office</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://support.nature.com/support/home"
                                                  data-track="click" data-track-action="contact us"
                                                  data-track-label="link">Contact us</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Discover content</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/siteindex"
                                                  data-track="click" data-track-action="journals a-z"
                                                  data-track-label="link">Journals A-Z</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/subjects"
                                                  data-track="click" data-track-action="article by subject"
                                                  data-track-label="link">Articles by subject</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.protocols.io/"
                                                  data-track="click" data-track-action="protocols.io"
                                                  data-track-label="link">protocols.io</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureindex.com/"
                                                  data-track="click" data-track-action="nature index"
                                                  data-track-label="link">Nature Index</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Publishing policies</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.nature.com/authors/editorial_policies"
                                                  data-track="click" data-track-action="Nature portfolio policies"
                                                  data-track-label="link">Nature portfolio policies</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.nature.com/nature-research/open-access"
                                                  data-track="click" data-track-action="open access"
                                                  data-track-label="link">Open access</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Author &amp; Researcher services</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/reprints"
                                                  data-track="click" data-track-action="reprints and permissions"
                                                  data-track-label="link">Reprints &amp; permissions</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.springernature.com/gp/authors/research-data"
                                                  data-track="click" data-track-action="data research service"
                                                  data-track-label="link">Research data</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://authorservices.springernature.com/language-editing/"
                                                  data-track="click" data-track-action="language editing"
                                                  data-track-label="link">Language editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://authorservices.springernature.com/scientific-editing/"
                                                  data-track="click" data-track-action="scientific editing"
                                                  data-track-label="link">Scientific editing</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://masterclasses.nature.com/"
                                                  data-track="click" data-track-action="nature masterclasses"
                                                  data-track-label="link">Nature Masterclasses</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://solutions.springernature.com/"
                                                  data-track="click" data-track-action="research solutions"
                                                  data-track-label="link">Research Solutions</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Libraries &amp; institutions</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.springernature.com/gp/librarians/tools-services"
                                                  data-track="click" data-track-action="librarian service and tools"
                                                  data-track-label="link">Librarian service &amp; tools</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.springernature.com/gp/librarians/manage-your-account/librarianportal"
                                                  data-track="click" data-track-action="librarian portal"
                                                  data-track-label="link">Librarian portal</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.nature.com/openresearch/about-open-access/information-for-institutions"
                                                  data-track="click" data-track-action="open research"
                                                  data-track-label="link">Open research</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://www.springernature.com/gp/librarians/recommend-to-your-library"
                                                  data-track="click" data-track-action="Recommend to library"
                                                  data-track-label="link">Recommend to library</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Advertising &amp; partnerships</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://partnerships.nature.com/product/digital-advertising/"
                                                  data-track="click" data-track-action="advertising"
                                                  data-track-label="link">Advertising</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://partnerships.nature.com/"
                                                  data-track="click" data-track-action="partnerships and services"
                                                  data-track-label="link">Partnerships &amp; Services</a></li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://partnerships.nature.com/media-kits/" data-track="click"
                                                  data-track-action="media kits" data-track-label="link">Media kits</a>
                    </li>
                    <li class="c-footer__item"><a class="c-footer__link"
                                                  href="https://partnerships.nature.com/product/branded-content-native-advertising/"
                                                  data-track-action="branded content" data-track-label="link">Branded
                        content</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Professional development</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/naturecareers/"
                                                  data-track="click" data-track-action="nature careers"
                                                  data-track-label="link">Nature Careers</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://conferences.nature.com"
                                                  data-track="click" data-track-action="nature conferences"
                                                  data-track-label="link">Nature<span class="u-visually-hidden"> </span>
                        Conferences</a></li>
                </ul>
            </div>

            <div class="c-footer__group">
                <h3 class="c-footer__heading u-mt-0">Regional websites</h3>
                <ul class="c-footer__list">
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natafrica"
                                                  data-track="click" data-track-action="nature africa"
                                                  data-track-label="link">Nature Africa</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="http://www.naturechina.com"
                                                  data-track="click" data-track-action="nature china"
                                                  data-track-label="link">Nature China</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nindia"
                                                  data-track="click" data-track-action="nature india"
                                                  data-track-label="link">Nature India</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/natitaly"
                                                  data-track="click" data-track-action="nature Italy"
                                                  data-track-label="link">Nature Italy</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.natureasia.com/ja-jp"
                                                  data-track="click" data-track-action="nature japan"
                                                  data-track-label="link">Nature Japan</a></li>
                    <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/nmiddleeast"
                                                  data-track="click" data-track-action="nature middle east"
                                                  data-track-label="link">Nature Middle East</a></li>
                </ul>
            </div>

        </div>
    </div>
    <div class="c-footer__container">
        <ul class="c-footer__links">
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/privacy"
                                          data-track="click" data-track-action="privacy policy" data-track-label="link">Privacy
                Policy</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/cookies"
                                          data-track="click" data-track-action="use of cookies" data-track-label="link">Use
                of cookies</a></li>
            <li class="c-footer__item">
                <button class="optanon-toggle-display c-footer__link" onclick="javascript:;"
                        data-cc-action="preferences" data-track="click" data-track-action="manage cookies"
                        data-track-label="link">Your privacy choices/Manage cookies
                </button>
            </li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/legal-notice"
                                          data-track="click" data-track-action="legal notice" data-track-label="link">Legal
                notice</a></li>
            <li class="c-footer__item"><a class="c-footer__link"
                                          href="https://www.nature.com/info/accessibility-statement" data-track="click"
                                          data-track-action="accessibility statement" data-track-label="link">Accessibility
                statement</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.nature.com/info/terms-and-conditions"
                                          data-track="click" data-track-action="terms and conditions"
                                          data-track-label="link">Terms &amp; Conditions</a></li>
            <li class="c-footer__item"><a class="c-footer__link" href="https://www.springernature.com/ccpa"
                                          data-track="click" data-track-action="california privacy statement"
                                          data-track-label="link">Your US state privacy rights</a></li>
            
        </ul>
    </div>
</div>


        <div class="c-footer__container">
    <a href="https://www.springernature.com/" class="c-footer__link">
        <img src="/static/images/logos/sn-logo-white-ea63208b81.svg" alt="Springer Nature" loading="lazy" width="200" height="20"/>
    </a>
    <p class="c-footer__legal" data-test="copyright">&copy; 2025 Springer Nature Limited</p>
</div>

    </div>
    <div class="u-visually-hidden" aria-hidden="true">
    
    <?xml version="1.0" encoding="UTF-8"?><!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><defs><path id="a" d="M0 .74h56.72v55.24H0z"/></defs><symbol id="icon-access" viewBox="0 0 18 18"><path d="m14 8c.5522847 0 1 .44771525 1 1v7h2.5c.2761424 0 .5.2238576.5.5v1.5h-18v-1.5c0-.2761424.22385763-.5.5-.5h2.5v-7c0-.55228475.44771525-1 1-1s1 .44771525 1 1v6.9996556h8v-6.9996556c0-.55228475.4477153-1 1-1zm-8 0 2 1v5l-2 1zm6 0v7l-2-1v-5zm-2.42653766-7.59857636 7.03554716 4.92488299c.4162533.29137735.5174853.86502537.226108 1.28127873-.1721584.24594054-.4534847.39241464-.7536934.39241464h-14.16284822c-.50810197 0-.92-.41189803-.92-.92 0-.30020869.1464741-.58153499.39241464-.75369337l7.03554714-4.92488299c.34432015-.2410241.80260453-.2410241 1.14692468 0zm-.57346234 2.03988748-3.65526982 2.55868888h7.31053962z" fill-rule="evenodd"/></symbol><symbol id="icon-account" viewBox="0 0 18 18"><path d="m10.2379028 16.9048051c1.3083556-.2032362 2.5118471-.7235183 3.5294683-1.4798399-.8731327-2.5141501-2.0638925-3.935978-3.7673711-4.3188248v-1.27684611c1.1651924-.41183641 2-1.52307546 2-2.82929429 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.30621883.83480763 2.41745788 2 2.82929429v1.27684611c-1.70347856.3828468-2.89423845 1.8046747-3.76737114 4.3188248 1.01762123.7563216 2.22111275 1.2766037 3.52946833 1.4798399.40563808.0629726.81921174.0951949 1.23790281.0951949s.83226473-.0322223 1.2379028-.0951949zm4.3421782-2.1721994c1.4927655-1.4532925 2.419919-3.484675 2.419919-5.7326057 0-4.418278-3.581722-8-8-8s-8 3.581722-8 8c0 2.2479307.92715352 4.2793132 2.41991895 5.7326057.75688473-2.0164459 1.83949951-3.6071894 3.48926591-4.3218837-1.14534283-.70360829-1.90918486-1.96796271-1.90918486-3.410722 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.44275929-.763842 2.70711371-1.9091849 3.410722 1.6497664.7146943 2.7323812 2.3054378 3.4892659 4.3218837zm-5.580081 3.2673943c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-alert" viewBox="0 0 18 18"><path d="m4 10h2.5c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-3.08578644l-1.12132034 1.1213203c-.18753638.1875364-.29289322.4418903-.29289322.7071068v.1715729h14v-.1715729c0-.2652165-.1053568-.5195704-.2928932-.7071068l-1.7071068-1.7071067v-3.4142136c0-2.76142375-2.2385763-5-5-5-2.76142375 0-5 2.23857625-5 5zm3 4c0 1.1045695.8954305 2 2 2s2-.8954305 2-2zm-5 0c-.55228475 0-1-.4477153-1-1v-.1715729c0-.530433.21071368-1.0391408.58578644-1.4142135l1.41421356-1.4142136v-3c0-3.3137085 2.6862915-6 6-6s6 2.6862915 6 6v3l1.4142136 1.4142136c.3750727.3750727.5857864.8837805.5857864 1.4142135v.1715729c0 .5522847-.4477153 1-1 1h-4c0 1.6568542-1.3431458 3-3 3-1.65685425 0-3-1.3431458-3-3z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-broad" viewBox="0 0 16 16"><path d="m6.10307866 2.97190702v7.69043288l2.44965196-2.44676915c.38776071-.38730439 1.0088052-.39493524 1.38498697-.01919617.38609051.38563612.38643641 1.01053024-.00013864 1.39665039l-4.12239817 4.11754683c-.38616704.3857126-1.01187344.3861062-1.39846576-.0000311l-4.12258206-4.11773056c-.38618426-.38572979-.39254614-1.00476697-.01636437-1.38050605.38609047-.38563611 1.01018509-.38751562 1.4012233.00306241l2.44985644 2.4469734v-8.67638639c0-.54139983.43698413-.98042709.98493125-.98159081l7.89910522-.0043627c.5451687 0 .9871152.44142642.9871152.98595351s-.4419465.98595351-.9871152.98595351z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 14 15)"/></symbol><symbol id="icon-arrow-down" viewBox="0 0 16 16"><path d="m3.28337502 11.5302405 4.03074001 4.176208c.37758093.3912076.98937525.3916069 1.367372-.0000316l4.03091977-4.1763942c.3775978-.3912252.3838182-1.0190815.0160006-1.4001736-.3775061-.39113013-.9877245-.39303641-1.3700683.003106l-2.39538585 2.4818345v-11.6147896l-.00649339-.11662112c-.055753-.49733869-.46370161-.88337888-.95867408-.88337888-.49497246 0-.90292107.38604019-.95867408.88337888l-.00649338.11662112v11.6147896l-2.39518594-2.4816273c-.37913917-.39282218-.98637524-.40056175-1.35419292-.0194697-.37750607.3911302-.37784433 1.0249269.00013556 1.4165479z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-left" viewBox="0 0 16 16"><path d="m4.46975946 3.28337502-4.17620792 4.03074001c-.39120768.37758093-.39160691.98937525.0000316 1.367372l4.1763942 4.03091977c.39122514.3775978 1.01908149.3838182 1.40017357.0160006.39113012-.3775061.3930364-.9877245-.00310603-1.3700683l-2.48183446-2.39538585h11.61478958l.1166211-.00649339c.4973387-.055753.8833789-.46370161.8833789-.95867408 0-.49497246-.3860402-.90292107-.8833789-.95867408l-.1166211-.00649338h-11.61478958l2.4816273-2.39518594c.39282216-.37913917.40056173-.98637524.01946965-1.35419292-.39113012-.37750607-1.02492687-.37784433-1.41654791.00013556z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-right" viewBox="0 0 16 16"><path d="m11.5302405 12.716625 4.176208-4.03074003c.3912076-.37758093.3916069-.98937525-.0000316-1.367372l-4.1763942-4.03091981c-.3912252-.37759778-1.0190815-.38381821-1.4001736-.01600053-.39113013.37750607-.39303641.98772445.003106 1.37006824l2.4818345 2.39538588h-11.6147896l-.11662112.00649339c-.49733869.055753-.88337888.46370161-.88337888.95867408 0 .49497246.38604019.90292107.88337888.95867408l.11662112.00649338h11.6147896l-2.4816273 2.39518592c-.39282218.3791392-.40056175.9863753-.0194697 1.3541929.3911302.3775061 1.0249269.3778444 1.4165479-.0001355z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-sub" viewBox="0 0 16 16"><path d="m7.89692134 4.97190702v7.69043288l-2.44965196-2.4467692c-.38776071-.38730434-1.0088052-.39493519-1.38498697-.0191961-.38609047.3856361-.38643643 1.0105302.00013864 1.3966504l4.12239817 4.1175468c.38616704.3857126 1.01187344.3861062 1.39846576-.0000311l4.12258202-4.1177306c.3861843-.3857298.3925462-1.0047669.0163644-1.380506-.3860905-.38563612-1.0101851-.38751563-1.4012233.0030624l-2.44985643 2.4469734v-8.67638639c0-.54139983-.43698413-.98042709-.98493125-.98159081l-7.89910525-.0043627c-.54516866 0-.98711517.44142642-.98711517.98595351s.44194651.98595351.98711517.98595351z" fill-rule="evenodd"/></symbol><symbol id="icon-arrow-up" viewBox="0 0 16 16"><path d="m12.716625 4.46975946-4.03074003-4.17620792c-.37758093-.39120768-.98937525-.39160691-1.367372.0000316l-4.03091981 4.1763942c-.37759778.39122514-.38381821 1.01908149-.01600053 1.40017357.37750607.39113012.98772445.3930364 1.37006824-.00310603l2.39538588-2.48183446v11.61478958l.00649339.1166211c.055753.4973387.46370161.8833789.95867408.8833789.49497246 0 .90292107-.3860402.95867408-.8833789l.00649338-.1166211v-11.61478958l2.39518592 2.4816273c.3791392.39282216.9863753.40056173 1.3541929.01946965.3775061-.39113012.3778444-1.02492687-.0001355-1.41654791z" fill-rule="evenodd"/></symbol><symbol id="icon-article" viewBox="0 0 18 18"><path d="m13 15v-12.9906311c0-.0073595-.0019884-.0093689.0014977-.0093689l-11.00158888.00087166v13.00506804c0 .5482678.44615281.9940603.99415146.9940603h10.27350412c-.1701701-.2941734-.2675644-.6357129-.2675644-1zm-12 .0059397v-13.00506804c0-.5562408.44704472-1.00087166.99850233-1.00087166h11.00299537c.5510129 0 .9985023.45190985.9985023 1.0093689v2.9906311h3v9.9914698c0 1.1065798-.8927712 2.0085302-1.9940603 2.0085302h-12.01187942c-1.09954652 0-1.99406028-.8927712-1.99406028-1.9940603zm13-9.0059397v9c0 .5522847.4477153 1 1 1s1-.4477153 1-1v-9zm-10-2h7v4h-7zm1 1v2h5v-2zm-1 4h7v1h-7zm0 2h7v1h-7zm0 2h7v1h-7z" fill-rule="evenodd"/></symbol><symbol id="icon-audio" viewBox="0 0 18 18"><path d="m13.0957477 13.5588459c-.195279.1937043-.5119137.193729-.7072234.0000551-.1953098-.193674-.1953346-.5077061-.0000556-.7014104 1.0251004-1.0168342 1.6108711-2.3905226 1.6108711-3.85745208 0-1.46604976-.5850634-2.83898246-1.6090736-3.85566829-.1951894-.19379323-.1950192-.50782531.0003802-.70141028.1953993-.19358497.512034-.19341614.7072234.00037709 1.2094886 1.20083761 1.901635 2.8250555 1.901635 4.55670148 0 1.73268608-.6929822 3.35779608-1.9037571 4.55880738zm2.1233994 2.1025159c-.195234.193749-.5118687.1938462-.7072235.0002171-.1953548-.1936292-.1954528-.5076613-.0002189-.7014104 1.5832215-1.5711805 2.4881302-3.6939808 2.4881302-5.96012998 0-2.26581266-.9046382-4.3883241-2.487443-5.95944795-.1952117-.19377107-.1950777-.50780316.0002993-.70141031s.5120117-.19347426.7072234.00029682c1.7683321 1.75528196 2.7800854 4.12911258 2.7800854 6.66056144 0 2.53182498-1.0120556 4.90597838-2.7808529 6.66132328zm-14.21898205-3.6854911c-.5523759 0-1.00016505-.4441085-1.00016505-.991944v-3.96777631c0-.54783558.44778915-.99194407 1.00016505-.99194407h2.0003301l5.41965617-3.8393633c.44948677-.31842296 1.07413994-.21516983 1.39520191.23062232.12116339.16823446.18629727.36981184.18629727.57655577v12.01603479c0 .5478356-.44778914.9919441-1.00016505.9919441-.20845738 0-.41170538-.0645985-.58133413-.184766l-5.41965617-3.8393633zm0-.991944h2.32084805l5.68047235 4.0241292v-12.01603479l-5.68047235 4.02412928h-2.32084805z" fill-rule="evenodd"/></symbol><symbol id="icon-block" viewBox="0 0 24 24"><path d="m0 0h24v24h-24z" fill-rule="evenodd"/></symbol><symbol id="icon-book" viewBox="0 0 18 18"><path d="m4 13v-11h1v11h11v-11h-13c-.55228475 0-1 .44771525-1 1v10.2675644c.29417337-.1701701.63571286-.2675644 1-.2675644zm12 1h-13c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1h13zm0 3h-13c-1.1045695 0-2-.8954305-2-2v-12c0-1.1045695.8954305-2 2-2h13c.5522847 0 1 .44771525 1 1v14c0 .5522847-.4477153 1-1 1zm-8.5-13h6c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-6c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1 2h4c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-4c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-broad" viewBox="0 0 24 24"><path d="m9.18274226 7.81v7.7999954l2.48162734-2.4816273c.3928221-.3928221 1.0219731-.4005617 1.4030652-.0194696.3911301.3911301.3914806 1.0249268-.0001404 1.4165479l-4.17620796 4.1762079c-.39120769.3912077-1.02508144.3916069-1.41671995-.0000316l-4.1763942-4.1763942c-.39122514-.3912251-.39767006-1.0190815-.01657798-1.4001736.39113012-.3911301 1.02337106-.3930364 1.41951349.0031061l2.48183446 2.4818344v-8.7999954c0-.54911294.4426881-.99439484.99778758-.99557515l8.00221246-.00442485c.5522847 0 1 .44771525 1 1s-.4477153 1-1 1z" fill-rule="evenodd" transform="matrix(-1 0 0 -1 20.182742 24.805206)"/></symbol><symbol id="icon-calendar" viewBox="0 0 18 18"><path d="m12.5 0c.2761424 0 .5.21505737.5.49047852v.50952148h2c1.1072288 0 2 .89451376 2 2v12c0 1.1072288-.8945138 2-2 2h-12c-1.1072288 0-2-.8945138-2-2v-12c0-1.1072288.89451376-2 2-2h1v1h-1c-.55393837 0-1 .44579254-1 1v3h14v-3c0-.55393837-.4457925-1-1-1h-2v1.50952148c0 .27088381-.2319336.49047852-.5.49047852-.2761424 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.2319336-.49047852.5-.49047852zm3.5 7h-14v8c0 .5539384.44579254 1 1 1h12c.5539384 0 1-.4457925 1-1zm-11 6v1h-1v-1zm3 0v1h-1v-1zm3 0v1h-1v-1zm-6-2v1h-1v-1zm3 0v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-3-2v1h-1v-1zm6 0v1h-1v-1zm-3 0v1h-1v-1zm-5.5-9c.27614237 0 .5.21505737.5.49047852v.50952148h5v1h-5v1.50952148c0 .27088381-.23193359.49047852-.5.49047852-.27614237 0-.5-.21505737-.5-.49047852v-3.01904296c0-.27088381.23193359-.49047852.5-.49047852z" fill-rule="evenodd"/></symbol><symbol id="icon-cart" viewBox="0 0 18 18"><path d="m5 14c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm10 0c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm-10 1c-.55228475 0-1 .4477153-1 1s.44771525 1 1 1 1-.4477153 1-1-.44771525-1-1-1zm10 0c-.5522847 0-1 .4477153-1 1s.4477153 1 1 1 1-.4477153 1-1-.4477153-1-1-1zm-12.82032249-15c.47691417 0 .88746157.33678127.98070211.80449199l.23823144 1.19501025 13.36277974.00045554c.5522847.00001882.9999659.44774934.9999659 1.00004222 0 .07084994-.0075361.14150708-.022474.2107727l-1.2908094 5.98534344c-.1007861.46742419-.5432548.80388386-1.0571651.80388386h-10.24805106c-.59173366 0-1.07142857.4477153-1.07142857 1 0 .5128358.41361449.9355072.94647737.9932723l.1249512.0067277h10.35933776c.2749512 0 .4979349.2228539.4979349.4978051 0 .2749417-.2227336.4978951-.4976753.4980063l-10.35959736.0041886c-1.18346732 0-2.14285714-.8954305-2.14285714-2 0-.6625717.34520317-1.24989198.87690425-1.61383592l-1.63768102-8.19004794c-.01312273-.06561364-.01950005-.131011-.0196107-.19547395l-1.71961253-.00064219c-.27614237 0-.5-.22385762-.5-.5 0-.27614237.22385763-.5.5-.5zm14.53193359 2.99950224h-13.11300004l1.20580469 6.02530174c.11024034-.0163252.22327998-.02480398.33844139-.02480398h10.27064786z"/></symbol><symbol id="icon-chevron-less" viewBox="0 0 10 10"><path d="m5.58578644 4-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 -1 -1 0 9 9)"/></symbol><symbol id="icon-chevron-more" viewBox="0 0 10 10"><path d="m5.58578644 6-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4.00000002c-.39052429.3905243-1.02368927.3905243-1.41421356 0s-.39052429-1.02368929 0-1.41421358z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/></symbol><symbol id="icon-chevron-right" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/></symbol><symbol id="icon-circle-fill" viewBox="0 0 16 16"><path d="m8 14c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-circle" viewBox="0 0 16 16"><path d="m8 12c2.209139 0 4-1.790861 4-4s-1.790861-4-4-4-4 1.790861-4 4 1.790861 4 4 4zm0 2c-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6 6 2.6862915 6 6-2.6862915 6-6 6z" fill-rule="evenodd"/></symbol><symbol id="icon-citation" viewBox="0 0 18 18"><path d="m8.63593473 5.99995183c2.20913897 0 3.99999997 1.79084375 3.99999997 3.99996146 0 1.40730761-.7267788 2.64486871-1.8254829 3.35783281 1.6240224.6764218 2.8754442 2.0093871 3.4610603 3.6412466l-1.0763845.000006c-.5310008-1.2078237-1.5108121-2.1940153-2.7691712-2.7181346l-.79002167-.329052v-1.023992l.63016577-.4089232c.8482885-.5504661 1.3698342-1.4895187 1.3698342-2.51898361 0-1.65683828-1.3431457-2.99996146-2.99999997-2.99996146-1.65685425 0-3 1.34312318-3 2.99996146 0 1.02946491.52154569 1.96851751 1.36983419 2.51898361l.63016581.4089232v1.023992l-.79002171.329052c-1.25835905.5241193-2.23817037 1.5103109-2.76917113 2.7181346l-1.07638453-.000006c.58561612-1.6318595 1.8370379-2.9648248 3.46106024-3.6412466-1.09870405-.7129641-1.82548287-1.9505252-1.82548287-3.35783281 0-2.20911771 1.790861-3.99996146 4-3.99996146zm7.36897597-4.99995183c1.1018574 0 1.9950893.89353404 1.9950893 2.00274083v5.994422c0 1.10608317-.8926228 2.00274087-1.9950893 2.00274087l-3.0049107-.0009037v-1l3.0049107.00091329c.5490631 0 .9950893-.44783123.9950893-1.00275046v-5.994422c0-.55646537-.4450595-1.00275046-.9950893-1.00275046h-14.00982141c-.54906309 0-.99508929.44783123-.99508929 1.00275046v5.9971821c0 .66666024.33333333.99999036 1 .99999036l2-.00091329v1l-2 .0009037c-1 0-2-.99999041-2-1.99998077v-5.9971821c0-1.10608322.8926228-2.00274083 1.99508929-2.00274083zm-8.5049107 2.9999711c.27614237 0 .5.22385547.5.5 0 .2761349-.22385763.5-.5.5h-4c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm3 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-1c-.27614237 0-.5-.2238651-.5-.5 0-.27614453.22385763-.5.5-.5zm4 0c.2761424 0 .5.22385547.5.5 0 .2761349-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238651-.5-.5 0-.27614453.2238576-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-close" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"/></symbol><symbol id="icon-collections" viewBox="0 0 18 18"><path d="m15 4c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2h1c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227l-.1166211-.00672773h-1v-1zm-4-3c1.1045695 0 2 .8954305 2 2v9c0 1.1045695-.8954305 2-2 2h-8c-1.1045695 0-2-.8954305-2-2v-9c0-1.1045695.8954305-2 2-2zm0 1h-8c-.51283584 0-.93550716.38604019-.99327227.88337887l-.00672773.11662113v9c0 .5128358.38604019.9355072.88337887.9932723l.11662113.0067277h8c.5128358 0 .9355072-.3860402.9932723-.8833789l.0067277-.1166211v-9c0-.51283584-.3860402-.93550716-.8833789-.99327227zm-1.5 7c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm0-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-5c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-compare" viewBox="0 0 18 18"><path d="m12 3c3.3137085 0 6 2.6862915 6 6s-2.6862915 6-6 6c-1.0928452 0-2.11744941-.2921742-2.99996061-.8026704-.88181407.5102749-1.90678042.8026704-3.00003939.8026704-3.3137085 0-6-2.6862915-6-6s2.6862915-6 6-6c1.09325897 0 2.11822532.29239547 3.00096303.80325037.88158756-.51107621 1.90619177-.80325037 2.99903697-.80325037zm-6 1c-2.76142375 0-5 2.23857625-5 5 0 2.7614237 2.23857625 5 5 5 .74397391 0 1.44999672-.162488 2.08451611-.4539116-1.27652344-1.1000812-2.08451611-2.7287264-2.08451611-4.5460884s.80799267-3.44600721 2.08434391-4.5463015c-.63434719-.29121054-1.34037-.4536985-2.08434391-.4536985zm6 0c-.7439739 0-1.4499967.16248796-2.08451611.45391156 1.27652341 1.10008123 2.08451611 2.72872644 2.08451611 4.54608844s-.8079927 3.4460072-2.08434391 4.5463015c.63434721.2912105 1.34037001.4536985 2.08434391.4536985 2.7614237 0 5-2.2385763 5-5 0-2.76142375-2.2385763-5-5-5zm-1.4162763 7.0005324h-3.16744736c.15614659.3572676.35283837.6927622.58425872 1.0006671h1.99892988c.23142036-.3079049.42811216-.6433995.58425876-1.0006671zm.4162763-2.0005324h-4c0 .34288501.0345146.67770871.10025909 1.0011864h3.79948181c.0657445-.32347769.1002591-.65830139.1002591-1.0011864zm-.4158423-1.99953894h-3.16831543c-.13859957.31730812-.24521946.651783-.31578599.99935097h3.79988742c-.0705665-.34756797-.1771864-.68204285-.315786-.99935097zm-1.58295822-1.999926-.08316107.06199199c-.34550042.27081213-.65446126.58611297-.91825862.93727862h2.00044041c-.28418626-.37830727-.6207872-.71499149-.99902072-.99927061z" fill-rule="evenodd"/></symbol><symbol id="icon-download-file" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.5046024 4c.27614237 0 .5.21637201.5.49209595v6.14827645l1.7462789-1.77990922c.1933927-.1971171.5125222-.19455839.7001689-.0069117.1932998.19329992.1910058.50899492-.0027774.70277812l-2.59089271 2.5908927c-.19483374.1948337-.51177825.1937771-.70556873-.0000133l-2.59099079-2.5909908c-.19484111-.1948411-.19043735-.5151448-.00279066-.70279146.19329987-.19329987.50465175-.19237083.70018565.00692852l1.74638684 1.78001764v-6.14827695c0-.27177709.23193359-.49209595.5-.49209595z" fill-rule="evenodd"/></symbol><symbol id="icon-download" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"/></symbol><symbol id="icon-editors" viewBox="0 0 18 18"><path d="m8.72592184 2.54588137c-.48811714-.34391207-1.08343326-.54588137-1.72592184-.54588137-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400182l-.79002171.32905522c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274v.9009805h-1v-.9009805c0-2.5479714 1.54557359-4.79153984 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4 1.09079823 0 2.07961816.43662103 2.80122451 1.1446278-.37707584.09278571-.7373238.22835063-1.07530267.40125357zm-2.72592184 14.45411863h-1v-.9009805c0-2.5479714 1.54557359-4.7915398 3.82548288-5.7411543-1.09870406-.71297106-1.82548288-1.95054399-1.82548288-3.3578652 0-2.209139 1.790861-4 4-4s4 1.790861 4 4c0 1.40732121-.7267788 2.64489414-1.8254829 3.3578652 2.2799093.9496145 3.8254829 3.1931829 3.8254829 5.7411543v.9009805h-1v-.9009805c0-2.1155483-1.2760206-4.0125067-3.2099783-4.8180274l-.7900217-.3290552v-1.02400184l.6301658-.40892721c.8482885-.55047139 1.3698342-1.489533 1.3698342-2.51900785 0-1.65685425-1.3431458-3-3-3-1.65685425 0-3 1.34314575-3 3 0 1.02947485.5215457 1.96853646 1.3698342 2.51900785l.6301658.40892721v1.02400184l-.79002171.3290552c-1.93395773.8055207-3.20997829 2.7024791-3.20997829 4.8180274z" fill-rule="evenodd"/></symbol><symbol id="icon-email" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-.0049107 2.55749512v1.44250488l-7 4-7-4v-1.44250488l7 4z" fill-rule="evenodd"/></symbol><symbol id="icon-error" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm2.8630343 4.71100931-2.8630343 2.86303426-2.86303426-2.86303426c-.39658757-.39658757-1.03281091-.39438847-1.4265779-.00062147-.39651227.39651226-.39348876 1.03246767.00062147 1.4265779l2.86303426 2.86303426-2.86303426 2.8630343c-.39658757.3965875-.39438847 1.0328109-.00062147 1.4265779.39651226.3965122 1.03246767.3934887 1.4265779-.0006215l2.86303426-2.8630343 2.8630343 2.8630343c.3965875.3965876 1.0328109.3943885 1.4265779.0006215.3965122-.3965123.3934887-1.0324677-.0006215-1.4265779l-2.8630343-2.8630343 2.8630343-2.86303426c.3965876-.39658757.3943885-1.03281091.0006215-1.4265779-.3965123-.39651227-1.0324677-.39348876-1.4265779.00062147z" fill-rule="evenodd"/></symbol><symbol id="icon-ethics" viewBox="0 0 18 18"><path d="m6.76384967 1.41421356.83301651-.8330165c.77492941-.77492941 2.03133823-.77492941 2.80626762 0l.8330165.8330165c.3750728.37507276.8837806.58578644 1.4142136.58578644h1.3496361c1.1045695 0 2 .8954305 2 2v1.34963611c0 .53043298.2107137 1.03914081.5857864 1.41421356l.8330165.83301651c.7749295.77492941.7749295 2.03133823 0 2.80626762l-.8330165.8330165c-.3750727.3750728-.5857864.8837806-.5857864 1.4142136v1.3496361c0 1.1045695-.8954305 2-2 2h-1.3496361c-.530433 0-1.0391408.2107137-1.4142136.5857864l-.8330165.8330165c-.77492939.7749295-2.03133821.7749295-2.80626762 0l-.83301651-.8330165c-.37507275-.3750727-.88378058-.5857864-1.41421356-.5857864h-1.34963611c-1.1045695 0-2-.8954305-2-2v-1.3496361c0-.530433-.21071368-1.0391408-.58578644-1.4142136l-.8330165-.8330165c-.77492941-.77492939-.77492941-2.03133821 0-2.80626762l.8330165-.83301651c.37507276-.37507275.58578644-.88378058.58578644-1.41421356v-1.34963611c0-1.1045695.8954305-2 2-2h1.34963611c.53043298 0 1.03914081-.21071368 1.41421356-.58578644zm-1.41421356 1.58578644h-1.34963611c-.55228475 0-1 .44771525-1 1v1.34963611c0 .79564947-.31607052 1.55871121-.87867966 2.12132034l-.8330165.83301651c-.38440512.38440512-.38440512 1.00764896 0 1.39205408l.8330165.83301646c.56260914.5626092.87867966 1.3256709.87867966 2.1213204v1.3496361c0 .5522847.44771525 1 1 1h1.34963611c.79564947 0 1.55871121.3160705 2.12132034.8786797l.83301651.8330165c.38440512.3844051 1.00764896.3844051 1.39205408 0l.83301646-.8330165c.5626092-.5626092 1.3256709-.8786797 2.1213204-.8786797h1.3496361c.5522847 0 1-.4477153 1-1v-1.3496361c0-.7956495.3160705-1.5587112.8786797-2.1213204l.8330165-.83301646c.3844051-.38440512.3844051-1.00764896 0-1.39205408l-.8330165-.83301651c-.5626092-.56260913-.8786797-1.32567087-.8786797-2.12132034v-1.34963611c0-.55228475-.4477153-1-1-1h-1.3496361c-.7956495 0-1.5587112-.31607052-2.1213204-.87867966l-.83301646-.8330165c-.38440512-.38440512-1.00764896-.38440512-1.39205408 0l-.83301651.8330165c-.56260913.56260914-1.32567087.87867966-2.12132034.87867966zm3.58698944 11.4960218c-.02081224.002155-.04199226.0030286-.06345763.002542-.98766446-.0223875-1.93408568-.3063547-2.75885125-.8155622-.23496767-.1450683-.30784554-.4531483-.16277726-.688116.14506827-.2349677.45314827-.3078455.68811595-.1627773.67447084.4164161 1.44758575.6483839 2.25617384.6667123.01759529.0003988.03495764.0017019.05204365.0038639.01713363-.0017748.03452416-.0026845.05212715-.0026845 2.4852814 0 4.5-2.0147186 4.5-4.5 0-1.04888973-.3593547-2.04134635-1.0074477-2.83787157-.1742817-.21419731-.1419238-.5291218.0722736-.70340353.2141973-.17428173.5291218-.14192375.7034035.07227357.7919032.97327203 1.2317706 2.18808682 1.2317706 3.46900153 0 3.0375661-2.4624339 5.5-5.5 5.5-.02146768 0-.04261937-.0013529-.06337445-.0039782zm1.57975095-10.78419583c.2654788.07599731.419084.35281842.3430867.61829728-.0759973.26547885-.3528185.419084-.6182973.3430867-.37560116-.10752146-.76586237-.16587951-1.15568824-.17249193-2.5587807-.00064534-4.58547766 2.00216524-4.58547766 4.49928198 0 .62691557.12797645 1.23496.37274865 1.7964426.11035133.2531347-.0053975.5477984-.25853224.6581497-.25313473.1103514-.54779841-.0053975-.65814974-.2585322-.29947131-.6869568-.45606667-1.43097603-.45606667-2.1960601 0-3.05211432 2.47714695-5.50006595 5.59399617-5.49921198.48576182.00815502.96289603.0795037 1.42238033.21103795zm-1.9766658 6.41091303 2.69835-2.94655317c.1788432-.21040373.4943901-.23598862.7047939-.05714545.2104037.17884318.2359886.49439014.0571454.70479387l-3.01637681 3.34277395c-.18039088.1999106-.48669547.2210637-.69285412.0478478l-1.93095347-1.62240047c-.21213845-.17678204-.24080048-.49206439-.06401844-.70420284.17678204-.21213844.49206439-.24080048.70420284-.06401844z" fill-rule="evenodd"/></symbol><symbol id="icon-expand"><path d="M7.498 11.918a.997.997 0 0 0-.003-1.411.995.995 0 0 0-1.412-.003l-4.102 4.102v-3.51A1 1 0 0 0 .98 10.09.992.992 0 0 0 0 11.092V17c0 .554.448 1.002 1.002 1.002h5.907c.554 0 1.002-.45 1.002-1.003 0-.539-.45-.978-1.006-.978h-3.51zm3.005-5.835a.997.997 0 0 0 .003 1.412.995.995 0 0 0 1.411.003l4.103-4.103v3.51a1 1 0 0 0 1.001 1.006A.992.992 0 0 0 18 6.91V1.002A1 1 0 0 0 17 0h-5.907a1.003 1.003 0 0 0-1.002 1.003c0 .539.45.978 1.006.978h3.51z" fill-rule="evenodd"/></symbol><symbol id="icon-explore" viewBox="0 0 18 18"><path d="m9 17c4.418278 0 8-3.581722 8-8s-3.581722-8-8-8-8 3.581722-8 8 3.581722 8 8 8zm0 1c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9zm0-2.5c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5c2.969509 0 5.400504-2.3575119 5.497023-5.31714844.0090007-.27599565.2400359-.49243782.5160315-.48343711.2759957.0090007.4924378.2400359.4834371.51603155-.114093 3.4985237-2.9869632 6.284554-6.4964916 6.284554zm-.29090657-12.99359748c.27587424-.01216621.50937715.20161139.52154336.47748563.01216621.27587423-.20161139.50937715-.47748563.52154336-2.93195733.12930094-5.25315116 2.54886451-5.25315116 5.49456849 0 .27614237-.22385763.5-.5.5s-.5-.22385763-.5-.5c0-3.48142406 2.74307146-6.34074398 6.20909343-6.49359748zm1.13784138 8.04763908-1.2004882-1.20048821c-.19526215-.19526215-.19526215-.51184463 0-.70710678s.51184463-.19526215.70710678 0l1.20048821 1.2004882 1.6006509-4.00162734-4.50670359 1.80268144-1.80268144 4.50670359zm4.10281269-6.50378907-2.6692597 6.67314927c-.1016411.2541026-.3029834.4554449-.557086.557086l-6.67314927 2.6692597 2.66925969-6.67314926c.10164107-.25410266.30298336-.45544495.55708602-.55708602z" fill-rule="evenodd"/></symbol><symbol id="icon-filter" viewBox="0 0 16 16"><path d="m14.9738641 0c.5667192 0 1.0261359.4477136 1.0261359 1 0 .24221858-.0902161.47620768-.2538899.65849851l-5.6938314 6.34147206v5.49997973c0 .3147562-.1520673.6111434-.4104543.7999971l-2.05227171 1.4999945c-.45337535.3313696-1.09655869.2418269-1.4365902-.1999993-.13321514-.1730955-.20522717-.3836284-.20522717-.5999978v-6.99997423l-5.69383133-6.34147206c-.3731872-.41563511-.32996891-1.0473954.09653074-1.41107611.18705584-.15950448.42716133-.2474224.67571519-.2474224zm-5.9218641 8.5h-2.105v6.491l.01238459.0070843.02053271.0015705.01955278-.0070558 2.0532976-1.4990996zm-8.02585008-7.5-.01564945.00240169 5.83249953 6.49759831h2.313l5.836-6.499z"/></symbol><symbol id="icon-home" viewBox="0 0 18 18"><path d="m9 5-6 6v5h4v-4h4v4h4v-5zm7 6.5857864v4.4142136c0 .5522847-.4477153 1-1 1h-5v-4h-2v4h-5c-.55228475 0-1-.4477153-1-1v-4.4142136c-.25592232 0-.51184464-.097631-.70710678-.2928932l-.58578644-.5857864c-.39052429-.3905243-.39052429-1.02368929 0-1.41421358l8.29289322-8.29289322 8.2928932 8.29289322c.3905243.39052429.3905243 1.02368928 0 1.41421358l-.5857864.5857864c-.1952622.1952622-.4511845.2928932-.7071068.2928932zm-7-9.17157284-7.58578644 7.58578644.58578644.5857864 7-6.99999996 7 6.99999996.5857864-.5857864z" fill-rule="evenodd"/></symbol><symbol id="icon-image" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm-3.49645283 10.1752453-3.89407257 6.7495552c.11705545.048464.24538859.0751995.37998328.0751995h10.60290092l-2.4329715-4.2154691-1.57494129 2.7288098zm8.49779013 6.8247547c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v13.98991071l4.50814957-7.81026689 3.08089884 5.33809539 1.57494129-2.7288097 3.5875735 6.2159812zm-3.0059397-11c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2-2-.8954305-2-2 .8954305-2 2-2zm0 1c-.5522847 0-1 .44771525-1 1s.4477153 1 1 1 1-.44771525 1-1-.4477153-1-1-1z" fill-rule="evenodd"/></symbol><symbol id="icon-info" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/></symbol><symbol id="icon-institution" viewBox="0 0 18 18"><path d="m7 16.9998189v-2.0003623h4v2.0003623h2v-3.0005434h-8v3.0005434zm-3-10.00181122h-1.52632364c-.27614237 0-.5-.22389817-.5-.50009056 0-.13995446.05863589-.27350497.16166338-.36820841l1.23156713-1.13206327h-2.36690687v12.00217346h3v-2.0003623h-3v-1.0001811h3v-1.0001811h1v-4.00072448h-1zm10 0v2.00036224h-1v4.00072448h1v1.0001811h3v1.0001811h-3v2.0003623h3v-12.00217346h-2.3695309l1.2315671 1.13206327c.2033191.186892.2166633.50325042.0298051.70660631-.0946863.10304615-.2282126.16169266-.3681417.16169266zm3-3.00054336c.5522847 0 1 .44779634 1 1.00018112v13.00235456h-18v-13.00235456c0-.55238478.44771525-1.00018112 1-1.00018112h3.45499992l4.20535144-3.86558216c.19129876-.17584288.48537447-.17584288.67667324 0l4.2053514 3.86558216zm-4 3.00054336h-8v1.00018112h8zm-2 6.00108672h1v-4.00072448h-1zm-1 0v-4.00072448h-2v4.00072448zm-3 0v-4.00072448h-1v4.00072448zm8-4.00072448c.5522847 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.4477153-1.00018112 1-1.00018112zm-12 0c.55228475 0 1 .44779634 1 1.00018112v2.00036226h-2v-2.00036226c0-.55238478.44771525-1.00018112 1-1.00018112zm5.99868798-7.81907007-5.24205601 4.81852671h10.48411203zm.00131202 3.81834559c-.55228475 0-1-.44779634-1-1.00018112s.44771525-1.00018112 1-1.00018112 1 .44779634 1 1.00018112-.44771525 1.00018112-1 1.00018112zm-1 11.00199236v1.0001811h2v-1.0001811z" fill-rule="evenodd"/></symbol><symbol id="icon-location" viewBox="0 0 18 18"><path d="m9.39521328 16.2688008c.79596342-.7770119 1.59208152-1.6299956 2.33285652-2.5295081 1.4020032-1.7024324 2.4323601-3.3624519 2.9354918-4.871847.2228715-.66861448.3364384-1.29323246.3364384-1.8674457 0-3.3137085-2.6862915-6-6-6-3.36356866 0-6 2.60156856-6 6 0 .57421324.11356691 1.19883122.3364384 1.8674457.50313169 1.5093951 1.53348863 3.1694146 2.93549184 4.871847.74077492.8995125 1.53689309 1.7524962 2.33285648 2.5295081.13694479.1336842.26895677.2602648.39521328.3793207.12625651-.1190559.25826849-.2456365.39521328-.3793207zm-.39521328 1.7311992s-7-6-7-11c0-4 3.13400675-7 7-7 3.8659932 0 7 3.13400675 7 7 0 5-7 11-7 11zm0-8c-1.65685425 0-3-1.34314575-3-3s1.34314575-3 3-3c1.6568542 0 3 1.34314575 3 3s-1.3431458 3-3 3zm0-1c1.1045695 0 2-.8954305 2-2s-.8954305-2-2-2-2 .8954305-2 2 .8954305 2 2 2z" fill-rule="evenodd"/></symbol><symbol id="icon-minus" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/></symbol><symbol id="icon-newsletter" viewBox="0 0 18 18"><path d="m9 11.8482489 2-1.1428571v-1.7053918h-4v1.7053918zm-3-1.7142857v-2.1339632h6v2.1339632l3-1.71428574v-6.41967746h-12v6.41967746zm10-5.3839632 1.5299989.95624934c.2923814.18273835.4700011.50320827.4700011.8479983v8.44575236c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-8.44575236c0-.34479003.1776197-.66525995.47000106-.8479983l1.52999894-.95624934v-2.75c0-.55228475.44771525-1 1-1h12c.5522847 0 1 .44771525 1 1zm0 1.17924764v3.07075236l-7 4-7-4v-3.07075236l-1 .625v8.44575236c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-8.44575236zm-10-1.92924764h6v1h-6zm-1 2h8v1h-8z" fill-rule="evenodd"/></symbol><symbol id="icon-orcid" viewBox="0 0 18 18"><path d="m9 1c4.418278 0 8 3.581722 8 8s-3.581722 8-8 8-8-3.581722-8-8 3.581722-8 8-8zm-2.90107518 5.2732337h-1.41865256v7.1712107h1.41865256zm4.55867178.02508949h-2.99247027v7.14612121h2.91062487c.7673039 0 1.4476365-.1483432 2.0410182-.445034s1.0511995-.7152915 1.3734671-1.2558144c.3222677-.540523.4833991-1.1603247.4833991-1.85942385 0-.68545815-.1602789-1.30270225-.4808414-1.85175082-.3205625-.54904856-.7707074-.97532211-1.3504481-1.27883343-.5797408-.30351132-1.2413173-.45526471-1.9847495-.45526471zm-.1892674 1.07933542c.7877654 0 1.4143875.22336734 1.8798852.67010873.4654977.44674138.698243 1.05546001.698243 1.82617415 0 .74343221-.2310402 1.34447791-.6931277 1.80315511-.4620874.4586773-1.0750688.6880124-1.8389625.6880124h-1.46810075v-4.98745039zm-5.08652545-3.71099194c-.21825533 0-.410525.08444276-.57681478.25333081-.16628977.16888806-.24943341.36245684-.24943341.58071218 0 .22345188.08314364.41961891.24943341.58850696.16628978.16888806.35855945.25333082.57681478.25333082.233845 0 .43390938-.08314364.60019916-.24943342.16628978-.16628977.24943342-.36375592.24943342-.59240436 0-.233845-.08314364-.43131115-.24943342-.59240437s-.36635416-.24163862-.60019916-.24163862z" fill-rule="evenodd"/></symbol><symbol id="icon-plus" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/></symbol><symbol id="icon-print" viewBox="0 0 18 18"><path d="m16.0049107 5h-14.00982141c-.54941618 0-.99508929.4467783-.99508929.99961498v6.00077002c0 .5570958.44271433.999615.99508929.999615h1.00491071v-3h12v3h1.0049107c.5494162 0 .9950893-.4467783.9950893-.999615v-6.00077002c0-.55709576-.4427143-.99961498-.9950893-.99961498zm-2.0049107-1v-2.00208688c0-.54777062-.4519464-.99791312-1.0085302-.99791312h-7.9829396c-.55661731 0-1.0085302.44910695-1.0085302.99791312v2.00208688zm1 10v2.0018986c0 1.103521-.9019504 1.9981014-2.0085302 1.9981014h-7.9829396c-1.1092806 0-2.0085302-.8867064-2.0085302-1.9981014v-2.0018986h-1.00491071c-1.10185739 0-1.99508929-.8874333-1.99508929-1.999615v-6.00077002c0-1.10435686.8926228-1.99961498 1.99508929-1.99961498h1.00491071v-2.00208688c0-1.10341695.90195036-1.99791312 2.0085302-1.99791312h7.9829396c1.1092806 0 2.0085302.89826062 2.0085302 1.99791312v2.00208688h1.0049107c1.1018574 0 1.9950893.88743329 1.9950893 1.99961498v6.00077002c0 1.1043569-.8926228 1.999615-1.9950893 1.999615zm-1-3h-10v5.0018986c0 .5546075.44702548.9981014 1.0085302.9981014h7.9829396c.5565964 0 1.0085302-.4491701 1.0085302-.9981014zm-9 1h8v1h-8zm0 2h5v1h-5zm9-5c-.5522847 0-1-.44771525-1-1s.4477153-1 1-1 1 .44771525 1 1-.4477153 1-1 1z" fill-rule="evenodd"/></symbol><symbol id="icon-search" viewBox="0 0 22 22"><path d="M21.697 20.261a1.028 1.028 0 01.01 1.448 1.034 1.034 0 01-1.448-.01l-4.267-4.267A9.812 9.811 0 010 9.812a9.812 9.811 0 1117.43 6.182zM9.812 18.222A8.41 8.41 0 109.81 1.403a8.41 8.41 0 000 16.82z" fill-rule="evenodd"/></symbol><symbol id="icon-social-facebook" viewBox="0 0 24 24"><path d="m6.00368507 20c-1.10660471 0-2.00368507-.8945138-2.00368507-1.9940603v-12.01187942c0-1.10128908.89451376-1.99406028 1.99406028-1.99406028h12.01187942c1.1012891 0 1.9940603.89451376 1.9940603 1.99406028v12.01187942c0 1.1012891-.88679 1.9940603-2.0032184 1.9940603h-2.9570132v-6.1960818h2.0797387l.3114113-2.414723h-2.39115v-1.54164807c0-.69911803.1941355-1.1755439 1.1966615-1.1755439l1.2786739-.00055875v-2.15974763l-.2339477-.02492088c-.3441234-.03134957-.9500153-.07025255-1.6293054-.07025255-1.8435726 0-3.1057323 1.12531866-3.1057323 3.19187953v1.78079225h-2.0850778v2.414723h2.0850778v6.1960818z" fill-rule="evenodd"/></symbol><symbol id="icon-social-twitter" viewBox="0 0 24 24"><path d="m18.8767135 6.87445248c.7638174-.46908424 1.351611-1.21167363 1.6250764-2.09636345-.7135248.43394112-1.50406.74870123-2.3464594.91677702-.6695189-.73342162-1.6297913-1.19486605-2.6922204-1.19486605-2.0399895 0-3.6933555 1.69603749-3.6933555 3.78628909 0 .29642457.0314329.58673729.0942985.8617704-3.06469922-.15890802-5.78835241-1.66547825-7.60988389-3.9574208-.3174714.56076194-.49978171 1.21167363-.49978171 1.90536824 0 1.31404706.65223085 2.47224203 1.64236444 3.15218497-.60350999-.0198635-1.17401554-.1925232-1.67222562-.47366811v.04583885c0 1.83355406 1.27302891 3.36609966 2.96411421 3.71294696-.31118484.0886217-.63651445.1329326-.97441718.1329326-.2357461 0-.47149219-.0229194-.69466516-.0672303.47149219 1.5065703 1.83253297 2.6036468 3.44975116 2.632678-1.2651707 1.0160946-2.85724264 1.6196394-4.5891906 1.6196394-.29861172 0-.59093688-.0152796-.88011875-.0504227 1.63450624 1.0726291 3.57548241 1.6990934 5.66104951 1.6990934 6.79263079 0 10.50641749-5.7711113 10.50641749-10.7751859l-.0094298-.48894775c.7229547-.53478659 1.3516109-1.20250585 1.8419628-1.96190282-.6632323.30100846-1.3751855.50422736-2.1217148.59590507z" fill-rule="evenodd"/></symbol><symbol id="icon-social-youtube" viewBox="0 0 24 24"><path d="m10.1415 14.3973208-.0005625-5.19318431 4.863375 2.60554491zm9.963-7.92753362c-.6845625-.73643756-1.4518125-.73990314-1.803375-.7826454-2.518875-.18714178-6.2971875-.18714178-6.2971875-.18714178-.007875 0-3.7861875 0-6.3050625.18714178-.352125.04274226-1.1188125.04620784-1.8039375.7826454-.5394375.56084773-.7149375 1.8344515-.7149375 1.8344515s-.18 1.49597903-.18 2.99138042v1.4024082c0 1.495979.18 2.9913804.18 2.9913804s.1755 1.2736038.7149375 1.8344515c.685125.7364376 1.5845625.7133337 1.9850625.7901542 1.44.1420891 6.12.1859866 6.12.1859866s3.78225-.005776 6.301125-.1929178c.3515625-.0433198 1.1188125-.0467854 1.803375-.783223.5394375-.5608477.7155-1.8344515.7155-1.8344515s.18-1.4954014.18-2.9913804v-1.4024082c0-1.49540139-.18-2.99138042-.18-2.99138042s-.1760625-1.27360377-.7155-1.8344515z" fill-rule="evenodd"/></symbol><symbol id="icon-subject-medicine" viewBox="0 0 18 18"><path d="m12.5 8h-6.5c-1.65685425 0-3 1.34314575-3 3v1c0 1.6568542 1.34314575 3 3 3h1v-2h-.5c-.82842712 0-1.5-.6715729-1.5-1.5s.67157288-1.5 1.5-1.5h1.5 2 1 2c1.6568542 0 3-1.34314575 3-3v-1c0-1.65685425-1.3431458-3-3-3h-2v2h1.5c.8284271 0 1.5.67157288 1.5 1.5s-.6715729 1.5-1.5 1.5zm-5.5-1v-1h-3.5c-1.38071187 0-2.5-1.11928813-2.5-2.5s1.11928813-2.5 2.5-2.5h1.02786405c.46573528 0 .92507448.10843528 1.34164078.31671843l1.13382424.56691212c.06026365-1.05041141.93116291-1.88363055 1.99667093-1.88363055 1.1045695 0 2 .8954305 2 2h2c2.209139 0 4 1.790861 4 4v1c0 2.209139-1.790861 4-4 4h-2v1h2c1.1045695 0 2 .8954305 2 2s-.8954305 2-2 2h-2c0 1.1045695-.8954305 2-2 2s-2-.8954305-2-2h-1c-2.209139 0-4-1.790861-4-4v-1c0-2.209139 1.790861-4 4-4zm0-2v-2.05652691c-.14564246-.03538148-.28733393-.08714006-.42229124-.15461871l-1.15541752-.57770876c-.27771087-.13885544-.583937-.21114562-.89442719-.21114562h-1.02786405c-.82842712 0-1.5.67157288-1.5 1.5s.67157288 1.5 1.5 1.5zm4 1v1h1.5c.2761424 0 .5-.22385763.5-.5s-.2238576-.5-.5-.5zm-1 1v-5c0-.55228475-.44771525-1-1-1s-1 .44771525-1 1v5zm-2 4v5c0 .5522847.44771525 1 1 1s1-.4477153 1-1v-5zm3 2v2h2c.5522847 0 1-.4477153 1-1s-.4477153-1-1-1zm-4-1v-1h-.5c-.27614237 0-.5.2238576-.5.5s.22385763.5.5.5zm-3.5-9h1c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5z" fill-rule="evenodd"/></symbol><symbol id="icon-success" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm3.4860198 4.98163161-4.71802968 5.50657859-2.62834168-2.02300024c-.42862421-.36730544-1.06564993-.30775346-1.42283677.13301307-.35718685.44076653-.29927542 1.0958383.12934879 1.46314377l3.40735508 2.7323063c.42215801.3385221 1.03700951.2798252 1.38749189-.1324571l5.38450527-6.33394549c.3613513-.43716226.3096573-1.09278382-.115462-1.46437175-.4251192-.37158792-1.0626796-.31842941-1.4240309.11873285z" fill-rule="evenodd"/></symbol><symbol id="icon-table" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587l-4.0059107-.001.001.001h-1l-.001-.001h-5l.001.001h-1l-.001-.001-3.00391071.001c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm-11.0059107 5h-3.999v6.9941413c0 .5572961.44630695 1.0058587.99508929 1.0058587h3.00391071zm6 0h-5v8h5zm5.0059107-4h-4.0059107v3h5.001v1h-5.001v7.999l4.0059107.001c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-12.5049107 9c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.2238576.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.2238576-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.2238576.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.2238576-.5-.5s.22385763-.5.5-.5zm-6-2c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-1c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm12 0c.2761424 0 .5.22385763.5.5s-.2238576.5-.5.5h-2c-.2761424 0-.5-.22385763-.5-.5s.2238576-.5.5-.5zm-6 0c.27614237 0 .5.22385763.5.5s-.22385763.5-.5.5h-2c-.27614237 0-.5-.22385763-.5-.5s.22385763-.5.5-.5zm1.499-5h-5v3h5zm-6 0h-3.00391071c-.54871518 0-.99508929.44887827-.99508929 1.00585866v1.99414134h3.999z" fill-rule="evenodd"/></symbol><symbol id="icon-tick-circle" viewBox="0 0 24 24"><path d="m12 2c5.5228475 0 10 4.4771525 10 10s-4.4771525 10-10 10-10-4.4771525-10-10 4.4771525-10 10-10zm0 1c-4.97056275 0-9 4.02943725-9 9 0 4.9705627 4.02943725 9 9 9 4.9705627 0 9-4.0294373 9-9 0-4.97056275-4.0294373-9-9-9zm4.2199868 5.36606669c.3613514-.43716226.9989118-.49032077 1.424031-.11873285s.4768133 1.02720949.115462 1.46437175l-6.093335 6.94397871c-.3622945.4128716-.9897871.4562317-1.4054264.0971157l-3.89719065-3.3672071c-.42862421-.3673054-.48653564-1.0223772-.1293488-1.4631437s.99421256-.5003185 1.42283677-.1330131l3.11097438 2.6987741z" fill-rule="evenodd"/></symbol><symbol id="icon-tick" viewBox="0 0 16 16"><path d="m6.76799012 9.21106946-3.1109744-2.58349728c-.42862421-.35161617-1.06564993-.29460792-1.42283677.12733148s-.29927541 1.04903009.1293488 1.40064626l3.91576307 3.23873978c.41034319.3393961 1.01467563.2976897 1.37450571-.0948578l6.10568327-6.660841c.3613513-.41848908.3096572-1.04610608-.115462-1.4018218-.4251192-.35571573-1.0626796-.30482786-1.424031.11366122z" fill-rule="evenodd"/></symbol><symbol id="icon-update" viewBox="0 0 18 18"><path d="m1 13v1c0 .5522847.44771525 1 1 1h14c.5522847 0 1-.4477153 1-1v-1h-1v-10h-14v10zm16-1h1v2c0 1.1045695-.8954305 2-2 2h-14c-1.1045695 0-2-.8954305-2-2v-2h1v-9c0-.55228475.44771525-1 1-1h14c.5522847 0 1 .44771525 1 1zm-1 0v1h-4.5857864l-1 1h-2.82842716l-1-1h-4.58578644v-1h5l1 1h2l1-1zm-13-8h12v7h-12zm1 1v5h10v-5zm1 1h4v1h-4zm0 2h4v1h-4z" fill-rule="evenodd"/></symbol><symbol id="icon-upload" viewBox="0 0 18 18"><path d="m10.0046024 0c.5497429 0 1.3179837.32258606 1.707238.71184039l4.5763192 4.57631922c.3931386.39313859.7118404 1.16760135.7118404 1.71431368v8.98899651c0 1.1092806-.8945138 2.0085302-1.9940603 2.0085302h-12.01187942c-1.10128908 0-1.99406028-.8926228-1.99406028-1.9950893v-14.00982141c0-1.10185739.88743329-1.99508929 1.99961498-1.99508929zm0 1h-7.00498742c-.55709576 0-.99961498.44271433-.99961498.99508929v14.00982141c0 .5500396.44491393.9950893.99406028.9950893h12.01187942c.5463747 0 .9940603-.4506622.9940603-1.0085302v-8.98899651c0-.28393444-.2150684-.80332809-.4189472-1.0072069l-4.5763192-4.57631922c-.2038461-.20384606-.718603-.41894717-1.0001312-.41894717zm-1.85576936 4.14572769c.19483374-.19483375.51177826-.19377714.70556874.00001334l2.59099082 2.59099079c.1948411.19484112.1904373.51514474.0027906.70279143-.1932998.19329987-.5046517.19237083-.7001856-.00692852l-1.74638687-1.7800176v6.14827687c0 .2717771-.23193359.492096-.5.492096-.27614237 0-.5-.216372-.5-.492096v-6.14827641l-1.74627892 1.77990922c-.1933927.1971171-.51252214.19455839-.70016883.0069117-.19329987-.19329988-.19100584-.50899493.00277731-.70277808z" fill-rule="evenodd"/></symbol><symbol id="icon-video" viewBox="0 0 18 18"><path d="m16.0049107 2c1.1018574 0 1.9950893.89706013 1.9950893 2.00585866v9.98828264c0 1.1078052-.8926228 2.0058587-1.9950893 2.0058587h-14.00982141c-1.10185739 0-1.99508929-.8970601-1.99508929-2.0058587v-9.98828264c0-1.10780515.8926228-2.00585866 1.99508929-2.00585866zm0 1h-14.00982141c-.54871518 0-.99508929.44887827-.99508929 1.00585866v9.98828264c0 .5572961.44630695 1.0058587.99508929 1.0058587h14.00982141c.5487152 0 .9950893-.4488783.9950893-1.0058587v-9.98828264c0-.55729607-.446307-1.00585866-.9950893-1.00585866zm-8.30912922 2.24944486 4.60460462 2.73982242c.9365543.55726659.9290753 1.46522435 0 2.01804082l-4.60460462 2.7398224c-.93655425.5572666-1.69578148.1645632-1.69578148-.8937585v-5.71016863c0-1.05087579.76670616-1.446575 1.69578148-.89375851zm-.67492769.96085624v5.5750128c0 .2995102-.10753745.2442517.16578928.0847713l4.58452283-2.67497259c.3050619-.17799716.3051624-.21655446 0-.39461026l-4.58452283-2.67497264c-.26630747-.15538481-.16578928-.20699944-.16578928.08477139z" fill-rule="evenodd"/></symbol><symbol id="icon-warning" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-checklist-banner" viewBox="0 0 56.69 56.69"><path style="fill:none" d="M0 0h56.69v56.69H0z"/><clipPath id="b"><use xlink:href="#a" style="overflow:visible"/></clipPath><path d="M21.14 34.46c0-6.77 5.48-12.26 12.24-12.26s12.24 5.49 12.24 12.26-5.48 12.26-12.24 12.26c-6.76-.01-12.24-5.49-12.24-12.26zm19.33 10.66 10.23 9.22s1.21 1.09 2.3-.12l2.09-2.32s1.09-1.21-.12-2.3l-10.23-9.22m-19.29-5.92c0-4.38 3.55-7.94 7.93-7.94s7.93 3.55 7.93 7.94c0 4.38-3.55 7.94-7.93 7.94-4.38-.01-7.93-3.56-7.93-7.94zm17.58 12.99 4.14-4.81" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round"/><path d="M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5m14.42-5.2V4.86s0-2.93-2.93-2.93H4.13s-2.93 0-2.93 2.93v37.57s0 2.93 2.93 2.93h15.01M8.26 9.75H28.6M8.26 15.98H28.6m-20.34 6.2h12.5" style="clip-path:url(#b);fill:none;stroke:#01324b;stroke-width:2;stroke-linecap:round;stroke-linejoin:round"/></symbol><symbol id="icon-chevron-down" viewBox="0 0 16 16"><path d="m5.58578644 3-3.29289322-3.29289322c-.39052429-.39052429-.39052429-1.02368927 0-1.41421356s1.02368927-.39052429 1.41421356 0l4 4c.39052429.39052429.39052429 1.02368927 0 1.41421356l-4 4c-.39052429.39052429-1.02368927.39052429-1.41421356 0s-.39052429-1.02368927 0-1.41421356z" fill-rule="evenodd" transform="matrix(0 1 -1 0 11 1)"/></symbol><symbol id="icon-eds-i-arrow-right-medium" viewBox="0 0 24 24"><path d="m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z"/></symbol><symbol id="icon-eds-i-check-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z"/></symbol><symbol id="icon-eds-i-chevron-down-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h4.99912834v-4.99912834c0-.55276616.44386482-1.00087166 1-1.00087166.55228475 0 1 .44463086 1 1.00087166v4.99912834h4.9991283c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-4.9991283v4.9991283c0 .5527662-.44386482 1.0008717-1 1.0008717-.55228475 0-1-.4446309-1-1.0008717v-4.9991283h-4.99912834c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/></symbol><symbol id="icon-eds-i-chevron-down-small" viewBox="0 0 16 16"><path d="M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z"/></symbol><symbol id="icon-eds-i-chevron-right-medium" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/></symbol><symbol id="icon-eds-i-chevron-right-small" viewBox="0 0 10 10"><path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/></symbol><symbol id="icon-eds-i-chevron-up-medium" viewBox="0 0 16 16"><path d="m2.00087166 7h11.99825664c.5527662 0 1.0008717.44386482 1.0008717 1 0 .55228475-.4446309 1-1.0008717 1h-11.99825664c-.55276616 0-1.00087166-.44386482-1.00087166-1 0-.55228475.44463086-1 1.00087166-1z" fill-rule="evenodd"/></symbol><symbol id="icon-eds-i-close-medium" viewBox="0 0 16 16"><path d="m2.29679575 12.2772478c-.39658757.3965876-.39438847 1.0328109-.00062148 1.4265779.39651227.3965123 1.03246768.3934888 1.42657791-.0006214l4.27724782-4.27724787 4.2772478 4.27724787c.3965876.3965875 1.0328109.3943884 1.4265779.0006214.3965123-.3965122.3934888-1.0324677-.0006214-1.4265779l-4.27724787-4.2772478 4.27724787-4.27724782c.3965875-.39658757.3943884-1.03281091.0006214-1.42657791-.3965122-.39651226-1.0324677-.39348875-1.4265779.00062148l-4.2772478 4.27724782-4.27724782-4.27724782c-.39658757-.39658757-1.03281091-.39438847-1.42657791-.00062148-.39651226.39651227-.39348875 1.03246768.00062148 1.42657791l4.27724782 4.27724782z" fill-rule="evenodd"/></symbol><symbol id="icon-eds-i-copy-link" viewBox="0 0 24 24"><path fill-rule="evenodd" clip-rule="evenodd" d="M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z"/><path d="M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z"/><path d="M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z"/><path d="M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z"/></symbol><symbol id="icon-eds-i-download-medium" viewBox="0 0 16 16"><path d="m12.9975267 12.999368c.5467123 0 1.0024733.4478567 1.0024733 1.000316 0 .5563109-.4488226 1.000316-1.0024733 1.000316h-9.99505341c-.54671233 0-1.00247329-.4478567-1.00247329-1.000316 0-.5563109.44882258-1.000316 1.00247329-1.000316zm-4.9975267-11.999368c.55228475 0 1 .44497754 1 .99589209v6.80214418l2.4816273-2.48241149c.3928222-.39294628 1.0219732-.4006883 1.4030652-.01947579.3911302.39125371.3914806 1.02525073-.0001404 1.41699553l-4.17620792 4.17752758c-.39120769.3913313-1.02508144.3917306-1.41671995-.0000316l-4.17639421-4.17771394c-.39122513-.39134876-.39767006-1.01940351-.01657797-1.40061601.39113012-.39125372 1.02337105-.3931606 1.41951349.00310701l2.48183446 2.48261871v-6.80214418c0-.55001601.44386482-.99589209 1-.99589209z" fill-rule="evenodd"/></symbol><symbol id="icon-eds-i-info-filled-medium" viewBox="0 0 18 18"><path d="m9 0c4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9zm0 7h-1.5l-.11662113.00672773c-.49733868.05776511-.88337887.48043643-.88337887.99327227 0 .47338693.32893365.86994729.77070917.97358929l.1126697.01968298.11662113.00672773h.5v3h-.5l-.11662113.0067277c-.42082504.0488782-.76196299.3590206-.85696816.7639815l-.01968298.1126697-.00672773.1166211.00672773.1166211c.04887817.4208251.35902055.761963.76398144.8569682l.1126697.019683.11662113.0067277h3l.1166211-.0067277c.4973387-.0577651.8833789-.4804365.8833789-.9932723 0-.4733869-.3289337-.8699473-.7707092-.9735893l-.1126697-.019683-.1166211-.0067277h-.5v-4l-.00672773-.11662113c-.04887817-.42082504-.35902055-.76196299-.76398144-.85696816l-.1126697-.01968298zm0-3.25c-.69035594 0-1.25.55964406-1.25 1.25s.55964406 1.25 1.25 1.25 1.25-.55964406 1.25-1.25-.55964406-1.25-1.25-1.25z" fill-rule="evenodd"/></symbol><symbol id="icon-eds-i-institution-medium" viewBox="0 0 24 24"><g><path fill-rule="evenodd" clip-rule="evenodd" d="M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z"/></g></symbol><symbol id="icon-eds-i-mail-medium" viewBox="0 0 24 24"><path d="m19.462 0c1.413 0 2.538 1.184 2.538 2.619v12.762c0 1.435-1.125 2.619-2.538 2.619h-16.924c-1.413 0-2.538-1.184-2.538-2.619v-12.762c0-1.435 1.125-2.619 2.538-2.619zm.538 5.158-7.378 6.258a2.549 2.549 0 0 1 -3.253-.008l-7.369-6.248v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619zm-.538-3.158h-16.924c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516z"/></symbol><symbol id="icon-eds-i-menu-medium" viewBox="0 0 24 24"><path d="M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z"/></symbol><symbol id="icon-eds-i-search-medium" viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z"/></symbol><symbol id="icon-eds-i-user-single-medium" viewBox="0 0 24 24"><path d="M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z"/></symbol><symbol id="icon-eds-i-warning-filled-medium" viewBox="0 0 18 18"><path d="m9 11.75c.69035594 0 1.25.5596441 1.25 1.25s-.55964406 1.25-1.25 1.25-1.25-.5596441-1.25-1.25.55964406-1.25 1.25-1.25zm.41320045-7.75c.55228475 0 1.00000005.44771525 1.00000005 1l-.0034543.08304548-.3333333 4c-.043191.51829212-.47645714.91695452-.99654578.91695452h-.15973424c-.52008864 0-.95335475-.3986624-.99654576-.91695452l-.33333333-4c-.04586475-.55037702.36312325-1.03372649.91350028-1.07959124l.04148683-.00259031zm-.41320045 14c-4.97056275 0-9-4.0294373-9-9 0-4.97056275 4.02943725-9 9-9 4.9705627 0 9 4.02943725 9 9 0 4.9705627-4.0294373 9-9 9z" fill-rule="evenodd"/></symbol><symbol id="icon-expand-image" viewBox="0 0 18 18"><path d="m7.49754099 11.9178212c.38955542-.3895554.38761957-1.0207846-.00290473-1.4113089-.39324695-.3932469-1.02238878-.3918247-1.41130883-.0029047l-4.10273549 4.1027355.00055454-3.5103985c.00008852-.5603185-.44832171-1.006032-1.00155062-1.0059446-.53903074.0000852-.97857527.4487442-.97866268 1.0021075l-.00093318 5.9072465c-.00008751.553948.44841131 1.001882 1.00174994 1.0017946l5.906983-.0009331c.5539233-.0000875 1.00197907-.4486389 1.00206646-1.0018679.00008515-.5390307-.45026621-.9784332-1.00588841-.9783454l-3.51010549.0005545zm3.00571741-5.83449376c-.3895554.38955541-.3876196 1.02078454.0029047 1.41130883.393247.39324696 1.0223888.39182478 1.4113089.00290473l4.1027355-4.10273549-.0005546 3.5103985c-.0000885.56031852.4483217 1.006032 1.0015506 1.00594461.5390308-.00008516.9785753-.44874418.9786627-1.00210749l.0009332-5.9072465c.0000875-.553948-.4484113-1.00188204-1.0017499-1.00179463l-5.906983.00093313c-.5539233.00008751-1.0019791.44863892-1.0020665 1.00186784-.0000852.53903074.4502662.97843325 1.0058884.97834547l3.5101055-.00055449z" fill-rule="evenodd"/></symbol><symbol id="icon-github" viewBox="0 0 100 100"><path fill-rule="evenodd" clip-rule="evenodd" d="M48.854 0C21.839 0 0 22 0 49.217c0 21.756 13.993 40.172 33.405 46.69 2.427.49 3.316-1.059 3.316-2.362 0-1.141-.08-5.052-.08-9.127-13.59 2.934-16.42-5.867-16.42-5.867-2.184-5.704-5.42-7.17-5.42-7.17-4.448-3.015.324-3.015.324-3.015 4.934.326 7.523 5.052 7.523 5.052 4.367 7.496 11.404 5.378 14.235 4.074.404-3.178 1.699-5.378 3.074-6.6-10.839-1.141-22.243-5.378-22.243-24.283 0-5.378 1.94-9.778 5.014-13.2-.485-1.222-2.184-6.275.486-13.038 0 0 4.125-1.304 13.426 5.052a46.97 46.97 0 0 1 12.214-1.63c4.125 0 8.33.571 12.213 1.63 9.302-6.356 13.427-5.052 13.427-5.052 2.67 6.763.97 11.816.485 13.038 3.155 3.422 5.015 7.822 5.015 13.2 0 18.905-11.404 23.06-22.324 24.283 1.78 1.548 3.316 4.481 3.316 9.126 0 6.6-.08 11.897-.08 13.526 0 1.304.89 2.853 3.316 2.364 19.412-6.52 33.405-24.935 33.405-46.691C97.707 22 75.788 0 48.854 0z"/></symbol><symbol id="icon-springer-arrow-left"><path d="M15 7a1 1 0 000-2H3.385l2.482-2.482a.994.994 0 00.02-1.403 1.001 1.001 0 00-1.417 0L.294 5.292a1.001 1.001 0 000 1.416l4.176 4.177a.991.991 0 001.4.016 1 1 0 00-.003-1.42L3.385 7H15z"/></symbol><symbol id="icon-springer-arrow-right"><path d="M1 7a1 1 0 010-2h11.615l-2.482-2.482a.994.994 0 01-.02-1.403 1.001 1.001 0 011.417 0l4.176 4.177a1.001 1.001 0 010 1.416l-4.176 4.177a.991.991 0 01-1.4.016 1 1 0 01.003-1.42L12.615 7H1z"/></symbol><symbol id="icon-submit-open" viewBox="0 0 16 17"><path d="M12 0c1.10457 0 2 .895431 2 2v5c0 .276142-.223858.5-.5.5S13 7.276142 13 7V2c0-.512836-.38604-.935507-.883379-.993272L12 1H6v3c0 1.10457-.89543 2-2 2H1v8c0 .512836.38604.935507.883379.993272L2 15h6.5c.276142 0 .5.223858.5.5s-.223858.5-.5.5H2c-1.104569 0-2-.89543-2-2V5.828427c0-.530433.210714-1.039141.585786-1.414213L4.414214.585786C4.789286.210714 5.297994 0 5.828427 0H12Zm3.41 11.14c.250899.250899.250274.659726 0 .91-.242954.242954-.649606.245216-.9-.01l-1.863671-1.900337.001043 5.869492c0 .356992-.289839.637138-.647372.637138-.347077 0-.647371-.285256-.647371-.637138l-.001043-5.869492L9.5 12.04c-.253166.258042-.649726.260274-.9.01-.242954-.242954-.252269-.657731 0-.91l2.942184-2.951303c.250908-.250909.66127-.252277.91353-.000017L15.41 11.14ZM5 1.413 1.413 5H4c.552285 0 1-.447715 1-1V1.413ZM11 3c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Zm0 2c.276142 0 .5.223858.5.5s-.223858.5-.5.5H7.5c-.276142 0-.5-.223858-.5-.5s.223858-.5.5-.5H11Z" fill-rule="nonzero"/></symbol></svg>
</div>
</footer>




    


    

<div class="c-site-messages message u-hide u-hide-print c-site-messages--nature-briefing c-site-messages--nature-briefing-email-variant c-site-messages--nature-briefing-redesign-2020 sans-serif c-site-messages--nature-briefing-transres"
data-component-id="nature-briefing-banner"
data-component-expirydays="30"
data-component-trigger-scroll-percentage="15"
data-track="in-view"
data-track-action="in-view"
data-track-category="nature briefing"
data-track-label="Briefing banner visible: TranslationalResearch">

    
    <div class="c-site-messages__banner-large">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close"
        data-track="click"
        data-track-category="nature briefing"
        data-track-label="Briefing banner dismiss: TranslationalResearch">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__form-container">

            <div class="grid grid-12 last">
                <div class="grid grid-4">
                    <img alt="Nature Briefing: Translational Research" src="/static/images/logos/nature-briefing-logo-transres-white-1245a3c374.svg" width="213" height="40">
                    <p class="c-site-messages--nature-briefing__strapline extra-tight-line-height">Sign up for the <em>Nature Briefing: Translational Research</em> newsletter — top stories in biotechnology, drug discovery and pharma.</p>
                </div>
                <div class="grid grid-8 last">
                    <form action="https://www.nature.com/briefing/translational_research" method="post" data-location="banner" data-track="signup_nature_briefing_banner" data-track-action="transmit-form" data-track-category="nature briefing" data-track-label="Briefing banner submit: TranslationalResearch">
                        <input id="briefing-banner-signup-form-input-track-originReferralPoint" type="hidden" name="track_originReferralPoint" value="TransResBriefingBanner">
                        <input id="briefing-banner-signup-form-input-track-formType" type="hidden" name="track_formType" value="DirectEmailBanner">

                        <input type="hidden" value="false" name="gdpr_tick" id="gdpr_tick_banner">
                        <input type="hidden" value="false" name="marketing" id="marketing_input_banner">
                        <input type="hidden" value="false" name="marketing_tick" id="marketing_tick_banner">
                        <input type="hidden" value="TransResBriefingBanner" name="brieferEntryPoint" id="brieferEntryPoint_banner">

                        <label class="nature-briefing-banner__email-label" for="emailAddress">Email address</label>

                        <div class="nature-briefing-banner__email-wrapper">
                            <input class="nature-briefing-banner__email-input box-sizing text14" type="email" id="emailAddress" name="emailAddress" value="" placeholder="e.g. jo.smith@university.ac.uk" required data-test-element="briefing-emailbanner-email-input">
                            
                            <input type="hidden" value="true" name="N:translational_research" id="defaultNewsletter_banner">
                            <button type="submit" class="nature-briefing-banner__submit-button box-sizing text14" data-test-element="briefing-emailbanner-signup-button">Sign up</button>
                        </div>

                        <div class="nature-briefing-banner__checkbox-wrapper grid grid-12 last">
                            <input class="nature-briefing-banner__checkbox-checkbox" id="gdpr-briefing-banner-checkbox" type="checkbox" name="gdpr" value="true" data-test-element="briefing-emailbanner-gdpr-checkbox" required>
                            <label class="nature-briefing-banner__checkbox-label box-sizing text13 sans-serif block tighten-line-height" for="gdpr-briefing-banner-checkbox">I agree my information will be processed in accordance with the <em>Nature</em> and Springer Nature Limited <a href="https://www.nature.com/info/privacy">Privacy Policy</a>.</label>
                        </div>
                    </form>
                </div>
            </div>

        </div>

    </div>

    
    <div class="c-site-messages__banner-small">

        
<div class="c-site-messages__close-container">
    <button class="c-site-messages__close"
        data-track="click"
        data-track-category="nature briefing"
        data-track-label="Briefing banner dismiss: TranslationalResearch">
        <svg width="25px" height="25px" focusable="false" aria-hidden="true" viewBox="0 0 25 25" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
            <title>Close banner</title>
            <defs></defs>
            <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
                <rect opacity="0" x="0" y="0" width="25" height="25"></rect>
                <path d="M6.29679575,16.2772478 C5.90020818,16.6738354 5.90240728,17.3100587 6.29617427,17.7038257 C6.69268654,18.100338 7.32864195,18.0973145 7.72275218,17.7032043 L12,13.4259564 L16.2772478,17.7032043 C16.6738354,18.0997918 17.3100587,18.0975927 17.7038257,17.7038257 C18.100338,17.3073135 18.0973145,16.671358 17.7032043,16.2772478 L13.4259564,12 L17.7032043,7.72275218 C18.0997918,7.32616461 18.0975927,6.68994127 17.7038257,6.29617427 C17.3073135,5.89966201 16.671358,5.90268552 16.2772478,6.29679575 L12,10.5740436 L7.72275218,6.29679575 C7.32616461,5.90020818 6.68994127,5.90240728 6.29617427,6.29617427 C5.89966201,6.69268654 5.90268552,7.32864195 6.29679575,7.72275218 L10.5740436,12 L6.29679575,16.2772478 Z" fill="#ffffff"></path>
            </g>
        </svg>
        <span class="visually-hidden">Close</span>
    </button>
</div>


        <div class="c-site-messages__content text14">
            <span class="c-site-messages--nature-briefing__strapline strong">Get what matters in translational research, free to your inbox weekly.</span>
            <a class="nature-briefing__link text14 sans-serif"
                data-track="click"
                data-track-category="nature briefing"
                data-track-label="Small-screen banner CTA to site"
                data-test-element="briefing-banner-link"
                target="_blank"
                rel="noreferrer noopener"
                href="/briefing/translational-research/?brieferEntryPoint=TransResBriefingBanner">Sign up for Nature Briefing: Translational Research
            </a>
        </div>

    </div>

</div>

    




<noscript>
    <img hidden src="https://verify.nature.com/verify/nature.png" width="0" height="0" style="display: none" alt="">
</noscript>




<script src="//content.readcube.com/ping?doi=10.1038/s41598-025-03387-9&amp;format=js&amp;last_modified=2025-06-01" async></script>
</body>
</html>